Gregg C. Fonarow

Q: What Schools Are Affiliated With Gregg C. Fonarow

Gregg C. Fonarow is affiliated with the following schools: University of Texas Southwestern Medical Center, University of Pennsylvania, University of Calgary, Capital Medical University, Boston University, University of California, Los Angeles, Baylor College of Medicine, Massachusetts General Hospital, Duke University, Stanford University, Michigan State University, University of Colorado, Case Western Reserve University, University of Washington

Gregg C. Fonarow's AcademicInfluence.com Rankings

Gregg C. Fonarow

Philosophy

#1614

World Rank

#2890

Historical Rank

Logic

#250

World Rank

#528

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Gregg C. Fonarow Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gregg C. Fonarow's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (9561)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (5272)
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (3504)
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond (2010) (3237)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (2433)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. (2006) (2183)
Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association (2013) (2088)
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). (2005) (1974)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1845)
Epidemiology and risk profile of heart failure (2011) (1716)
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (2014) (1566)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1330)
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. (2005) (1245)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. (2006) (1221)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2018) (1054)
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. (2007) (1041)
Epidemiology and aetiology of heart failure (2016) (1026)
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. (2006) (976)
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (2005) (966)
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. (2010) (964)
Body mass index and mortality in heart failure: a meta-analysis. (2008) (790)
State of the art: Using natriuretic peptide levels in clinical practice (2008) (780)
The relationship between obesity and mortality in patients with heart failure. (2001) (778)
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. (2006) (738)
High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. (2007) (719)
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). (2005) (704)
Cardiac troponin and outcome in acute heart failure. (2008) (679)
Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes (2012) (672)
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. (2004) (670)
Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL (2004) (666)
Rehospitalization for heart failure: problems and perspectives. (2013) (608)
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. (2002) (604)
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010) (596)
Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure (2003) (592)
Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment (2003) (581)
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. (2018) (580)
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. (2013) (572)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (560)
Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. (1997) (555)
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. (2017) (554)
Cardiorenal interactions: insights from the ESCAPE trial. (2008) (552)
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. (2007) (547)
Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). (2001) (537)
Association between performance measures and clinical outcomes for patients hospitalized with heart failure. (2007) (535)
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2008) (531)
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (529)
Effect of nesiritide in patients with acute decompensated heart failure. (2011) (516)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (505)
Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction (2008) (502)
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. (2020) (501)
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes (2011) (498)
Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack (2009) (492)
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. (2003) (486)
Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis (2009) (482)
Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. (2014) (477)
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. (2007) (473)
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. (2021) (468)
Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. (2008) (467)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (467)
Systematic review of the incidence of sudden cardiac death in the United States. (2011) (465)
Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. (2016) (463)
An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. (2007) (460)
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. (2016) (445)
Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States (2014) (415)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. (2018) (409)
Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2008) (405)
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). (2007) (403)
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. (2010) (397)
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure (2021) (395)
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. (2007) (393)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention (2014) (389)
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. (2013) (388)
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. (2000) (387)
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) (2010) (381)
Relation of loop diuretic dose to mortality in advanced heart failure. (2006) (381)
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. (2004) (376)
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. (2009) (376)
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (372)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association (2017) (367)
A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines Program (2010) (366)
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry. (2016) (360)
Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. (2002) (359)
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. (2014) (348)
Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative (2011) (343)
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation (2015) (343)
Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. (2004) (341)
Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up (2005) (340)
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. (2003) (340)
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. (2013) (338)
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. (2007) (336)
Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis (2005) (329)
Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure (2017) (328)
The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. (2003) (324)
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. (2010) (324)
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. (1997) (323)
Albumin levels predict survival in patients with systolic heart failure. (2008) (317)
Developing therapies for heart failure with preserved ejection fraction: current state and future directions. (2014) (317)
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. (2009) (313)
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. (2000) (311)
The obesity paradox in the elderly: potential mechanisms and clinical implications. (2009) (297)
Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia (2008) (295)
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. (2005) (288)
Pathophysiologic targets in the early phase of acute heart failure syndromes. (2005) (286)
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. (2015) (285)
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. (2014) (285)
Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. (2005) (283)
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. (2009) (279)
Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke (2010) (268)
Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). (2007) (267)
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials (2020) (267)
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. (2009) (265)
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. (2021) (263)
Use of aldosterone antagonists in heart failure. (2009) (263)
High-density lipoprotein function recent advances. (2005) (262)
Obesity and the obesity paradox in heart failure. (2014) (255)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (250)
Risk Score for In-Hospital Ischemic Stroke Mortality Derived and Validated Within the Get With The Guidelines–Stroke Program (2010) (249)
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction. (2019) (246)
Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction: Data From the National Registry of Myocardial Infarction 3 (2001) (242)
Secondary preventive medication persistence and adherence 1 year after stroke (2011) (239)
Improving survival for patients with atrial fibrillation and advanced heart failure. (1996) (238)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (235)
B-type natriuretic peptide levels in obese patients with advanced heart failure. (2006) (235)
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. (2005) (235)
American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers (2013) (234)
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. (1997) (233)
Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches (2017) (232)
Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients: Results From Heart Failure and a Controlled Trial to Investigate Outcomes of Exercise Training (2012) (232)
Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. (1995) (230)
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (2018) (229)
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. (2014) (229)
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. (2015) (225)
Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. (2012) (224)
Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke (2010) (223)
Use and Outcomes Associated With Bridging During Anticoagulation Interruptions in Patients With Atrial Fibrillation (2015) (219)
Regional Brain Gray Matter Loss in Heart Failure. (2003) (215)
Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. (1998) (214)
In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. (2011) (212)
A Call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): A National Effort to Promote Timely Clinical Feedback and Support Continuous Quality Improvement for Acute Myocardial Infarction (2009) (212)
Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population‐Based Study (2014) (210)
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. (2011) (210)
The paradox of dysfunctional high-density lipoprotein (2007) (206)
Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. (2016) (206)
Paraoxonase and coronary heart disease. (2002) (205)
Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. (1999) (204)
Emergency Medical Service Hospital Prenotification Is Associated With Improved Evaluation and Treatment of Acute Ischemic Stroke (2012) (203)
Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways (2004) (201)
Impact of left ventricular cavity size on survival in advanced heart failure. (1993) (201)
The vulnerable phase after hospitalization for heart failure (2015) (200)
Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator: Findings From Get With The Guidelines–Stroke (2011) (199)
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. (2009) (199)
Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF (2008) (198)
Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). (2006) (198)
Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator (2012) (194)
Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients With Ischemic Stroke (2010) (193)
Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. (2010) (192)
The “Golden Hour” and Acute Brain Ischemia: Presenting Features and Lytic Therapy in >30 000 Patients Arriving Within 60 Minutes of Stroke Onset (2010) (192)
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. (2004) (191)
Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. (2005) (190)
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. (2013) (189)
Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. (2015) (187)
Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry. (2018) (187)
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. (2013) (186)
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2007) (186)
Discharge to a Skilled Nursing Facility and Subsequent Clinical Outcomes Among Older Patients Hospitalized for Heart Failure (2011) (184)
Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1993) (183)
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. (2008) (182)
Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. (2019) (181)
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. (1992) (178)
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims (2011) (176)
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). (2015) (175)
Improvement in exercise capacity of candidates awaiting heart transplantation. (1995) (175)
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). (2008) (173)
Home monitoring for heart failure management. (2012) (172)
The Prevention of Hospital Readmissions in Heart Failure. (2016) (169)
Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality (2018) (167)
Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. (2008) (167)
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. (2016) (166)
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. (2012) (165)
Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. (2009) (163)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary. (2006) (162)
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) (2015) (162)
Quality of Care in Women With Ischemic Stroke in the GWTG Program (2009) (160)
Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. (1994) (159)
Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score. (2011) (158)
Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation (2017) (157)
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. (2012) (157)
Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. (2016) (156)
Epidemiology and risk stratification in acute heart failure. (2008) (156)
Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke (2012) (155)
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD‐AF, ORBIT‐AF I, and ORBIT‐AF II registries (2017) (154)
Nutritional and anti-inflammatory interventions in chronic heart failure. (2008) (154)
Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report from the ADHERE Registry (2005) (154)
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. (2008) (153)
Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure. (2016) (152)
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. (2014) (152)
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. (2011) (152)
Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. (2008) (151)
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. (2007) (151)
An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. (2006) (149)
Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. (2013) (149)
Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association (2017) (148)
Association between direct measures of body composition and prognostic factors in chronic heart failure. (2010) (146)
Racial and Ethnic Differences in the Treatment of Acute Myocardial Infarction: Findings From the Get With The Guidelines-Coronary Artery Disease Program (2010) (145)
Patterns of Emergency Medical Services Use and Its Association With Timely Stroke Treatment: Findings From Get With the Guidelines-Stroke (2013) (144)
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. (2017) (143)
Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. (2016) (143)
Compliance Behaviors of Elderly Patients With Advanced Heart Failure (2003) (142)
Effects of a home-based exercise program on clinical outcomes in heart failure. (2007) (142)
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. (2009) (142)
Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. (2010) (141)
Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward (2010) (141)
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. (2004) (141)
Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. (2012) (140)
Early vasoactive drugs improve heart failure outcomes. (2009) (140)
Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. (2016) (139)
Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry. (2015) (137)
Targeting myocardial substrate metabolism in heart failure: potential for new therapies (2012) (137)
Cardiorenal syndrome: pathophysiology and potential targets for clinical management (2013) (137)
ACCF/AHA Clinical Practice Guideline Methodology Summit Report: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (136)
Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II) (2018) (136)
Trends in death attributed to heart failure over the past two decades in Europe (2012) (133)
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. (2013) (132)
Micronutrient deficiencies an unmet need in heart failure. (2009) (132)
Times From Symptom Onset to Hospital Arrival in the Get With The Guidelines–Stroke Program 2002 to 2009: Temporal Trends and Implications (2012) (132)
Temporal Trends in Patient Characteristics and Treatment With Intravenous Thrombolysis Among Acute Ischemic Stroke Patients at Get With the Guidelines–Stroke Hospitals (2013) (131)
Self-Study from Web-Based and Printed Guideline Materials (2000) (130)
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. (2009) (129)
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. (2012) (128)
Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. (2012) (128)
Hospital-Level Variation in Mortality and Rehospitalization for Medicare Beneficiaries With Acute Ischemic Stroke (2011) (128)
An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement program. (2008) (128)
Quality of care for atrial fibrillation among patients hospitalized for heart failure. (2009) (128)
Why are acute ischemic stroke patients not receiving IV tPA? (2016) (126)
Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction. (2012) (125)
Get With The Guidelines Program Participation, Process of Care, and Outcome for Medicare Patients Hospitalized With Heart Failure (2012) (124)
Obesity and the Obesity Paradox in Heart Failure. (2018) (124)
Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review (2018) (124)
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. (2009) (124)
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. (2016) (124)
The NCDR ACTION Registry–GWTG: transforming contemporary acute myocardial infarction clinical care (2010) (123)
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. (2004) (123)
Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease (2017) (121)
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. (2014) (120)
Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score (2019) (120)
Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database (2016) (119)
Impact of Early Initiation of Intravenous Therapy for Acute Decompensated Heart Failure on Outcomes in ADHERE (2006) (119)
Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. (2010) (118)
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. (2007) (118)
Soluble guanylate cyclase: a potential therapeutic target for heart failure (2013) (118)
Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure: Have the Previously Observed Sex and Racial Disparities Changed Over Time? (2012) (117)
Incremental Value of Clinical Data Beyond Claims Data in Predicting 30-Day Outcomes After Heart Failure Hospitalization (2011) (116)
Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. (2010) (116)
Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review. (2019) (115)
Racial and survival paradoxes in chronic kidney disease (2007) (115)
Muscle mechanoreceptor sensitivity in heart failure. (2004) (115)
Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?: Findings From ASCEND-HF (2013) (115)
Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. (2015) (114)
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2017) (114)
Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry. (2017) (112)
Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). (2009) (112)
Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population (2017) (111)
Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). (2009) (111)
Impact of Time of Presentation on the Care and Outcomes of Acute Myocardial Infarction (2008) (111)
Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2007) (111)
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). (2014) (111)
Therapeutic targets in heart failure: refocusing on the myocardial interstitium. (2014) (111)
Off-Hour Admission and In-Hospital Stroke Case Fatality in the Get With The Guidelines-Stroke Program (2009) (110)
Dietary Sodium Intake in Heart Failure (2012) (109)
Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (2013) (108)
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2017) (107)
Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. (2009) (107)
Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry (2013) (106)
Synthesizing Lessons Learned From Get With The Guidelines: The Value of Disease-Based Registries in Improving Quality and Outcomes (2013) (106)
Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines–Heart Failure Registry (2018) (106)
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. (2009) (106)
Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. (2014) (106)
Genetic Basis of Atherosclerosis: Part II: Clinical Implications (2004) (104)
Exaggerated muscle mechanoreflex control of reflex renal vasoconstriction in heart failure. (2001) (104)
Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome: Findings From the CCC Project (2019) (104)
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term OutcomesClinical Perspective (2011) (104)
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (103)
Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study (2011) (103)
National Survey of Hospital Strategies to Reduce Heart Failure Readmissions: Findings From the Get With the Guidelines-Heart Failure Registry (2012) (103)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (103)
Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. (2013) (103)
Representativeness of the Get With The Guidelines–Stroke Registry: Comparison of Patient and Hospital Characteristics Among Medicare Beneficiaries Hospitalized With Ischemic Stroke (2012) (103)
Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart Failure: An Analysis of Get With The Guidelines–Heart Failure (2012) (103)
Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry. (2016) (102)
Review of current and investigational pharmacologic agents for acute heart failure syndromes. (2007) (102)
Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction (2017) (101)
National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity (2017) (101)
Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. (2000) (100)
The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection. (1994) (100)
Process of Care Performance Measures and Long-Term Outcomes in Patients Hospitalized With Heart Failure (2010) (99)
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE‐HF (2012) (99)
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF). (2017) (99)
Feasibility and Safety of Autologous Myoblast Transplantation in Patients with Ischemic Cardiomyopathy (2005) (98)
The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. (2011) (98)
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). (2013) (98)
Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis. (2016) (97)
Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement. (2017) (97)
Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure: implications for 'triggering' adverse cardiac events. (1997) (97)
Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials (2017) (96)
Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure (2008) (96)
Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. (2015) (96)
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. (2008) (96)
Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients. (2002) (95)
Brain axonal and myelin evaluation in heart failure (2011) (95)
Heart failure performance measures and outcomes: real or illusory gains. (2009) (94)
Is coping style linked to emotional states in heart failure patients? (2004) (94)
COVID-19 Pandemic: Cardiovascular Complications and Future Implications (2020) (94)
ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health Records: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (2011) (93)
Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week. (2019) (93)
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. (2017) (92)
Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization. (2019) (92)
Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. (2012) (91)
QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. (2013) (91)
Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. (2005) (91)
Coenzyme Q10 and Heart Failure: A State-of-the-Art Review (2016) (91)
Exaggerated renal vasoconstriction during exercise in heart failure patients. (2000) (90)
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program. (2008) (90)
Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. (2011) (90)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (90)
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. (2015) (89)
A Risk Score for In‐Hospital Death in Patients Admitted With Ischemic or Hemorrhagic Stroke (2013) (89)
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (2018) (89)
Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure. (2009) (89)
High density associated enzymes: their role in vascular biology. (1998) (88)
Updating the Model for Risk-Standardizing Survival for In-Hospital Cardiac Arrest to Facilitate Hospital Comparisons (2013) (88)
Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. (2011) (88)
Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. (2010) (88)
Drip and Ship Thrombolytic Therapy for Acute Ischemic Stroke: Use, Temporal Trends, and Outcomes (2015) (88)
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF (2012) (88)
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure. (2016) (88)
Epidemiology of dialysis patients and heart failure patients. (2006) (87)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2015) (87)
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program. (2007) (87)
Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target Stroke (2017) (87)
Associations Between Outpatient Heart Failure Process-of-Care Measures and Mortality (2011) (86)
Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post‐Thrombolysis: Findings From Get With The Guidelines‐Stroke (2015) (86)
Use of two recipient lists for adults requiring heart transplantation. (2003) (85)
Representativeness of a National Heart Failure Quality-of-Care Registry: Comparison of OPTIMIZE-HF and Non–OPTIMIZE-HF Medicare Patients (2009) (85)
Emotional well-being of heart failure patients and their caregivers. (2002) (85)
Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. (2014) (85)
The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care (2017) (84)
Regional Variation in the Incidence and Outcomes of In-Hospital Cardiac Arrest in the United States (2015) (84)
In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. (2001) (84)
Depression in patients with heart failure. (2005) (83)
Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. (2009) (83)
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program (2009) (83)
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. (2010) (82)
Rationale and design of the multicentre, randomized, double‐blind, placebo‐controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) (2011) (82)
Mammillary bodies and fornix fibers are injured in heart failure (2009) (82)
Risks and Benefits of Anticoagulation in Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry (2013) (82)
Anti-Inflammatory Properties of HDL (2004) (82)
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). (2008) (82)
The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider. (2017) (80)
Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke (2017) (80)
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. (2021) (80)
Strategies Used by Hospitals to Improve Speed of Tissue-Type Plasminogen Activator Treatment in Acute Ischemic Stroke (2014) (79)
Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States (2016) (79)
Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). (2014) (79)
Development of Stroke Performance Measures: Definitions, Methods, and Current Measures (2010) (79)
Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles. (2000) (79)
Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy (2007) (78)
Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines. (2011) (78)
Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study. (2008) (78)
Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations (2014) (78)
Reduced Body Weight and Adiposity With a High-Protein Diet Improves Functional Status, Lipid Profiles, Glycemic Control, and Quality of Life in Patients With Heart Failure: A Feasibility Study (2009) (77)
Improving patient satisfaction through physician education, feedback, and incentives. (2015) (77)
High-density lipoprotein: Is it always atheroprotective? (2006) (77)
Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives. (2008) (77)
Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. (2015) (77)
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. (2012) (77)
Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program (2016) (76)
Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease: Results From the Get With the Guidelines Program (2009) (76)
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. (2016) (76)
Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy: Report From IMPROVE HF (2010) (76)
Non‐ST‐Elevation Myocardial Infarction in the United States: Contemporary Trends in Incidence, Utilization of the Early Invasive Strategy, and In‐Hospital Outcomes (2014) (76)
Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures (2015) (76)
Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed. (2021) (76)
Workplace Wellness Recognition for Optimizing Workplace Health: A Presidential Advisory From the American Heart Association (2015) (75)
Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure). (2011) (75)
Quality of Care and Outcomes for In-Hospital Ischemic Stroke: Findings From the National Get With The Guidelines-Stroke (2014) (75)
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance. (2009) (74)
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic StrokeClinical Perspective (2011) (74)
Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. (2010) (74)
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis (2017) (74)
Lack of Concordance Between Empirical Scores and Physician Assessments of Stroke and Bleeding Risk in Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry (2014) (74)
The Hospital Readmissions Reduction Program—learning from failure of a healthcare policy (2018) (74)
Interscan variation in coronary artery calcium quantification in a large asymptomatic patient population. (2000) (74)
Quality of Care and Outcomes in Patients With Diabetes Hospitalized With Ischemic Stroke: Findings From Get With the Guidelines–Stroke (2010) (73)
Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure—Reply (2005) (73)
Beta Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Is Associated with Decreased Th1/Th2 Cytokine Ratios and Inflammatory Cytokine Production in Patients with Chronic Heart Failure (2004) (73)
Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States (2019) (73)
Reduced regional cerebral blood flow in patients with heart failure (2017) (72)
Atherosclerosis Secondary Prevention Performance Measures After Coronary Bypass Graft Surgery Compared With Percutaneous Catheter Intervention and Nonintervention Patients in the Get With the Guidelines Database (2007) (72)
The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. (2007) (72)
Heart failure disease management programs: a cost-effectiveness analysis. (2008) (72)
Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization (2015) (72)
Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes. (2016) (71)
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. (2009) (71)
Concomitant diabetes mellitus and heart failure. (2015) (71)
Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF). (2013) (71)
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE‐US registry and ADHERE‐International registry (2011) (71)
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE‐HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) * (2008) (71)
Cachexia: common, deadly, with an urgent need for precise definition and new therapies. (2008) (71)
Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients With Ischemic Stroke Receiving Thrombolytic Therapy (2014) (71)
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure (2010) (71)
Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China (2016) (71)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Reverse Epidemiology beyond Dialysis Patients: Chronic Heart Failure, Geriatrics, Rheumatoid Arthritis, COPD, and AIDS (2007) (70)
Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group. (2015) (70)
Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart Failure: Findings From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) (2008) (70)
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. (2012) (69)
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. (2007) (69)
Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America. (2015) (69)
Target heart failure populations for newer therapies. (1995) (69)
Translating Evidence Into Practice: A Decade of Efforts by the American Heart Association/American Stroke Association to Reduce Death and Disability Due to Stroke: A Presidential Advisory From the American Heart Association/American Stroke Association (2010) (69)
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? (2010) (69)
Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. (2016) (69)
Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement (2017) (67)
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. (2013) (67)
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. (2013) (67)
Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial (2018) (67)
Smoker's Paradox in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (2016) (66)
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. (2009) (66)
International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries☆☆☆ (2014) (66)
Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. (2008) (66)
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. (2012) (66)
Paradoxical Association of Smoking With In‐Hospital Mortality Among Patients Admitted With Acute Ischemic Stroke (2013) (66)
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. (2020) (65)
Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. (1998) (65)
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction (2018) (65)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry. (2014) (65)
Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. (2019) (65)
Trends in Coronary Angiography, Revascularization, and Outcomes of Cardiogenic Shock Complicating Non-ST-Elevation Myocardial Infarction. (2016) (64)
Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF). (2009) (64)
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. (2013) (64)
The confounding issue of comorbid renal insufficiency. (2006) (64)
Regional hippocampal damage in heart failure (2015) (64)
Trends in Endovascular Therapy and Clinical Outcomes Within the Nationwide Get With The Guidelines-Stroke Registry (2015) (64)
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standar (2012) (63)
Utility of Socioeconomic Status in Predicting 30-Day Outcomes After Heart Failure Hospitalization (2015) (63)
The Need for Multiple Measures of Hospital Quality: Results From the Get With The Guidelines–Heart Failure Registry of the American Heart Association (2011) (63)
Racial and Ethnic Differences in Outcomes in Older Patients With Acute Ischemic Stroke (2013) (63)
Mode and mechanisms of death after orthotopic heart transplantation. (2009) (62)
Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction. (2014) (62)
Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study (2015) (62)
Relationships between emerging measures of heart failure processes of care and clinical outcomes. (2010) (61)
Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure. (2005) (61)
Predictors of adherence to performance measures in patients with acute myocardial infarction. (2013) (61)
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. (2013) (61)
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. (2013) (61)
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure (2013) (61)
Combined neprilysin and renin–angiotensin system inhibition in heart failure with reduced ejection fraction: a meta‐analysis (2016) (60)
Cost‐Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System (2017) (60)
Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period. (2016) (60)
Sexuality of patients with advanced heart failure and their spouses or partners. (1999) (60)
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. (2017) (60)
Temporal Trends in Treatment and Outcomes for Advanced Heart Failure With Reduced Ejection Fraction From 1993–2010: Findings From a University Referral Center (2013) (60)
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. (2014) (60)
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). (2010) (60)
Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter? (2020) (59)
Contemporary Trends and Predictors of Postacute Service Use and Routine Discharge Home After Stroke (2015) (59)
Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study. (2019) (59)
Global variation in clinical profile, management, and post‐discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial (2015) (59)
Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study. (2010) (59)
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure (2018) (59)
Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. (2014) (58)
Trends in 30- and 90-Day Readmission Rates for Heart Failure (2021) (58)
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure (2017) (58)
Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. (2007) (58)
Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries (2016) (57)
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons (2015) (57)
A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. (2008) (57)
Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease. (2019) (57)
Home-Time After Discharge Among Patients Hospitalized With Heart Failure. (2018) (57)
Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure (2019) (57)
In‐hospital worsening heart failure (2015) (57)
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. (2008) (57)
Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. (2020) (56)
The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes. (2009) (56)
Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new‐onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT‐AF II) (2017) (56)
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions (2014) (56)
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial. (2013) (56)
Sex and Race/Ethnicity–Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults (2016) (55)
Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy. (2015) (55)
Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure. (2020) (55)
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. (2013) (55)
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017. (2021) (55)
Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days. (2013) (55)
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study (2017) (55)
In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization (2014) (54)
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. (2009) (54)
The treatment targets in acute decompensated heart failure. (2001) (54)
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial (2019) (54)
Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke (2018) (54)
Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack (2015) (54)
Association between obesity and health-related quality of life in patients with coronary artery disease (2010) (54)
Seasonal and circadian variations of acute myocardial infarction: Findings from the Get With The Guidelines–Coronary Artery Disease (GWTG‐CAD) program (2017) (54)
Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction. (2015) (54)
Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project (2018) (54)
Stroke Outcomes Measures Must Be Appropriately Risk Adjusted to Ensure Quality Care of Patients: A Presidential Advisory From the American Heart Association/American Stroke Association (2014) (54)
Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure. (2004) (53)
Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. (2015) (53)
Racial/Ethnic and Sex Differences in Emergency Medical Services Transport Among Hospitalized US Stroke Patients: Analysis of the National Get With The Guidelines–Stroke Registry (2015) (53)
Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database. (2011) (53)
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. (2009) (53)
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons. (2015) (52)
hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation. (2003) (52)
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. (2016) (52)
Secondary prevention after ischemic stroke or transient ischemic attack. (2014) (52)
Hypoalbuminaemia and incident heart failure in older adults (2011) (52)
Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry. (2018) (52)
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? (2011) (52)
Payment source, quality of care, and outcomes in patients hospitalized with heart failure. (2011) (52)
Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines--Stroke. (2013) (52)
The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database. (2016) (52)
Medication dosing for heart failure with reduced ejection fraction — opportunities and challenges (2018) (52)
Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. (2016) (52)
Pharmacologic therapies for acutely decompensated heart failure. (2002) (52)
Length of hospital stay and 30‐day readmission following heart failure hospitalization: insights from the EVEREST trial (2015) (51)
Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. (2008) (51)
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. (2009) (51)
Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry (2017) (51)
Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis (2017) (51)
Resting Heart Rate and Risk of Incident Heart Failure: Three Prospective Cohort Studies and a Systematic Meta‐Analysis (2015) (51)
Quality of Care and Outcomes in Women Hospitalized for Heart Failure (2011) (51)
"Targeting the Heart" in Heart Failure: Myocardial Recovery in Heart Failure With Reduced Ejection Fraction. (2015) (51)
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2016) (50)
Stroke Quality Metrics: Systematic Reviews of the Relationships to Patient-Centered Outcomes and Impact of Public Reporting (2012) (50)
Recent Trends in Early Outcome of Adult Patients after Heart Transplantation: A Single‐institution Review of 251 Transplants Using Standard Donor Organs 1 (2002) (50)
Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel. (2021) (50)
Angiotensin receptor blockers and outcomes in real‐world older patients with heart failure and preserved ejection fraction: a propensity‐matched inception cohort clinical effectiveness study (2012) (50)
Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). (2013) (50)
Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation (2019) (50)
Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection Fraction: Findings From Get With The Guidelines–Heart Failure (2012) (50)
The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations. (2019) (50)
Isolated Diastolic Hypotension and Incident Heart Failure in Older Adults (2011) (50)
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). (2013) (49)
Use of hearts transplanted from donors with atraumatic intracranial bleeds. (2001) (49)
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis (2017) (49)
Heart rate is associated with progression of atrial fibrillation, independent of rhythm (2015) (49)
Sex and Racial Disparities in Cardiac Rehabilitation Referral at Hospital Discharge and Gaps in Long‐Term Mortality (2018) (49)
Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry. (2013) (49)
Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. (2010) (49)
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. (2011) (49)
Characteristics and outcomes in African American patients with decompensated heart failure. (2008) (49)
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. (2013) (48)
Guideline Adherence After ST-Segment Elevation Versus Non-ST Segment Elevation Myocardial Infarction (2012) (48)
Association of Chronic Renal Insufficiency With In-Hospital Outcomes After Percutaneous Coronary Intervention (2015) (48)
Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes (2017) (48)
Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. (2015) (48)
Kidney Function and Outcomes in Patients Hospitalized with Heart Failure. (2021) (48)
Total cholesterol levels and mortality risk in nonischemic systolic heart failure. (2006) (48)
Impairment of activities of daily living and incident heart failure in community‐dwelling older adults (2012) (47)
Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure. (2000) (47)
Renal Dysfunction Is Associated With Poststroke Discharge Disposition and In-Hospital Mortality: Findings From Get With The Guidelines–Stroke (2017) (47)
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden) (2021) (47)
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. (2009) (47)
The alternate recipient list for heart transplantation: does it work? (1997) (47)
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. (2015) (47)
Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review. (2004) (47)
Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives. (2013) (47)
Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke (2016) (46)
Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. (2015) (46)
Differential prognostic effect of systolic blood pressure on mortality according to left‐ventricular function in patients with acute heart failure (2010) (46)
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2020) (46)
Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke (2010) (46)
Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure. (2013) (46)
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non–Vitamin K Antagonist Oral Anticoagulants Before Stroke (2017) (46)
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain. (2017) (46)
Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure (2017) (46)
Comparison of Composite Measure Methodologies for Rewarding Quality of Care: An Analysis From the American Heart Association's Get With The Guidelines Program (2011) (46)
Use of Tissue-Type Plasminogen Activator Before and After Publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke (2012) (46)
Obesity and the obesity paradox in heart failure. (2015) (46)
Hemoconcentration-guided diuresis in heart failure. (2014) (46)
Reduced Regional Brain Cortical Thickness in Patients with Heart Failure (2015) (46)
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. (2016) (45)
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure. (2016) (45)
Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke (2017) (45)
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study. (2015) (45)
Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). (2008) (45)
Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure. (2010) (45)
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). (2010) (45)
Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. (2013) (44)
Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. (2011) (44)
Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart FailureCLINICAL PERSPECTIVE (2008) (44)
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. (2010) (44)
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. (2020) (44)
Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. (2011) (44)
Contemporary Sex-Based Differences by Age in Presenting Characteristics, Use of an Early Invasive Strategy, and Inhospital Mortality in Patients With Non–ST-Segment–Elevation Myocardial Infarction in the United States (2018) (44)
Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States (2018) (44)
Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient‐Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2015) (44)
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. (2016) (44)
Translating Research Into Practice for Healthcare Providers: The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke (2008) (44)
Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure (2013) (44)
Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient—part 1 (2009) (44)
Validity of pedometers for measuring exercise adherence in heart failure patients. (2005) (43)
Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. (2003) (43)
Strategies and opportunities for drug development in heart failure. (2013) (43)
Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing an invasive strategy: a meta-analysis of randomized clinical trials. (2010) (43)
Trends in prevalence of comorbidities in heart failure clinical trials (2020) (43)
Get With The Guidelines AFIB: Novel Quality Improvement Registry for Hospitalized Patients With Atrial Fibrillation (2014) (43)
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study (2015) (43)
Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure. (2012) (43)
Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score. (2019) (43)
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry. (2020) (42)
Four-Variable Risk Model in Men and Women With Heart Failure (2014) (42)
Impact of Insurance Status on Outcomes and Use of Rehabilitation Services in Acute Ischemic Stroke: Findings From Get With The Guidelines‐Stroke (2016) (42)
Long‐Term Mortality of Older Patients With Acute Myocardial Infarction Treated in US Clinical Practice (2018) (42)
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2009) (42)
Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes. (2014) (42)
Extended comparison of quality of life between stable heart failure patients and heart transplant recipients. (1994) (42)
Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States (2017) (42)
Azygos Vein Lead Implantation: (2004) (42)
Patient factors associated with quality of life in atrial fibrillation. (2016) (42)
Factors associated with variations in hospital expenditures for acute heart failure in the United States. (2015) (41)
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines–Heart Failure Program (2017) (41)
The impact of obesity on survival in patients with heart failure. (2002) (41)
Educational needs of patients with advanced heart failure and their caregivers. (2001) (41)
Postmarketing Adverse Events Related to the CardioMEMS HF System (2017) (41)
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF) (2015) (41)
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). (2010) (41)
Assessing stroke patients for rehabilitation during the acute hospitalization: findings from the get with the guidelines-stroke program. (2013) (41)
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction. (2021) (41)
Patterns, Predictors, Variations, and Temporal Trends in Emergency Medical Service Hospital Prenotification for Acute Ischemic Stroke (2012) (41)
Relationship of Race/Ethnicity With Door‐to‐Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST‐Elevation Myocardial Infarction: Findings From Get With the Guidelines–Coronary Artery Disease (2013) (40)
Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts. (2006) (40)
Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002‐2011 (2017) (40)
Impact of obesity on quality of life and depression in patients with heart failure (2006) (40)
Trends in Clinical, Demographic, and Biochemical Characteristics of Patients With Acute Myocardial Infarction From 2003 to 2008: A Report From the American Heart Association Get With The Guidelines Coronary Artery Disease Program (2012) (40)
Change the management of patients with heart failure: Rationale and design of the CHAMP‐HF registry (2017) (40)
Are Quality Improvements in the Get With The Guidelines-Stroke Program Related to Better Care or Better Data Documentation? (2011) (40)
Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. (2017) (40)
Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. (2006) (40)
Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI. (2013) (40)
A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure. (2015) (39)
Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure. (2013) (39)
Heart failure disease management programs: not a class effect. (2004) (39)
Cardiovascular implications of COVID-19 versus influenza infection: a review (2020) (39)
Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). (2010) (39)
Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure. (2006) (39)
Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction. (2013) (39)
Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis. (2014) (39)
Quality of care and outcomes in acute decompensated heart failure: The ADHERE registry (2004) (39)
Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry (2018) (39)
Aberrant central nervous system responses to the Valsalva maneuver in heart failure. (2007) (38)
Improving Quality of Care and Outcomes for Heart Failure (2011) (38)
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. (2014) (38)
Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials (2020) (38)
Culprit Vessel–Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment–Elevation Myocardial Infarction: A Collaborative Meta-Analysis (2017) (38)
Association of Body Mass Index With Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis (2016) (38)
Transesophageal echocardiography during radiofrequency catheter ablation of ventricular tachycardia. (1993) (38)
Clinical Effectiveness of Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy in Men and Women With Heart Failure: Findings From IMPROVE HF (2014) (38)
Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis (2017) (38)
Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. (2013) (38)
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). (2007) (38)
Relation of dyspnea severity on admission for acute heart failure with outcomes and costs. (2015) (37)
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. (2021) (37)
Differences in mechanisms of SR dysfunction in ischemic vs. idiopathic dilated cardiomyopathy. (2000) (37)
Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease (2017) (37)
Racial/Ethnic differences in B-type natriuretic peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure. (2013) (37)
Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. (2011) (37)
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation) (2017) (37)
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]). (2017) (36)
Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF. (2007) (36)
Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. (2013) (36)
Heart Failure With Mid-range Ejection Fraction (2020) (36)
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. (2019) (36)
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. (2013) (36)
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure. (2016) (36)
Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable: First Results From Get With The Guidelines–Atrial Fibrillation (GWTG-AFIB) (2019) (36)
Use and Associated Risks of Concomitant Aspirin Therapy with Oral Anticoagulation in Patients with Atrial Fibrillation: Insights from the ORBIT-AF Registry (2013) (36)
Modifying the anti-inflammatory effects of high-density lipoprotein (2007) (35)
Incremental cost-effectiveness of guideline-directed medical therapies for heart failure. (2013) (35)
Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). (2009) (35)
Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes: an analysis from the get with the guidelines coronary artery disease program. (2010) (35)
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2016) (35)
Recent US Patterns and Predictors of Prevalent Diabetes among Acute Myocardial Infarction Patients (2011) (35)
Electronic health records and quality of care for heart failure. (2010) (35)
Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction (2013) (35)
Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research) (2016) (35)
Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. (2016) (35)
Cardiac Resynchronization Therapy Response is Associated with Shorter Duration of Atrial Fibrillation (2007) (35)
Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study. (1995) (35)
Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry. (2016) (35)
Global and regional putamen volume loss in patients with heart failure (2011) (35)
Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program (2019) (35)
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. (2015) (35)
Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization (2017) (35)
Two-year follow-up of quality of life in patients referred for heart transplant. (2005) (35)
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization. (2020) (34)
Orthostatic hypotension and incident heart failure in community-dwelling older adults. (2014) (34)
Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management. (2008) (34)
Insurance status and outcome after intracerebral hemorrhage: findings from Get With The Guidelines-stroke. (2014) (34)
Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction. (2016) (34)
Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. (2013) (34)
Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure (2018) (34)
Hospital case volume is associated with mortality in patients hospitalized with subarachnoid hemorrhage. (2014) (34)
The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry. (2018) (34)
Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. (2011) (34)
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (2016) (34)
Racial/Ethnic Differences in Process of Care and Outcomes Among Patients Hospitalized With Intracerebral Hemorrhage (2014) (34)
Relation of smoking status to outcomes after cardiopulmonary resuscitation for in-hospital cardiac arrest. (2014) (34)
Effective strategies for long-term statin use. (2003) (34)
The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program. (2011) (33)
Variation in Hospital Use and Outcomes Associated With Pulmonary Artery Catheterization in Heart Failure in the United States (2016) (33)
Statins and n-3 fatty acid supplementation in heart failure (2008) (33)
Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins. (2013) (33)
An approach to heart failure and diabetes mellitus. (2005) (33)
Chronic Kidney Disease and Bleeding Complications After Intravenous Thrombolytic Therapy for Acute Ischemic Stroke (2014) (33)
Nitrate therapy for heart failure: benefits and strategies to overcome tolerance. (2013) (33)
Reperfusion Strategies and Quality of Care in 5339 Patients Age 80 Years or Older Presenting With ST‐Elevation Myocardial Infarction: Analysis from Get With The Guidelines‐Coronary Artery Disease (2012) (33)
Patient Characteristics and Outcomes After Hemorrhagic Stroke in Pregnancy (2015) (33)
Transient and persistent worsening renal function during hospitalization for acute heart failure. (2014) (33)
Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care (2007) (33)
Sustained sex‐based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry (2018) (33)
Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States (2018) (33)
Representativeness of RELAX-AHF Clinical Trial Population in Acute Heart Failure (2014) (33)
Beyond Coronary Sinus Angiography: The Value of Coronary Arteriography and Identification of the Pericardiophrenic Vein During Left Ventricular Lead Placement (2005) (33)
Evidence-Based Policy Making: Assessment of the American Heart Association’s Strategic Policy Portfolio A Policy Statement From the American Heart Association (2016) (33)
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction. (2019) (33)
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. (2014) (33)
Secondary prevention after coronary bypass: the American Heart Association "Get with the Guidelines" program. (2003) (32)
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. (2019) (32)
Lipid Testing and Statin Dosing After Acute Myocardial Infarction (2018) (32)
Relation of Obesity to Survival After In-Hospital Cardiac Arrest. (2016) (32)
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial (2018) (32)
Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure. (2011) (32)
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2020) (32)
Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. (2018) (32)
Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure (2016) (32)
Predicting costs among medicare beneficiaries with heart failure. (2012) (32)
Effects of Elamipretide on Left Ventricular Function in Patients with Heart Failure with Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial. (2020) (32)
A Qualitative Assessment of Practices Associated With Shorter Door-to-Needle Time for Thrombolytic Therapy in Acute Ischemic Stroke (2011) (32)
The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions. (2020) (32)
Get with the guidelines steering committee and investigators. Impact of time of presentation on the care and outcome of acute myocardial infarction (2008) (32)
International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation. (2011) (31)
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. (2014) (31)
Do anthropometric indices accurately reflect directly measured body composition in men and women with chronic heart failure? (2011) (31)
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]). (2017) (31)
Smoking Paradox in Patients Hospitalized With Coronary Artery Disease or Acute Ischemic Stroke: Findings From Get With The Guidelines (2015) (31)
ACCF/AHA consensus conference report on professionalism and ethics. (2004) (31)
Influence of stroke subtype on quality of care in the Get With The Guidelines–Stroke Program (2009) (31)
Congestion is an important diagnostic and therapeutic target in heart failure. (2006) (31)
Water and Sodium in Heart Failure: A Spotlight on Congestion (2014) (31)
Effect of serum insulin on the association between hyperuricemia and incident heart failure. (2010) (31)
Tipping the scale: heart failure, body mass index, and prognosis. (2007) (31)
Is Exercise Adherence Associated with Clinical Outcomes in Patients with Advanced Heart Failure? (2009) (31)
Global and regional brain mean diffusivity changes in patients with heart failure (2014) (31)
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. (2013) (31)
Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Regis (2017) (31)
Comparison of direct body composition assessment methods in patients with chronic heart failure. (2010) (31)
Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study. (2016) (30)
Hospital Variation in Intravenous Inotrope Use for Patients Hospitalized With Heart Failure: Insights From Get With The Guidelines (2014) (30)
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes (2018) (30)
Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure. (2019) (30)
Patterns of Care Quality and Prognosis Among Hospitalized Ischemic Stroke Patients With Chronic Kidney Disease (2014) (30)
Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure. (2016) (30)
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. (2015) (30)
Unintended Harm Associated With the Hospital Readmissions Reduction Program. (2018) (30)
Unexplained Variation for Hospitals’ Use of Inpatient Rehabilitation and Skilled Nursing Facilities After an Acute Ischemic Stroke (2017) (30)
Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction (2021) (30)
Anemia and Associated Clinical Outcomes in Patients With Heart Failure Due to Reduced Left Ventricular Systolic Function (2013) (30)
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction. (2020) (30)
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure (2012) (30)
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction. (2017) (30)
Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006. (2009) (30)
Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. (2015) (30)
Guideline-Directed Low-Density Lipoprotein Management in High-Risk Patients With Ischemic Stroke: Findings From Get With The Guidelines-Stroke 2003 to 2012 (2014) (30)
Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women (2016) (30)
Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM). (2008) (30)
Lessons learned in acute heart failure (2018) (29)
Pre‐discharge and early post‐discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial (2018) (29)
Impact of Time of Presentation on Process Performance and Outcomes in ST-Segment–Elevation Myocardial Infarction: A Report From the American Heart Association: Mission Lifeline Program (2014) (29)
Heart failure: recent advances in prevention and treatment. (2000) (29)
Cognitive Test Performance and Brain Pathology (2008) (29)
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. (2009) (29)
Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines–Heart Failure Registry (2018) (29)
Chest Pain Center Accreditation Is Associated With Improved In‐Hospital Outcomes of Acute Myocardial Infarction Patients in China: Findings From the CCC‐ACS Project (2019) (29)
Use of Pulmonary Artery Catheterization in US Patients With Heart Failure, 2001-2012. (2016) (29)
Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006). (2011) (29)
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure. (2020) (29)
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. (2016) (29)
Associations between use of the hospitalist model and quality of care and outcomes of older patients hospitalized for heart failure. (2013) (29)
Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data. (2013) (29)
Anticoagulation in heart failure: current status and future direction (2013) (29)
How old is too old for heart transplantation? (2000) (29)
Association of Physical Activity or Fitness With Incident Heart Failure: A Systematic Review and Meta-Analysis. (2015) (29)
Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism? (2012) (28)
The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure. (2009) (28)
In-hospital initiation of statins: taking advantage of the 'teachable moment'. (2003) (28)
How well are chronic heart failure patients being managed? (2006) (28)
Regional Variation Across the United States in Management and Outcomes of ST‐Elevation Myocardial Infarction: Analysis of the 2003 to 2010 Nationwide Inpatient Sample Database (2014) (28)
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial (2015) (28)
Practical considerations of beta-blockade in the management of the post-myocardial infarction patient. (2005) (28)
Quality Indicators for the Management of Heart Failure in Vulnerable Elders (2001) (28)
Calcium Channel Blockers and Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction (2014) (28)
Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial. (2015) (28)
Achievement of Guideline-Concordant Care and In-Hospital Outcomes in Patients With Coronary Artery Disease in Teaching and Nonteaching Hospitals: Results From the Get With The Guidelines–Coronary Artery Disease Program (2013) (28)
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. (2011) (28)
Primary prevention implantable cardioverter-defibrillators and survival in older women. (2015) (28)
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry. (2020) (28)
Care and Outcomes of Asian-American Acute Myocardial Infarction Patients: Findings From the American Heart Association Get With The Guidelines-Coronary Artery Disease Program (2012) (28)
Self-Study from Web-Based and Printed Guideline Material (2001) (28)
Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation (2019) (28)
Comparison of Outcomes of Transfemoral Versus Transapical Approach for Transcatheter Aortic Valve Implantation. (2018) (27)
Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure. (2014) (27)
Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations (2013) (27)
Trends in the Burden of Adult Congenital Heart Disease in US Emergency Departments (2016) (27)
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2017) (27)
Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. (2010) (27)
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. (2010) (27)
Influence of hospital length of stay for heart failure on quality of care. (2008) (27)
Hospital Variation in Functional Recovery After Stroke (2017) (27)
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary (2022) (27)
Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database). (2016) (27)
Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure. (2012) (27)
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results (2020) (27)
Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure (2015) (27)
Clinical Effectiveness of Hydralazine–Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry (2016) (27)
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period (2011) (27)
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. (2004) (27)
ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2014) (27)
Trends in characteristics of cardiovascular clinical trials 2001-2012. (2015) (27)
Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries. (2020) (27)
Modeling Distribution of Donor Hearts to Maximize Early Candidate Survival (1992) (27)
Weighting Components of Composite End Points in Clinical Trials: An Approach Using Disability-Adjusted Life-Years (2011) (27)
Evaluation of the SIPAT instrument to assess psychosocial risk in heart transplant candidates: A retrospective single center study (2017) (27)
Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes. (2010) (27)
Managing the patient with diabetes mellitus and heart failure: issues and considerations. (2004) (27)
Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure. (2011) (26)
Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy. (2016) (26)
Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From the Acute Study Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) (2013) (26)
Association of the Affordable Care Act’s Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure (2018) (26)
Impaired Cerebellar and Limbic Responses to the Valsalva Maneuver in Heart Failure (2012) (26)
Obesity paradox as a component of reverse epidemiology in heart failure. (2005) (26)
Participation in Get With The Guidelines–Stroke and Its Association With Quality of Care for Stroke (2018) (26)
Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study (2018) (26)
Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial (2018) (26)
Impact of Reduced Kidney Function on Cardiopulmonary Fitness in Patients with Systolic Heart Failure (2010) (26)
Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. (2019) (26)
Clinical diagnosis and prognosis of acute limb ischemia. (2002) (26)
Lipid Profile, Lipid-lowering Medications, and Intracerebral Hemorrhage After tPA in Get With The Guidelines–Stroke (2013) (26)
Noninvasive Bioelectrical Impedance for Predicting Clinical Outcomes in Outpatients With Heart Failure (2017) (26)
Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry. (2013) (26)
Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke (2019) (26)
Intravenous Tissue Plasminogen Activator in Stroke Mimics. (2019) (26)
Improving quality of care and outcomes for heart failure. -Role of registries-. (2011) (26)
Cerebral Impairment in Heart Failure (2014) (26)
Temporal Trends and Factors Associated With Cardiac Rehabilitation Participation Among Medicare Beneficiaries With Heart Failure. (2021) (26)
Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis. (2017) (26)
Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes. (2019) (25)
Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF. (2012) (25)
Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG). (2013) (25)
Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study (2017) (25)
Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke (2017) (25)
Quality Indicators for the Care of Heart Failure in Vulnerable Elders (2007) (25)
Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients. (2020) (25)
The Role of Biomarkers in Detection of Cardio-toxicity (2017) (25)
Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). (2017) (25)
ACC/AHA/AACVPR/AAFP/ANA Concepts for Clinician–Patient Shared Accountability in Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (2014) (25)
Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction. (2013) (25)
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). (2016) (25)
Invasive Management Strategies and Antithrombotic Treatments in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China) (2017) (25)
Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial (2020) (25)
Trends in Heart Failure Clinical Trials From 2001-2012. (2016) (25)
Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes (2017) (24)
The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure. (2019) (24)
Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation. (2017) (24)
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation (2018) (24)
Diabetes medications and heart failure: recognizing the risk. (2014) (24)
Components and Trends in Door to Treatment Times for Endovascular Therapy in Get With The Guidelines-Stroke Hospitals (2019) (24)
Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project. (2012) (24)
Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. (2014) (24)
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). (2010) (24)
Derivation and Validation of a Geriatric‐Sensitive Perioperative Cardiac Risk Index (2017) (24)
The role of in-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes. (2003) (24)
Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators. (2015) (24)
Relation of systolic blood pressure to survival in both ischemic and nonischemic systolic heart failure. (2008) (24)
In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction. (2021) (24)
Patterns of glucose‐lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR) (2018) (24)
Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction: Temporal Trends and Association With In-Hospital Outcomes. (2015) (24)
Clinical risk prediction tools in patients hospitalized with heart failure. (2012) (24)
Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone (2014) (23)
Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure (2016) (23)
Abstract WP313: Quality of Ischemic Stroke-related Care in Patients With Chronic Kidney Disease (CKD) on Dialysis: Findings From Get With the Guidelines-stroke (2016) (23)
Comprehensive coronary artery disease care in a safety-net hospital: results of Get With The Guidelines quality improvement initiative. (2007) (23)
Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure. (2008) (23)
Frequency and Determinants of Lipid Testing in Ischemic Stroke and Transient Ischemic Attack: Findings From Get With The Guidelines–Stroke (2010) (23)
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation (2018) (23)
Risk stratification for in-hospital mortality in heart failure using classification and regression tree (CART) methodology: analysis of 33,046 patients in the ADHERE registry (2003) (23)
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) (2017) (23)
Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD). (2011) (23)
ACC/AHA 2013 Methodology for Developing Clinical Data Standards: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (2014) (23)
Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age (2016) (23)
Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory. (2020) (23)
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure. (2014) (23)
Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals. Analysis of the ADHERE Registry (2005) (23)
New medications for heart failure. (2016) (23)
Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era. (2020) (23)
Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management. (2014) (23)
Disease understanding in patients newly diagnosed with atrial fibrillation (2017) (22)
Team-Based Care for Outpatients with Heart Failure. (2015) (22)
The Hospital Readmissions Reduction Program: Evidence for Harm. (2018) (22)
Venous thromboembolism prophylaxis in hospitalized heart failure patients. (2008) (22)
Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. (2015) (22)
Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. (2016) (22)
Bioelectrical impedance analysis of body composition and survival in patients with heart failure (2018) (22)
Patient and Facility Variation in Costs of VA Heart Failure Patients. (2016) (22)
Lack of Association Between Electronic Health Record Systems and Improvement in Use of Evidence‐Based Heart Failure Therapies in Outpatient Cardiology Practices (2012) (22)
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. (2016) (22)
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). (2010) (22)
The Role of Data Registries in the Time of COVID-19. (2020) (22)
Influence of atrial fibrillation on post‐discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial (2017) (21)
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. (2010) (21)
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF. (2019) (21)
Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN). (2007) (21)
Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction. (2019) (21)
Procedural Patterns and Safety of Atrial Fibrillation Ablation (2020) (21)
Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. (2010) (21)
Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. (2004) (21)
Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study. (2017) (21)
Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. (2014) (21)
Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). (2014) (21)
Variation and Trends in the Documentation of National Institutes of Health Stroke Scale in GWTG-Stroke Hospitals (2015) (21)
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. (2019) (21)
Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes. (2019) (21)
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate. (2018) (21)
An evidence-based score to detect prevalent peripheral artery disease (PAD) (2012) (21)
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non–Vitamin K Antagonist Oral Anticoagulants Preceding Stroke (2018) (21)
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure. (2019) (21)
Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study. (2017) (21)
Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. (2018) (21)
Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19 (2020) (21)
Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program. (2011) (21)
Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score‐matched analysis of in‐hospital outcomes in the United States (2018) (20)
Mechanical assist strategy using the BVS 5000i for patients with heart failure. (2000) (20)
Heart Failure Management in Skilled Nursing Facilities: A Scientific Statement From the American Heart Association and the Heart Failure Society of America (2015) (20)
Incident heart failure in relation to vascular disease: Insights from the Health, Aging, and Body Composition Study (2014) (20)
Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial. (2011) (20)
Hospital distance, socioeconomic status, and timely treatment of ischemic stroke (2019) (20)
Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. (2014) (20)
The hemodynamic effects of isotonic exercise using hand-held weights in patients with heart failure. (2000) (20)
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure. (2017) (20)
Reinforcing a Continuum of Care: In-Hospital Initiation of Long-Term Secondary Prevention Following Acute Coronary Syndromes (2007) (20)
Diabetic cardiomyopathy. (2006) (20)
Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency (2019) (20)
Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. (2004) (20)
Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease (2016) (20)
Association of Obesity With In-Hospital Mortality of Cardiogenic Shock Complicating Acute Myocardial Infarction. (2017) (19)
549 Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HeFT (2006) (19)
Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure. (2015) (19)
Comparison of Performance Achievement Award Recognition With Primary Stroke Center Certification for Acute Ischemic Stroke Care (2013) (19)
Management of post-myocardial infarction patients with left ventricular systolic dysfunction. (2007) (19)
Approach to the management of diabetic patients with heart failure: role of thiazolidinediones. (2004) (19)
Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database). (2008) (19)
1069-114 Impact of renal insufficiency and chronic diuretic therapy on outcome and resource utilization in patients with acute decompensated heart failure (2004) (19)
Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis. (2003) (19)
Comparative effectiveness of diuretic regimens. (2011) (19)
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF I) Registry (2016) (19)
Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation. (2015) (19)
Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations. (2020) (19)
Thrombolysis in young adults with stroke (2019) (19)
Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. (2014) (19)
Shock Index Predicts Patient‐Related Clinical Outcomes in Stroke (2018) (19)
Quality of Care and Outcomes Among Patients With Acute Myocardial Infarction by Level of Kidney Function at Admission: Report From the Get With The Guidelines Coronary Artery Disease Program (2012) (19)
Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction. (2018) (19)
Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke. (2015) (19)
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. (2019) (18)
Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008. (2014) (18)
Timing and Duration of Interventions in Clinical Trials for Patients With Hospitalized Heart Failure (2013) (18)
Refining Classification of Heart Failure Based on Ejection Fraction. (2017) (18)
Discharge home health services referral and 30-day all-cause readmission in older adults with heart failure (2018) (18)
Assessment of Heart Failure Patients’ Interest in Mobile Health Apps for Self-Care: Survey Study (2019) (18)
Rationale and design of a cluster-randomized multifaceted intervention trial to improve stroke care quality in China: The GOLDEN BRIDGE-Acute Ischemic Stroke. (2015) (18)
Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial). (2016) (18)
The cardiorenal connection in heart failure (2008) (18)
Role of carvedilol controlled-release in cardiovascular disease (2009) (18)
Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines–Heart Failure (2016) (18)
Association between depression and readmission of heart failure: A national representative database study. (2020) (18)
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2020) (18)
Extracorporeal Ultra fi ltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research (18)
A Randomized Trial of Liraglutide for High-Risk Heart Failure Patients With Reduced Ejection Fraction (2015) (18)
Randomization-There Is No Substitute. (2016) (18)
Patient Perceptions and Familiarity With Medical Therapy for Heart Failure. (2019) (18)
Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke (2015) (18)
Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure. (2021) (18)
Control and Prevention American Heart Association, the American College of Cardiology, and the Centers for Disease An Effective Approach to High Blood Pressure Control: A Science Advisory From the (2013) (18)
Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation (2016) (18)
Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients (2015) (18)
Similar clinical benefits from below‐target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial (2018) (17)
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). (2011) (17)
Cardioversion and subsequent quality of life and natural history of atrial fibrillation (2017) (17)
Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients (2017) (17)
Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation. (2012) (17)
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation. (2020) (17)
Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA’s Mission: Lifeline (2020) (17)
Comparison of in-hospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: an analysis from a large prospective registry database (2003) (17)
Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure (2015) (17)
B-Type Natriuretic Peptide: Spectrum of Application. Nesiritide (Recombinant BNP) for Heart Failure (2003) (17)
In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits. (2005) (17)
Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade. (2006) (17)
Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. (2017) (17)
Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction. (2019) (17)
Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics. (2013) (17)
Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. (2016) (17)
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation (2018) (17)
Statin therapy after acute myocardial infarction: Are we adequately treating high-risk patients? (2002) (17)
Mobile health applications in cardiovascular research. (2018) (17)
Left Ventricular Ejection Fraction: What Is "Normal"? (2016) (17)
Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial. (2020) (17)
Troponin in Heart Failure. (2018) (17)
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes (2020) (17)
Clinical Characteristics, Management, and In-Hospital Outcomes in Patients With Stroke or Transient Ischemic Attack in China (2021) (17)
Temperature and Precipitation Associate With Ischemic Stroke Outcomes in the United States (2018) (16)
Evaluation of Risk-Adjusted Home Time After Hospitalization for Heart Failure as a Potential Hospital Performance Metric. (2020) (16)
International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines––Stroke Program (2018) (16)
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF (2018) (16)
Clinical commentary on "Certain uncertainty: life after stroke from the patient's perspective". (2014) (16)
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial (2017) (16)
Clinical implications of the obesity paradox in patients with coronary artery disease. (2009) (16)
Drug therapy to reduce early readmission risk in heart failure: ready for prime time? (2013) (16)
Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. (2016) (16)
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. (2014) (16)
Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map (2021) (16)
Mean platelet volume and mortality risk in a national incident hemodialysis cohort. (2016) (16)
Acute decompensated heart failure: challenges and opportunities. (2007) (16)
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons. (2015) (16)
Predictors of 30-Day Unplanned Readmission After Carotid Artery Stenting Using Artificial Intelligence (2021) (16)
Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure (2014) (16)
A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients? (2020) (16)
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone. (2017) (16)
Site selection for heart failure clinical trials in the USA (2015) (16)
Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines—Heart Failure (2018) (16)
Digoxin use and lower risk of 30‐day all‐cause readmission in older patients with heart failure and reduced ejection fraction receiving β‐blockers (2018) (16)
Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017. (2020) (16)
Relative roles of heart transplantation and long-term mechanical circulatory support in contemporary management of advanced heart failure - a critical appraisal 10 years after REMATCH. (2011) (16)
Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with He (2010) (16)
Quality of Care for Patients With Acute Coronary Syndromes as a Function of Hospital Revascularization Capability: Insights From Get With The Guidelines‐CAD (2014) (15)
Economic Issues in Heart Failure in the United States. (2022) (15)
Clinical inertia and medical therapy for heart failure: the unintended harms of ‘first, do no harm’ (2021) (15)
Prevalence, Mechanisms, and Clinical Implications (2010) (15)
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities from the TRANSLATE-ACS Study (2015) (15)
Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry. (2011) (15)
Epidemiology of hospitalized heart failure: differences and similarities between patients with reduced versus preserved ejection fraction. (2013) (15)
Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction (2017) (15)
Managed care interventions for improving outcomes in acute heart failure syndromes. (2008) (15)
Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. (2016) (15)
Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project. (2019) (15)
Sex and Age Interactions and Differences in Outcomes After Intracerebral Hemorrhage. (2017) (15)
Factors Associated with Improvement in Guideline‐Based Use of ICDs in Eligible Heart Failure Patients (2012) (15)
The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes. (2002) (15)
Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association. (2022) (15)
Long‐term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines–Heart Failure Registry (2019) (15)
Cholesterol and mortality in heart failure: the bad gone good? (2003) (15)
In‐hospital initiation of quadruple medical therapy for heart failure: making the post‐discharge vulnerable phase far less vulnerable (2021) (15)
Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. (2022) (15)
Rapid Change in Prescribing Behavior in Hospitals Participating in Get With The Guidelines–Stroke After Release of the Management of Atherothrombosis With Clopidogrel in High-Risk Patients (MATCH) Clinical Trial Results (2010) (15)
Profile of carvedilol controlled-release: a new once-daily formulation of carvedilol (2006) (15)
Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission: Get With The Guidelines-Stroke (2018) (15)
The relationship between body mass index and mortality in patients hospitalized with acute decompensated heart failure. (2007) (15)
Higher risk for incident heart failure and cardiovascular mortality among community‐dwelling octogenarians without pneumococcal vaccination (2015) (15)
Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions (2018) (15)
Prevalence of Apparent Treatment‐Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline (2019) (15)
Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction (2020) (14)
Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial. (2009) (14)
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF). (2019) (14)
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention (2015) (14)
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry (2015) (14)
High-Density Lipoprotein Function (2016) (14)
Thrombolysis 3 to 4.5 hours after acute ischemic stroke. (2008) (14)
Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials. (2016) (14)
Association of Physical Activity or Fitness With Incident Heart FailureCLINICAL PERSPECTIVE (2015) (14)
The University of California at Los Angeles experience in heart transplantation. (1998) (14)
Beta-blocker therapy for heart failure: the standard of care. (2002) (14)
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2020) (14)
Measures of obesity and outcomes after myocardial infarction. (2008) (14)
The management of the diabetic patient with prior cardiovascular events. (2003) (14)
Prevention of heart failure: effective strategies to combat the growing epidemic. (2003) (14)
Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke (2015) (14)
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry. (2018) (14)
Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment. (2013) (14)
Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes (2017) (14)
Risk of Heart Failure and Death After Prolonged Smoking CessationCLINICAL PERSPECTIVE (2015) (14)
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. (2021) (14)
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. (2019) (14)
Current Practice Trends for Use of Early Venous Thromboembolism Prophylaxis After Intracerebral Hemorrhage (2018) (14)
Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries. (2020) (14)
Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database). (2008) (14)
Pharmacologic Prophylaxis for Venous Thromboembolism and 30‐Day Outcomes Among Older Patients Hospitalized With Heart Failure: An Analysis From the ADHERE National Registry Linked to Medicare Claims (2011) (14)
Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction (2015) (13)
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction (2021) (13)
National Survey of Hospital Strategies to Reduce Heart Failure ReadmissionsClinical Perspective (2012) (13)
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction. (2016) (13)
Performance measures for patients hospitalized with heart failure: are they predictive of clinical outcomes? (2007) (13)
Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation (2018) (13)
Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations. (2006) (13)
Brain metabolites in autonomic regulatory insular sites in heart failure (2014) (13)
Outcomes Associated With Warfarin Use in Older Patients With Heart Failure and Atrial Fibrillation and a Cardiovascular Implantable Electronic Device: Findings From the ADHERE Registry Linked to Medicare Claims (2012) (13)
Statins and the Prevention of Heart Disease. (2017) (13)
Trends in Smoking Cessation Counseling: Experience From American Heart Association‐Get With The Guidelines (2012) (13)
Performance achievement award program for Get With The Guidelines--Coronary Artery Disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarction. (2010) (13)
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial. (2013) (13)
Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines–Stroke Hospitals (2017) (13)
Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation. (2016) (13)
Risk Profiles in Heart Failure (2020) (13)
Relation Between Hospital Length of Stay and Quality of Care in Patients With Acute Coronary Syndromes (from the American Heart Association's Get With the Guidelines--Coronary Artery Disease Data Set). (2016) (13)
Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome (2014) (13)
Estimation of the left ventricular ejection fraction using a novel multiphase, dark-blood, breath-hold MR imaging technique. (1997) (13)
Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study (2017) (13)
Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States. (2017) (13)
Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE). (2016) (13)
Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure (2019) (13)
Compliance with guideline‐directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines–Coronary Artery Disease (GWTG‐CAD) program (2017) (12)
Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications. (2004) (12)
Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis (2021) (12)
A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults. (2011) (12)
Strategies to improve the use of evidence-based heart failure therapies. (2005) (12)
Availability and Use of Shared Data From Cardiometabolic Clinical Trials (2017) (12)
Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation. (2020) (12)
Endothelin and the vascular choir in heart failure. (1992) (12)
Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT (2017) (12)
A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years. (2011) (12)
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). (2016) (12)
Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry). (2018) (12)
Variation in heart failure quality of care indicators among U.S. hospitals: analysis of 230 hospitals in the ADHERE registry (2003) (12)
Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study). (2018) (12)
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation (2020) (12)
Validity of Performance and Outcome Measures for Heart Failure (2018) (11)
Shared Decision Making in Atrial Fibrillation: Patient-Reported Involvement in Treatment Decisions. (2020) (11)
981-46 Impact of a Comprehensive Management Program on the Hospitalization Rate for Patients with Advanced Heart Failure (1995) (11)
Performance in Federal Value-Based Programs of Hospitals Recognized by the American Heart Association and American College of Cardiology for High-Quality Heart Failure and Acute Myocardial Infarction Care. (2020) (11)
Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement. (2019) (11)
Prevention of Heart Failure. (2017) (11)
National Outcomes in Hospitalized Patients With Cancer and Comorbid Heart Failure. (2019) (11)
Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. (2021) (11)
Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program. (2015) (11)
Distinct Short-Term Outcomes in Patients With Mild Versus Rapidly Improving Stroke Not Treated With Thrombolytics (2016) (11)
PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. (2020) (11)
Get With the Guidelines–Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or TIA. (2008) (11)
Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment–Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines (2017) (11)
Inflammatory Mediators and Clinical Outcome in Patients With Advanced Heart Failure Receiving Cardiac Resynchronization Therapy. (2016) (11)
Acute Ischemic Stroke in Patients With COVID-19 (2021) (11)
Management and outcomes of ST-elevation myocardial infarction in nursing home versus community-dwelling older patients: a propensity matched study. (2014) (11)
Age Differences in the Use of Implantable Cardioverter‐Defibrillators Among Older Patients Hospitalized with Heart Failure (2013) (11)
Digoxin Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. (2019) (11)
Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry. (2015) (11)
Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials? (2019) (11)
Relationship of physical activity and healthy eating with mortality and incident heart failure among community‐dwelling older adults with normal body mass index (2015) (11)
Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity: Findings From the Get With the Guidelines–Heart Failure Registry (2019) (11)
Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database. (2020) (11)
Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia (2021) (11)
Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale. (2016) (11)
Cardiovascular Disease in Hospitalized Patients With a Diagnosis of Coronavirus From the Pre–COVID-19 Era in United States: National Analysis From 2016-2017 (2020) (11)
Cerebral Blood Flow Velocity and Vasomotor Reactivity During Autonomic Challenges in Heart Failure (2014) (11)
Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Study (2015) (11)
Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients. (2019) (11)
Body mass index and outcomes of cardiac resynchronization with implantable cardioverter‐defibrillator therapy in older patients with heart failure (2019) (11)
Characteristics and Outcomes of Patients With Advanced Chronic Systolic Heart Failure Receiving Care at the Veterans Affairs Versus Other Hospitals: Insights From the Beta-blocker Evaluation of Survival Trial (BEST) (2014) (11)
Early transition to comfort measures only in acute stroke patients: Analysis from the Get With The Guidelines–Stroke registry (2017) (11)
Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes. (2004) (11)
Use of Renin–Angiotensin System Blockers in Acute Coronary Syndromes: Findings From Get With the Guidelines-Coronary Artery Disease Program (2012) (11)
Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary (2016) (11)
The University of California at Los Angeles heart transplantation experience. (2005) (11)
In‐Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC‐ACS (Improving Care for Cardiovascular Disease in China‐Acute Coronary Syndrome) Project (2018) (11)
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. (2011) (11)
National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients. (2019) (11)
Primary Prevention Implantable Cardioverter-Defibrillators in Older Racial and Ethnic Minority Patients (2015) (10)
Fluid Retention is Associated with Cardiovascular Mortality in Chronic Hemodialysis Patients (2009) (10)
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. (2016) (10)
Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry (2021) (10)
Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China. (2022) (10)
Identifying a low‐flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial (2019) (10)
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes (2016) (10)
Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle? (2017) (10)
Integrating remote monitoring into heart failure patients’ care regimen: A pilot study (2020) (10)
Randomized clinical outcome trials of statins in heart failure. (2008) (10)
Comparison of Patient‐Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT‐AF Registry (2019) (10)
Sixteen-year experience with 1,000 heart transplants at UCLA. (2000) (10)
Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review. (2021) (10)
A Hospital Level Analysis of 30‐Day Readmission Performance for Heart Failure Patients and Long‐Term Survival: Findings from Get With The Guidelines‐Heart Failure (2018) (10)
A practical approach to reducing cardiovascular risk factors. (2007) (10)
Effectiveness and Safety of Aldosterone Antagonist Therapy Use Among Older Patients With Reduced Ejection Fraction After Acute Myocardial Infarction (2016) (10)
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. (2021) (10)
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry). (2019) (10)
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (2019) (10)
Lateralized Resting-State Functional Brain Network Organization Changes in Heart Failure (2016) (10)
Incorporating Patient and Caregiver Experiences Into Cardiovascular Clinical Trial Design (2017) (10)
Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis (2002) (10)
Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital? (2016) (10)
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation (2017) (10)
Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT). (2020) (10)
Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure). (2019) (10)
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. (2021) (10)
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation (2020) (10)
Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy. (2002) (10)
Impact of an Expanded Hospital Recognition Program for Stroke Quality of Care (2017) (10)
Demographic and Regional Trends of Heart Failure-Related Mortality in Young Adults in the US, 1999-2019. (2022) (10)
Relationship between Stage of Kidney Disease and Incident Heart Failure in Older Adults (2011) (10)
Association between smoking and outcomes in older adults with atrial fibrillation. (2012) (10)
Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials (2022) (10)
Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims. (2013) (9)
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). (2020) (9)
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function. (2017) (9)
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry (2018) (9)
Timing of Postdischarge Follow‐Up and Medication Adherence Among Patients With Heart Failure (2018) (9)
High‐sensitivity C‐reactive protein elevation in patients with prior myocardial infarction in the United States (2018) (9)
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. (2014) (9)
A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology (2008) (9)
Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of Care (2014) (9)
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial). (2013) (9)
Association of Medicaid Expansion with Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018. (2020) (9)
Brain structural changes associated with aberrant functional responses to the Valsalva maneuver in heart failure (2018) (9)
Phase II trials in heart failure: the role of cardiovascular imaging. (2011) (9)
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy. (2017) (9)
Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry. (2015) (9)
The global burden of atherosclerotic vascular disease (2007) (9)
Decompensated heart failure: is there a role for the outpatient use of nesiritide? (2004) (9)
Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy (2019) (9)
Outcomes of Biventricular Mechanical Support Patients Discharged to Home to Await Heart Transplantation (2015) (9)
Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance. (2016) (9)
Rates, Characteristics, and Outcomes of Patients Transferred to Specialized Stroke Centers for Advanced Care (2018) (9)
Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke (2016) (9)
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension. (2020) (9)
Nesiritide: practical guide to its safe and effective use. (2001) (9)
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure (2019) (9)
Implementation of a Best Practice in Cardiology (BPC) Program Adapted from Get With The Guidelines®in Brazilian Public Hospitals: Study Design and Rationale. (2020) (9)
Pretransplant Coagulopathy and In‐hospital Outcomes Among Heart Transplant Recipients: A Propensity‐Matched Nationwide Inpatient Sample Study (2015) (9)
A review of evidence-based beta-blockers in special populations with heart failure. (2008) (9)
Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison (2018) (9)
In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program. (2003) (9)
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. (2019) (9)
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction (9)
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry (2018) (9)
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden (2020) (9)
Beyond Disease Reduction : The American Heart Association ’ s Strategic Impact Goal Defining and Setting National Goals for Cardiovascular Health Promotion (2010) (9)
Clinical phenomapping and outcomes after heart transplantation. (2018) (9)
Evidence-Based Performance Measures and Outcomes in Patients With Acute Ischemic Stroke: Findings From the China National Stroke Registry (2018) (8)
Task Force on Practice Guidelines Report of the American College of Cardiology Foundation/American Heart Association 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A (2013) (8)
Early pharmacological treatment of acute heart failure syndromes: A systematic review of clinical trials (2007) (8)
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. (2019) (8)
Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines: Atrial Fibrillation Registry. (2021) (8)
A Point‐by‐Point Response to Recent Arguments Against the Use of Statins in Primary Prevention (2012) (8)
Association of Dual Eligibility for Medicare and Medicaid With Heart Failure Quality and Outcomes Among Get With The Guidelines-Heart Failure Hospitals. (2021) (8)
Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure (2020) (8)
Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial). (2014) (8)
Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). (2019) (8)
Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy (2013) (8)
Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF (2018) (8)
High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events. (2004) (8)
Medicare Shared Savings ACOs and Hospice Care for Ischemic Stroke Patients (2019) (8)
Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction. (2003) (8)
Cost and Value in Contemporary Heart Failure Clinical Guidance Documents. (2021) (8)
Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018. (2022) (8)
National Heart, Lung, and Blood Institute and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary (2006) (8)
Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage (2021) (8)
HDL function as a target of lipid-modifying therapy. (2007) (8)
Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries (2021) (8)
A HOSPITAL LEVEL ANALYSIS OF 30-DAY READMISSION RATES FOR HEART FAILURE PATIENTS AND LONG-TERM SURVIVAL AMONG HIGHEST AND LOWEST PERFORMING HOSPITALS, FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE (2017) (8)
Heart failure medications prescribed at discharge for patients with left ventricular assist devices. (2016) (8)
Factors Associated with Improvement in Utilization of Cardiac Resynchronization Therapy in Eligible Heart Failure Patients: Findings from IMPROVE HF (2013) (8)
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (2017) (8)
Severe Hypoglycemia and Incident Heart Failure among Adults With Type 2 Diabetes. (2021) (8)
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. (2012) (8)
The need for increased pragmatism in cardiovascular clinical trials (2022) (8)
Measuring heart failure care by 30-day readmission: Rethinking the quality of outcome measures. (2013) (8)
In-hospital initiation of cardiovascular protective medications for patients undergoing percutaneous coronary intervention: taking advantage of the teachable moment. (2003) (8)
Thrombolytic therapy in older acute ischemic stroke patients with gastrointestinal malignancy or recent bleeding (2020) (8)
Abstract 15606: Clevidipine Improves Dyspnea in Emergency Department Acute Heart Failure: A Randomized, Open Label Study (2012) (8)
Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus. (2019) (8)
Obesity, weight reduction and survival in heart failure: Reply (2002) (8)
Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease (2019) (8)
All‐cause unplanned readmissions in the United States: insights from the Nationwide Readmission Database (2021) (8)
Targeted versus standard feedback: results from a randomized quality improvement trial. (2015) (8)
Changes in parameters of right ventricular function with cardiac resynchronization therapy (2017) (8)
Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2‐VASc Scores: Findings From the ORBIT‐AF I and II Registries (2018) (8)
Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling (2017) (7)
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial. (2020) (7)
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. (2019) (7)
Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance (2013) (7)
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. (2020) (7)
Congestion in acute heart failure syndromes: importance of early recognition and treatment. (2006) (7)
Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review. (2017) (7)
Beneficios del tratamiento con estatinas según los valores plasmáticos del antígeno carbohidrato 125 tras un ingreso por insuficiencia cardiaca aguda (2011) (7)
Frailty, Guideline-Directed Medical Therapy, and Outcomes in Heart Failure With Reduced Ejection Fraction (2022) (7)
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. (2012) (7)
Trends in Use, Outcomes, and Disparities in Endovascular Thrombectomy in US Patients With Stroke Aged 80 Years and Older Compared With Younger Patients (2022) (7)
High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial (2021) (7)
Heart Failure: State of the Art (2014) (7)
A Review of Evidence-Based β-Blockers in Special Populations With Heart Failure (2008) (7)
Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in Patients with Heart Failure. (2021) (7)
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). (2011) (7)
Contextualizing Risk Among Patients With Heart Failure. (2021) (7)
Effects of a Home-Based Exercise Program on Clinical Outcomes in Advanced Heart Failure (2007) (7)
AHA / ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death (7)
Incremental prognostic value of renal function for stroke prediction in atrial fibrillation. (2019) (7)
Benefits of Statin Therapy Based on Plasma Carbohydrate Antigen 125 Values Following an Admission for Acute Heart Failure (2011) (7)
Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction (2020) (7)
Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States⋆. (2019) (7)
What's Next for Acute Heart Failure Research? (2018) (7)
The Need for Multiple Measures of Hospital QualityClinical Perspective (2011) (7)
Consequences of Reductions in Hospital Readmissions. (2017) (7)
The Changing Landscape of Aortic Valve Replacement in the United States. (2019) (7)
Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults With Diabetes. (2020) (7)
CATHETER ABLATION OF VENTRICULAR TACHYCARDIA: TEN-YEAR TRENDS IN UTILIZATION, IN-HOSPITAL COMPLICATIONS, AND IN-HOSPITAL MORTALITY IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY (2014) (7)
Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non-ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project. (2019) (7)
OUTCOMES OF MEDICARE BENEFICIARIES WITH HEART FAILURE AND ATRIAL FIBRILLATION (2013) (7)
Incorporating Stroke Severity Into Hospital Measures of 30-Day Mortality After Ischemic Stroke Hospitalization (2017) (7)
Differences in health care use and outcomes by the timing of in-hospital worsening heart failure. (2015) (7)
Sources of Hospital-Level Variation in Major Bleeding Among Patients With Non–ST-Segment Elevation Myocardial Infarction: A Report From the National Cardiovascular Data Registry (NCDR) (2014) (7)
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry (2018) (7)
Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes (2022) (7)
Comparison of Survival After In-Hospital Cardiac Arrest in Patients With Versus Without Diabetes Mellitus. (2017) (7)
The Medicare Shared Savings Program and Outcomes for Ischemic Stroke Patients: a Retrospective Cohort Study (2019) (7)
Ultrafiltration in heart failure with cardiorenal syndrome. (2013) (7)
Association of Hospital Racial Composition and Payer Mix With Mortality in Acute Coronary Syndrome (2019) (6)
Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease. (2013) (6)
The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence (2021) (6)
Heart Failure with Carfilzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials. (2020) (6)
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure. (2017) (6)
30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis. (2021) (6)
Impact of end stage renal disease on in-hospital outcomes of patients with systolic and diastolic heart failure (insights from the Nationwide Inpatient Sample 2010 to 2014). (2018) (6)
Heart failure quality of care and in‐hospital outcomes during the COVID‐19 pandemic: findings from the Get With The Guidelines‐Heart Failure registry (2022) (6)
Medicaid Expansion and Utilization of Antihyperglycemic Therapies (2020) (6)
Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure (2020) (6)
Smoking and Provision of Smoking Cessation Interventions among Inpatients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project (2020) (6)
Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs (2020) (6)
Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines. (2016) (6)
Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction (2020) (6)
Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion (2022) (6)
Cost effectiveness of Positron Emission Tomography (PET) in the management of ischemic cardiomyopathy patients who are referred for cardiac transplantation (1996) (6)
HEART FAILURE ADMISSION IN HIV-INFECTED PATIENTS (2014) (6)
Survival with angiotensin-converting-enzyme inhibition vs. direct vasodilation for the same hemodynamic goals in advanced heart failure: 106 randomized patients (1991) (6)
Home-time Is a Patient-Centered Outcome Variable for Stroke: An Executive Summary (2019) (6)
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT‐AF Registry (2015) (6)
In-Hospital Initiation of Angiotensin Receptor-Neprilysin Inhibitors-The Time Is Now. (2019) (6)
Analysis of Adverse Events Related to Impella® Usage (From the Manufacturer and User Facility Device Experience and National Inpatient Sample Databases). (2020) (6)
The past, present, and future of statin therapy. (2005) (6)
Pathogenesis and treatment of cardiomyopathy. (2001) (6)
1001-24 Long-term follow-up of safety and feasibility of autologous skeletal myoblast transplantation in patients undergoing coronary artery bypass graft surgery (2004) (6)
Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure (2019) (6)
Mejorar la calidad de la asistencia cardiaca: un imperativo mundial (2015) (6)
Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion. (2020) (6)
Hospital protocols and evidence‐based therapies: The importance of integrating aldosterone blockade into the management of patients with post—acute myocardial infarction heart failure (2006) (6)
Prosthesis – Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement (2018) (5)
Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure. (2022) (5)
Management Strategies and Outcomes of ST‐Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States (2016) (5)
Safety and feasibility of autologous myoblast transplantation in patients undergoing coronary artery bypass grafting: Results from the United States experience (2003) (5)
The Association of Discharge Aspirin Dose With Outcomes After Acute (2015) (5)
United Network for Organ Sharing 2018 Heart Transplant Reallocation Policy: Aiming for Evidence-Based Policy. (2020) (5)
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization (2021) (5)
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of IMPROVE HF (2009) (5)
Urgent Balloon Aortic Valvuloplasty or Urgent TAVR in Patients With Severe Aortic Stenosis: A Propensity-Matched Analysis. (2020) (5)
Cardiovascular Risk Factors and Complications in Patients Infected with COVID-19: A Systematic Review (2020) (5)
Development and Initial Testing of the Stroke Rapid-Treatment Readiness Tool (2014) (5)
Physicians Voluntarily Using an EHR-Based CDS Tool Improved Patients' Guideline-Related Statin Prescription Rates: A Retrospective Cohort Study (2019) (5)
Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure. (2020) (5)
Improving Quality of Cardiac Care: A Global Mandate. (2015) (5)
Early impact of guideline publication on angiotensin‐receptor neprilysin inhibitor use among patients hospitalized for heart failure (2018) (5)
The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure. (2016) (5)
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial. (2022) (5)
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure. (2012) (5)
Aberrant Brain Functional Connectivity Dynamic Responses to the Valsalva Maneuver in Heart Failure. (2019) (5)
The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP‐HF (2022) (5)
Temporal Trends in Risk Profiles Among Patients Hospitalized for Heart Failure. (2020) (5)
Associations Between Anticoagulation Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Atrial Fibrillation (2014) (5)
Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction. (2022) (5)
Prevention of Heart Failure in Patients with Diabetes: Role of Diabetes Medications (2018) (5)
Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention (2021) (5)
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial. (2019) (5)
Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials (2020) (5)
Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes (2022) (5)
Expenditure on Heart Failure in the United States: The Medical Expenditure Panel Survey 2009-2018. (2022) (5)
LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project. (2021) (5)
Acute Heart Failure Mortality Is Dependent on Time to Intravenous Vasoactive Administration (2006) (5)
The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials: A Report of 348 Studies Registered With ClinicalTrials.gov. (2017) (5)
Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China (2021) (5)
Impact of atrial fibrillation on outcomes in heart failure. (2013) (5)
Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysis (2019) (5)
Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation. (2021) (5)
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic (2020) (5)
Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. (2020) (5)
Hypokalaemia and outcomes in older patients hospitalized for heart failure (2020) (5)
Biomarker-Guided vs Guideline-Directed Titration of Medical Therapy for Heart Failure. (2017) (5)
Under-utilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change? (2022) (5)
Prevention of heart failure (2002) (5)
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF (2012) (5)
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. (2020) (4)
Postdischarge International Normalized Ratio Testing and Long‐term Clinical Outcomes of Patients With Heart Failure Receiving Warfarin: Findings From the ADHERE Registry Linked to Medicare Claims (2013) (4)
Initial Hospital, Patient, and Performance Measure Characteristics of the Organized Program To Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Program (2004) (4)
Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction? (2015) (4)
238: Does Time to IV Diuretic Matter in the Emergency Treatment of Acute Decompensated Heart Failure? (2007) (4)
GW29-e1038 Relationship between medical insurance status and reperfusion therapy in patients 75 years and older with STEMI: findings from the CCC-ACS Project (2018) (4)
Use of Bioelectrical Impedance Analysis To Assess Body Composition in Heart Failure Patients (2012) (4)
Hyponatremia in acute heart failure syndromes: A potential therapeutic target (2007) (4)
DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (2014) (4)
Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain (2016) (4)
Disparate quality of care for black and hispanic heart failure (HF) patients: A report from Get With the Guidelines-Heart Failure (GWTG-HF) (2007) (4)
Preface. Team-based Care for Heart Failure. (2015) (4)
Claims Data to Ascertain Clinical Events: Lost in Translation. (2017) (4)
Safety and Ef ﬁ cacy of Exercise Training in Patients With an Implantable Cardioverter-De ﬁ brillator A Meta-Analysis (2017) (4)
Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors over Time in Heart Failure with Reduced Ejection Fraction. (2021) (4)
Abstract 16889: Digoxin Use and Subsequent Outcomes Among Patients with and without Heart Failure in a Contemporary Atrial Fibrillation Cohort: Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) (2014) (4)
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. (2021) (4)
Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the Targets (2017) (4)
Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months (2020) (4)
Non-Pharmaceutical Interventions and COVID-19 Burden in the United States (2021) (4)
Prescribing warfarin at discharge for heart failure patients: findings from the Get With The Guidelines-Heart Failure Registry. (2014) (4)
Evaluating Readmission-Need for More Clarity on Methods-Reply. (2018) (4)
Trends in Costs and Risk Factors of 30-Day Readmissions for Transcatheter Aortic Valve Implantation. (2020) (4)
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling. (2016) (4)
TEMPORAL TRENDS IN CARDIAC REHABILITATION REFERRAL AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: ANALYSIS FROM AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-HEART FAILURE REGISTRY (2015) (4)
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. (2016) (4)
Gender Bias Trends in Implantable Cardioverter-Defibrillator Therapy (2014) (4)
Outcomes After Endovascular Thrombectomy With or Without Alteplase in Routine Clinical Practice. (2022) (4)
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation. (2019) (4)
PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized with Heart Failure. (2019) (4)
Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations. (2020) (4)
Hospital Readmission Reduction Program for Heart Failure: The Spread of Intended and Unintended Consequences. (2019) (4)
OBSTRUCTIVE SLEEP APNEA AND ATRIAL FIBRILLATION: FINDINGS FROM ORBIT-AF (2014) (4)
Dynamics of muscle sympathetic nerve activity in advanced heart failure patients. (1996) (4)
Acute myocardial infarction in the young with diabetes mellitus- national inpatient sample study with sex-based difference in outcomes. (2020) (4)
Measuring and Improving the Quality of Heart Failure Care Globally. (2020) (4)
Heart Failure Management in Skilled Nursing Facilities (2015) (4)
Implementação do Programa Boas Práticas em Cardiologia adaptado do Get With The Guidelines ® em Hospitais Brasileiros: Desenho do Estudo e Fundamento (2020) (4)
Impact of vasodilator regimen on sudden death in advanced heart failure: A randomized trial of angiotensin-converting-enzyme inhibition and direct vasodilation (1991) (4)
Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes (2018) (4)
Effect of weight loss on renal function in overweight and obese patients with heart failure. (2015) (4)
ACCF/AHA Practice Guideline (2013) (4)
Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care (2017) (4)
When to initiate beta-blockers in heart failure: Is it ever too early? (2005) (4)
Action Potential-Evoked Calcium Release Is Impaired in Single Skeletal Muscle Fibers from Heart Failure Patients (2014) (4)
Sudden cardiac arrest prevention pathways and tools. (2009) (4)
Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines‐Heart Failure Registry (2022) (3)
Patterns of oral anticoagulation use with cardioversion in clinical practice (2020) (3)
Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus. (2019) (3)
Variability of adiposity indices and incident heart failure among adults with type 2 diabetes (2022) (3)
The 2017 AHA/ACC Performance and Quality Measures for Patients With Acute Myocardial Infarction. (2018) (3)
Is the Affordable Care Act Medicaid Expansion Associated with Receipt of Heart Failure Guideline-Directed Medical Therapy By Race and Ethnicity? (2021) (3)
Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019 (2021) (3)
Impact of Pulmonary Hypertension on In-Hospital Outcomes and 30-Day Readmissions Following Percutaneous Coronary Interventions. (2021) (3)
Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?-New Measures to Quantify Subclinical Systolic Dysfunction. (2021) (3)
Relationship of Hospital Teaching Status with In-Hospital Outcomes for ST-Segment Elevation Myocardial Infarction. (2017) (3)
Identifying Treatments for Stage C2 Heart Failure. (2021) (3)
Best of the AHA Scientific Sessions 2009 (2009) (3)
Assessment of Heterogeneity in Heart Failure–Related Meta-Analyses (2020) (3)
Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries (2022) (3)
Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results (2020) (3)
Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy? (2014) (3)
Rapid change in prescribing behavior in hospitals participating in Get With the Guidelines- Stroke after release of the MATCH clinical trial results (2007) (3)
OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CIRRHOSIS (2014) (3)
Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012). (2015) (3)
DO COUNTRIES OR HOSPITALS WITH LONGER STAYS HAVE LOWER READMISSION RATES? FINDINGS FROM THE ASCEND-HF TRIAL (2012) (3)
The American Heart Association's Get With the Guidelines coronary artery disease program is associated with improved care for men and women of all ages (2005) (3)
Racial and Ethnic Differences in Heart Failure Etiology, Prognosis, and Management (2014) (3)
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF (2022) (3)
Guideline-concordant-phenotyping: Identifying patient indications for implantable cardioverter defibrillators from electronic health records (2020) (3)
Classifying heart failure based on ejection fraction: imperfect but enduring (2022) (3)
Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure (2022) (3)
THE MYTH OF THE STABLE INR PATIENT: RESULTS FROM ORBIT-AF (2015) (3)
Income disparity and incident cardiovascular disease in older Americans. (2021) (3)
THE ASSOCIATION OF DISCHARGE ASPIRIN DOSE AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY (2013) (3)
Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-Day Readmission. (2021) (3)
Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry (2020) (3)
Progress or lack of progress in hospitalized heart failure (2013) (3)
Revisiting cardiac injury during acute heart failure: further characterization and a possible target for therapy. (2015) (3)
Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure (AVOID-HF) Trial (2015) (3)
A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients (2019) (3)
Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation: Insights From the American Heart Association Get With The Guidelines–Atrial Fibrillation Program (2018) (3)
Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations in COVID-19 Pandemic, March – October 2020 (2022) (3)
B-type natriuretic peptide and multimarker approaches in cardiovascular medicine. (2003) (3)
Heart Failure Performance Measures and Outcomes (2017) (3)
Get with the guidelines steering committee and hospitals, sex and racial differences in the use of implantable cardioverter & defibrillators among patients hospitalized with heart failure (2007) (3)
University of Groningen Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research (2017) (3)
Meta-Analysis Comparing Outcomes of Smokers Versus Nonsmokers With Acute Coronary Syndrome Underwent Percutaneous Coronary Intervention. (2018) (3)
Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes (2020) (3)
Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke. (2020) (3)
Abstract 3466: Hypertension Treatment and Control Among Patients Hospitalized with Heart Failure: An Analysis of Get With The Guidelines Heart Failure (2007) (3)
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry (2021) (3)
Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT‐HF risk model (2021) (3)
The Effect of Postural Changes on Intracardiac Filling Pressures (2008) (3)
Systolic Blood Pressure and Outcomes in Patients Hospitalized With Acute Heart Failure—Reply (2007) (3)
COMPARISON OF SYMPTOMS AND QUALITY OF LIFE IN ATRIAL FIBRILLATION: RESULTS FROM THE ORBIT-AF REGISTRY (2012) (3)
Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19 (2021) (3)
Abstract 169: Contemporary Trends in Utilization and Outcomes of Percutaneous Ventricular Assist Devices in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction in the United States (2015) (3)
Acute heart failure syndromes: Potential strategies to improve post-discharge outcomes (2008) (3)
The New Hypertension Guidelines: Compelling Population Benefit, Manageable Risk, and Time to Implement. (2018) (3)
Aggressive treatment of atherosclerosis: the time is now. (2003) (3)
RACIAL/ETHNIC DIFFERENCES IN ATRIAL FIBRILLATION SYMPTOMS, TREATMENT PATTERNS, AND OUTCOMES: INSIGHTS FROM OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT FOR ATRIAL FIBRILLATION (ORBIT-AF) REGISTRY (2015) (3)
Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations (2015) (3)
Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey. (2022) (3)
Is Risk-Standardized In-Hospital Stroke Mortality an Adequate Proxy for Risk-Standardized 30-Day Stroke Mortality Data?: Findings From Get With The Guidelines–Stroke (2017) (3)
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended. (2022) (3)
FACTORS ASSOCIATED WITH HOSPITAL LENGTH OF STAY IN ACUTE HEART FAILURE IN THE UNITED STATES (2014) (3)
Abstract W MP99: Race/Ethnic and Sex Differences in EMS Transport among Hospitalized U.S. Stroke Patients: Analysis of the National Get With The Guidelines-Stroke Registry (2015) (3)
MANAGEMENT AND OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND CANCER: THE ORBIT-AF REGISTRY (2016) (3)
Patterns and Predictors of Discharge Statin Prescription Among Hospitalized Patients With Intracerebral Hemorrhage (2010) (3)
Post‐discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial (2019) (3)
Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure-There Is No Time for Delay. (2021) (3)
[Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure]. (2011) (3)
Exploring the Potential Benefits and Risks of Anticoagulation for Atrial Fibrillation During Hospitalization for Sepsis. (2016) (3)
Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. (2022) (3)
Longitudinal Trajectories of Hospital Performance across Targeted Cardiovascular Conditions in the United States. (2019) (3)
Relationship between Hospital 30-Day Mortality Rates for Heart Failure and Patterns of Early Inpatient Comfort Care (2018) (3)
The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes (2011) (3)
Abstract 252: PredischaRge Initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial (2019) (3)
Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries (2020) (2)
Heart Failure Self-care Associated With Brain Injury in Executive Control Regions. (2016) (2)
Intracoronary dexmedetomidine does not produce coronary vasoconstriction at therapeutic blood levels in chronically instrumented anaesthetized swine (1994) (2)
Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction. (2022) (2)
PREDICTORS OF IN-HOSPITAL MORTALITY IN A CONTEMPORARY ACUTE MYOCARDIAL INFARCTION POPULATION: RESULTS FROM THE ACTION REGISTRY-GET WITH THE GUIDELINES PROGRAM (2010) (2)
Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke (2022) (2)
Assessing clinical risk prediction tools. (2007) (2)
Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure". (2018) (2)
Improved survival with statin therapy in ischemic and non-ischemic heart failure (2003) (2)
GW29-e1002 The current status of cardiac rehabilitation guidance before discharge for patients with acute coronary syndrome in China: Findings from CCC - ACS Project (2018) (2)
Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes? (2018) (2)
An Unmet Need in Heart Failure (2009) (2)
Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente. (2016) (2)
Abstract 14: Clinical Characteristics and Treatment Patterns of Medicaid Patients with Atrial Fibrillation: Insights From the ORBIT-AF I Registry (2015) (2)
Directions for research in the post-myocardial infarction patient with left ventricular dysfunction. (2008) (2)
When Payment Models Distort Perceptions and Care Delivery forPatients With Heart Failure. (2019) (2)
Heart failure: Wireless hemodynamic monitoring—a new approach for managing HF (2011) (2)
Abstract 86: Progress in Achieving More Rapid Door-to-Needle Times in Acute Ischemic Stroke: Interim Findings From Target: Stroke Phase II (2017) (2)
Abstract WP403: Factors Associated With Patient-Reported Shared Decision-Making for Stroke Prevention in Atrial Fibrillation (2019) (2)
Should I Participate in a Cardiac Rehabilitation Program? (2018) (2)
Abstract 2947: Evolving Patterns of Use of Aldosterone Inhibition in Chronic Heart Failure; A Report from Get with the Guidelines HF (2008) (2)
QT dispersion and malignant ventricular arrhythmia in patients with end-stage heart failure caused by ischemic vs. idiopathic cardiomyopathy (1996) (2)
The Need for Speed. (2018) (2)
Proton Pump Inhibitors and In-Hospital Gastrointestinal Bleeding in Patients With Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy. (2022) (2)
Abstract 2736: The Effect of Increased Hemoglobin Concentration on Clinical Outcomes in Patients With Symptomatic Heart Failure and Anemia: Results From STAMINA-HeFT (2006) (2)
Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction. (2019) (2)
Admission, Discharge, or Change in BNP and Long-Term Outcomes: Data from OPTIMIZE-HF Linked to Medicare Claims (2011) (2)
Time to intravenous therapy and clinical outcomes in older patients presenting with acute decompensated heart failure: an analysis of the adhere registry emergency module (2013) (2)
Abstract 103: Temporal Trends in Patient Characteristics and Use of IV tPA in Acute Ischemic Stroke Patients Treated at GWTG-Stroke Hospitals (2013) (2)
Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16]. (2017) (2)
The association of pre‐ and posthospital medication adherence in myocardial infarction patients (2019) (2)
Abstract 29: Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population-Based Study (2014) (2)
ORAL ANTICOAGULANT SELECTION IN COMMUNITY PATIENTS WITH NEW-ONSET ATRIAL FIBRILLATION: RESULTS FROM THE ORBIT-AF II REGISTRY (2016) (2)
Documentation of QRS Duration and NYHA Class in HF Patients after a Performance Improvement Initiative: IMPROVE HF (2010) (2)
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure (2021) (2)
Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction. (2008) (2)
Risk Stratification Models and Predictors of Mortality in Acute Heart Failure Syndromes, Based on United States Registries (2008) (2)
Statins are associated with improved survival in advanced heart failure irrespective of total cholesterol levels (2004) (2)
Heart failure clinical trials: how do we define success?: Heart failure (2013) (2)
Assessing Risks of Glucose Lowering Therapy in Heart Failure: Should We Rely on Post-hoc Analyses? (2016) (2)
Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry (2020) (2)
1031–33 Intravenous Triiodothyronine in Patients with Advanced Heart Failure (1995) (2)
Abstract P35: Mild or Improving Stroke is the Most Frequently Documented Reason for Not Giving rt-PA in Time-Eligible Acute Ischemic Stroke Patients: Findings From Get With the Guidelines-Stroke (2011) (2)
Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial (2018) (2)
Low Serum Albumin Levels Are Strongly Associated with Inflammation but Not with Body Mass Index in Advanced Heart Failure Patients (2007) (2)
Frequency, Characteristics, and Outcomes of Endovascular Thrombectomy in Patients With Stroke Beyond 6 Hours of Onset in US Clinical Practice (2021) (2)
In-hospital initiation of statin therapy in patients with acute coronary events (2003) (2)
CHRONIC OPIOID USE IS ASSOCIATED WITH SIGNIFICANT HIGHER 12-MONTH ALL-CAUSE READMISSION AND ALL-CAUSE MORTALITY BUT NOT ASSOCIATED WITH 30-DAY ALL-CAUSE READMISSION OR ALL-CAUSE MORTALITY IN OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2016) (2)
A COST-EFFECTIVENESS ANALYSIS IN THE US OF LCZ696 (SACUBITRIL/VALSARTAN) VERSUS RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION (2016) (2)
Influence of the American Heart Association's Get With The Guidelines (GWTG) Program on the Quality of Care for Patients Hospitalized with Heart Failure (2006) (2)
Abstract 203: Health Status Variations Across Practices in Outpatients With Heart Failure: Health Status Variations Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry (2018) (2)
Prognostic implications of pre-existing medical comorbidity in Takotsubo cardiomyopathy (2020) (2)
Admission, Discharge, or Change in BNP and Long-Term Mortality: Data from OPTIMIZE-HF Linked with Medicare Claims (2010) (2)
LONGITUDINAL CHANGES IN MEDICATION DOSING AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FROM THE CHAMP-HF REGISTRY (2019) (2)
A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option (2021) (2)
Abstract 16415: Patterns of Atrial Fibrillation and Treatment Strategies Vary According to Provider Specialty Across Community Practice Settings: Findings From the ORBIT-AF Registry (2011) (2)
Role of β-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction. The post-myocardial infarction guideline committee (2003) (2)
Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. (2021) (2)
Prevalence and temporal trends of anemia in patients with heart failure. (2021) (2)
Initial changes in peak aortic jet velocity and mean gradient predict progression to severe aortic stenosis (2019) (2)
Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure. (2020) (2)
The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE‐ACS study (2018) (2)
Temporal Trends in Racial and Ethnic Disparities in Endovascular Therapy in Acute Ischemic Stroke (2022) (2)
Lack of Improvement in 30-day Readmission Rates for Patients Hospitalized with Heart Failure: Data from Get With The Guidelines-Heart Failure Registry (2015) (2)
Abstract 159: Trends in Dual Antiplatelet Therapy Prescription Patterns for Secondary Prevention in Patients With Noncardioembolic Ischemic Stroke (2020) (2)
The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation. (2011) (2)
New insights into understanding cardiometabolic risk. Introduction. (2007) (2)
REPORT‐HF: the unique blend of global heart failure registry and longitudinal cohort study (2015) (2)
National surveillance of stroke quality of care and outcomes by applying post-stratification survey weights on the Get With The Guidelines-Stroke patient registry (2020) (2)
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction. (2023) (2)
Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes (2018) (2)
Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States. (2023) (2)
Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors (2021) (2)
Reply: To PMID 23273288. (2013) (2)
Optimal blood pressure levels in patients with coronary artery disease. (2006) (2)
Cardiovascular clinical trials with noninferiority or equivalence designs from 2001 to 2012. (2016) (2)
Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US. (2022) (2)
Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry. (2022) (2)
US Surveillance of Acute Ischemic Stroke Patient Characteristics, Care Quality, and Outcomes for 2019 (2022) (2)
Temporal Associations and Outcomes of Breast Cancer and Heart Failure in Postmenopausal Women (2020) (2)
EQUITABLE IMPROVEMENT FOR WOMEN AND MEN IN THE USE OF GUIDELINE-RECOMMENDED THERAPIES FOR HEART FAILURE: FINDINGS FROM IMPROVE HF (2010) (2)
Primary and Secondary Prevention Strategies for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device: A Systematic Review and Network Meta-analysis. (2021) (2)
Clinical Effectiveness of CRT and ICD Therapy in Men and Women with Heart Failure: Findings from IMPROVE HF (2013) (2)
Dilated cardiomyopathy can result from mutations in sarcomere protein genes. (2001) (2)
Reply: What Is Important for Digoxin Treatment in Patients With Heart Failure. (2019) (2)
Probing the Effective Treatment Thresholds for Alteplase in Acute Ischemic Stroke With Regression Discontinuity Designs (2020) (2)
Association Between 2010 Medicare Reforms and Utilization of Postacute Inpatient Rehabilitation in Ischemic Stroke (2020) (2)
Anticipating a New Era in Heart Transplantation. (2020) (2)
Abstract 2382: The Influence of Electronic Health Records on Quality of Care for Heart Failure (2008) (2)
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation (2020) (2)
Nutritional supplementation with amino acids in cardiovascular and metabolic diseases: hypermetabolic syndrome as a therapeutic target. Introduction. (2008) (2)
Abstract 50: Shape of the TPA Time - Benefit Curve: Insights From The National US Get With The Guidelines - Stroke Population (2015) (2)
Length of stay and readmission in older adults hospitalized for heart failure (2020) (2)
Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults with Type 2 Diabetes. (2022) (2)
Embolic myocardial infarction in atrial fibrillation: multiple territory injury revealed by cardiac magnetic resonance (2010) (2)
Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥ 65 Years of Age with a Low Ejection Fraction Following Coronary Revascularization. (2020) (2)
INCIDENCE OF RECURRENT MYOCARDIAL INFARCTION AMONG OLDER ADULTS IN U.S. COMMUNITY PRACTICE (2017) (2)
Abstract 3280: Heart Failure Quality of Care in the Outpatient Cardiology Practice Setting: A Report from IMPROVE HF (2007) (2)
Profile of Patients Hospitalized for Heart Failure Who Leave Against Medical Advice. (2021) (2)
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients with HFrEF: Results from the CONNECT-HF Trial. (2022) (2)
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II) (2021) (2)
Sacubitril/valsartan Initiation and Adherence Patterns Following Hospitalization for Heart Failure (2020) (2)
Impediments to Implementing Guideline-Directed Medical Therapies. (2019) (2)
Transforming the Paradigm for Lipid Lowering. (2021) (2)
Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis (2022) (2)
DOES FRAILTY ALTER THE BENEFITS OF ORAL ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION (2017) (2)
Abstract 2740: Influence of the American Heart Association's Get with the Guidelines Heart Failure (GWTG-HF) Program on Emerging Performance Measures for Patients Hospitalized with Heart Failure (2006) (1)
Abstract 12509: Initial Reports on the Safety of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Novel Oral Anticoagulants (NOACs) (2015) (1)
Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry (2021) (1)
Sex Differences in Endovascular Therapy for Ischemic Stroke: Results From the Get With The Guidelines–Stroke Registry (2022) (1)
TEMPORAL TRENDS IN REVASCULARIZATION AND OUTCOMES OF ST-ELEVATION MYOCARDIAL INFARCTION IN YOUNGER ADULTS IN THE UNITED STATES (2015) (1)
Sleep-disordered breathing in heart failure (2003) (1)
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock. (2022) (1)
Letter to editorReply (2002) (1)
Abstract 1176: Exercise Training and Heart Failure: Will Patients Feel Better If They Exercise? (2009) (1)
Predictors of natural killer cell-mediated cytotoxicity deficiency in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. (1997) (1)
Prosthesis – Patient Mismatch in 62,125 Patients Following Transcatheter Aortic Valve Replacement (2018) (1)
Reply: Diuretics After Heart Failure Hospitalization, Not for All! (2020) (1)
Gaps in the Heart Failure Guidelines. (2015) (1)
Abstract 227: Aldosterone Antagonists in Post-Acute Myocardial Infarction Use, Predictors, and Temporal Trends of a Class I Recommendation (2012) (1)
Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction. (2014) (1)
Do psychological scores improve as an effect of time and treatment in advanced heart failure patients (2003) (1)
Insulin resistance and incident heart failure: a meta‐analysis (2022) (1)
Telemedicine in Heart Failure-Ineffective or Just Ill Used?-Reply. (2016) (1)
Abstract 115: Improving Door-to-Needle Times in Acute Ischemic Stroke: Interim Findings From Target: Stroke Phase II (2016) (1)
Questions and Answers (2012) (1)
Medication-Attributable Adverse Events in Heart Failure Trials. (2023) (1)
, Among Patients With Heart Failure and Atrial Fibrillation Associations Between Anticoagulation Therapy and Risks of Mortality and Readmission (1)
Association Between Hospital Volumes and Clinical Outcomes for Patients With Nontraumatic Subarachnoid Hemorrhage (2021) (1)
Patterns of Care for First-detected Atrial Fibrillation: Insights from the Get With The Guidelines Atrial Fibrillation Registry. (2022) (1)
Abstract 18649: Comparative Impact of Isolated Systolic Hypertension vs Systolic-Diastolic Hypertension on Incident Heart Failure and All-Cause Mortality in Community-Dwelling Older Adults (2014) (1)
Quality of Care Among Patients with Diabetes and Cerebrovascular Disease. Insights from The Diabetes Collaborative Registry. (2022) (1)
COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis (2022) (1)
Abstract 342: Differences in Health Care Utilization and Outcomes Based on Timing of In-Hospital Worsening Heart Failure (2015) (1)
Cardiac autonomic dysfunction and risk of incident stroke among adults with type 2 diabetes (2022) (1)
Periprocedural Risk and Survival after ICD Placement in Patients with Advanced Heart Failure (2018) (1)
Abstract 12064: Low Income, Regardless of Education Level, is a Significant Independent Predictor of Incident Heart Failure in Community-Dwelling, Medicare-Eligible Older Adults (2011) (1)
Abstract 3993: Quality of Care for Heart Failure Patients with Concomitant Kidney Disease in the American Heart Association’s Get With The Guidelines Heart Failure (GWTG-HF) Program (2006) (1)
Abstract WMP34: Use of Intravenous Tissue Plasminogen Activator in Patients Without a Stroke (Stroke Mimics): Findings From the get With the Guidelines Stroke Registry (2016) (1)
Baseline Hypokalemia and Long-Term Outcomes in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) and New York Heart Association Class III-IV: A Propensity-Matched Study of Beta-Blocker Evaluation of Survival Trial (BEST) (2016) (1)
POOR OUTCOMES ASSOCIATED WITH DIGOXIN DISCONTINUATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) MAY DIFFER BY BETA-BLOCKER USE (2020) (1)
Does the American Heart Association's Get With the Guidelines program improve the quality of cardiovascular care in hospitalized patients with diabetes (2004) (1)
Reviewers for the Journal, January-June 2016. (2016) (1)
Trends in Heart Failure-Related Mortality Among Older Adults in the United States From 1999-2019. (2022) (1)
Sodium–glucose co‐transporter 2 inhibitors for heart failure: clinical trial efficacy and clinical practice effectiveness (2021) (1)
Trends in Bleeding Events Among Patients With Acute Coronary Syndrome in China, 2015 to 2019: Insights From the CCC-ACS Project (2021) (1)
Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities (1)
Is exercise adherence related to clinical outcomes in patients with advanced heart failure (2010) (1)
Abstract 99: Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population (2013) (1)
2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention (2014) (1)
Abstract 4142: Metabolic Syndrome in Patients with CAD: Is it More than Obesity? Analysis of 79,677 Hospitalizations in Get with the Guidelines (2006) (1)
Race, Social Determinants of Health, and Length of Stay Among Hospitalized Patients With Heart Failure: An Analysis From the Get With The Guidelines-Heart Failure Registry (2022) (1)
Abstract 13642: Hospitalist Care and Associated Outcomes for Patients Hospitalized with Heart Failure: Insights from Get With The Guidelines-Heart Failure (2011) (1)
PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN (2019) (1)
The vagrancy of B-type natriuretic peptide levels in heart transplant recipients receiving tacrolimus (2003) (1)
Neighborhood Household Income and Trends in 30-Day Readmission for Patients With Heart Failure. (2022) (1)
What factors increase anxiety and depression in advanced heart failure (2006) (1)
SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. (2022) (1)
MANAGEMENT AND OUTCOMES OF ST-ELEVATION MYOCARDIAL INFARCTION IN RENAL TRANSPLANT RECIPIENTS VERSUS END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS (2016) (1)
Abstract 214: Trends in Venous Thromboembolism in Hospitalized Heart Failure Patients in the United States: Analysis of the 2002 to 2011 Nationwide Inpatient Sample Database (2014) (1)
Abstract WP312: The Association of Chronic Kidney Disease (CKD) With 30-day and 1-year Post Ischemic Stroke Mortality and Rehospitalization: Get With the Guidelines (GWTG) Stroke (2016) (1)
Abstract 336: Real-World Experiences with Novel Anticoagulants for AF: Initial Insights from ORBIT-AF Phase II (2014) (1)
Abstract 29: Low Socioeconomic Status and Longer Home-to-Hospital Distances Are Associated With Less Timely Treatment of Ischemic Stroke (2019) (1)
Cost-Effectiveness of Comprehensive Quadruple Therapy for Heart Failure With Reduced Ejection Fraction. (2023) (1)
Abstract P105: Women with Atrial Fibrillation have Increased Risk of Incident Stroke: Insights from a Propensity-Matched Study of the AFFIRM Trial (2012) (1)
TRENDS IN RACIAL DIFFERENCES IN 30-DAY READMISSION RATE FOR ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS FROM THE NCDR CHEST PAIN-MI REGISTRY (2019) (1)
Abstract 159: Treatment with Intravenous Tissue Plasminogen Activator in the “Golden Hour” in the National US Get With The Guidelines-Stroke Population (2015) (1)
Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program". (2017) (1)
Cryptogenic stroke: Contemporary trends, treatments, and outcomes in the United States. (2019) (1)
CLINICAL PROFILES, MEDICAL THERAPIES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HF ACROSS THE SPECTRUM OF KIDNEY FUNCTION: THE GWTG-HF REGISTRY (2021) (1)
Risk of Stroke in Older Adults With Heart Failure. (2022) (1)
The Association of Digital Health Application Use with Heart Failure Care and Outcomes: Insights from CONNECT-HF. (2022) (1)
Abstract 16855: Machine Learning Generated Risk Model to Predict Unplanned Hospital Admission in Heart Failure (2017) (1)
New Insights into Understanding Cardiometabolic Risk (1)
Abstract 1: Patient and Hospital Factors Associated with Lack of IV tPA Use among Eligible Patients with Acute Ischemic Stroke: Findings from Get with the Guidelines-Stroke (2013) (1)
Abstract 13246: Data Quality in the American Heart Association Get With the Guidelines-Stroke: Results from a National Data Validation Audit (2011) (1)
Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study (2022) (1)
Acute ischemic stroke and timing of treatment--reply. (2013) (1)
Abstract 18832: The ORBIT-AF Bleeding Score: a Simple Score to Assess Major Bleeding Risk in Atrial Fibrillation (2014) (1)
Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus (2020) (1)
Patterns of Care for Atrial Fibrillation Before, During, and at Discharge From Hospitalization (2021) (1)
Abstract 12863: Sex Differences for Heart Failure Patients with Preserved and Reduced Systolic Function: Data from the American Heart Association Get With the Guidelines-Heart Failure (2011) (1)
Analysis of triple drug therapy in heart failure: cumulative benefit? (2003) (1)
ESTIMATING HEALTH CARE EXPENDITURE ON HEART FAILURE IN THE UNITED STATES: THE MEDICAL EXPENDITURE PANEL SURVEY 2008-2017 (2021) (1)
Proactive monitoring and management of the chronic heart failure patient. Introduction. (2006) (1)
Abstract 2394: Metformin Therapy in Advanced, Systolic Heart Failure Patients with Diabetes is Associated with Improved Survival and Improved Cardiac Function (2008) (1)
Abstract 11118: Temporal Trends in Clinical Characteristics of Patients Without Known Coronary Artery Disease Presenting With a First Episode of Myocardial Infarction (2013) (1)
Abstract 12794: Hospital Length of Stay and Readmissions Post Heart Failure Hospitalization in the EVEREST Trial (2014) (1)
News thefrom NCDR Treatments , Trends , and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary Intervention (2010) (1)
THE ASSOCIATION OF LEFT VENTRICULAR EJECTION FRACTION WITH 1-YEAR MORTALITY AFTER MYOCARDIAL INFARCTION: FINDINGS FROM THE ACTION REGISTRY-GWTG MEDICARE LINKED DATABASE (2015) (1)
TEMPORAL TRENDS IN TREATMENT AND OUTCOMES FOR ADVANCED SYSTOLIC HEART FAILURE FROM 1993 TO 2010: FINDINGS FROM A UNIVERSITY REFERRAL CENTER (2012) (1)
USE OF NON-AMLODIPINE CALCIUM CHANNEL BLOCKERS IS NOT ASSOCIATED WITH OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (2013) (1)
Abstract WP280: Use of Strategies to Improve Door-to-Needle Times with Tissue Plasminogen Activator in Acute Ischemic Stroke by US Hospitals: Findings from the Target: Stroke Survey (2013) (1)
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness afterMyocardial Infarction Study ( ARTEMIS ) : A multicenter , cluster-randomized trial of P 2 Y 12 receptor inhibitor copayment reduction after myocardial infarction (2016) (1)
Abstract 1580: Prediction of In-Hospital Mortality in Ischemic Stroke Using Data From Get With the Guidelines Stroke (2009) (1)
Burden of Microvascular Disease and Risk of Atrial Fibrillation in Adults with Type 2 Diabetes. (2022) (1)
Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis (2022) (1)
ORTHOSTATIC HYPOTENSION: A NEW RISK FACTOR FOR INCIDENT HEART FAILURE IN COMMUNITY-DWELLING OLDER ADULTS (2011) (1)
223: Brain Gray Matter Loss in Heart Failure Is Gender-Dependent (2009) (1)
Abstract TMP79: Use of Intravenous Tissue Plasminogen Activator in Patients With History of Prior Stroke Plus Diabetes Mellitus (2019) (1)
Erratum: Variables Measured during Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure (Journal of the American College of Cardiology (2016) 67 (780-789)) (2016) (1)
Abstract 384: Affordable Care Act Medicaid Expansion Then and Now: Racial/Ethnic Differences in Receipt of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations (2020) (1)
One- to 10-Day Versus 11- to 30-Day All-Cause Readmission and Mortality in Older Patients With Heart Failure. (2019) (1)
Cardiovascular disease in African Americans. Closing the knowledge, treatment, and outcome gap. (2004) (1)
Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke (2021) (1)
Obesity, weight reduction and survival in heart failure [1] (multiple letters) (2002) (1)
National Trends in Age-Adjusted Heart Failure Hospitalizations From 2002 to 2013 by Gender and Ethnicity (2016) (1)
Patients with Higher Fat Mass Have Longer Survival in Heart Failure (2014) (1)
Reply (2013) (1)
Chronic Kidney Disease and Higher Risk of 30-Day All-Cause Readmissions in Heart Failure: Findings from a Propensity-Matched Study (2014) (1)
Kidney function assessment and endpoint ascertainment in clinical trials. (2021) (1)
Abstract 1124: Greater Brain Hippocampal Volume Loss in Female Over Male Heart Failure Patients (2009) (1)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial) : a randomised, double-blind, placebo-controlled trial. Commentary (2008) (1)
Abstract 16785: Atrial Fibrillation Clinical Phenotypes: A Cluster Analysis (2017) (1)
In-Hospital Weight Loss and Outcomes in Patients with Heart Failure (2021) (1)
Abstract 4348: Quality of Acute Myocardial Infarction Care and Outcomes in 33,997 Patients Aged 80 Years or Older: Results From GWTG-CAD (2009) (1)
Major Depression and Anxiety Among Patients Hospitalized with Heart Failure. (2020) (1)
Do Hospitals That Provide Heart Failure Patient Education Prior To Discharge Also Promote Continuity of Care? A Report from OPTIMIZE-HF (2006) (1)
Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. (2022) (1)
Does the AHA get with with guidelines program improve the quality of care in hospitalized patients with coronary artery disease at both teaching and non-teaching hospitals (2003) (1)
Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease (2021) (1)
Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure (1)
Abstract 15541: In-Hospital Mortality in Obese Patients With Cardiogenic Shock Complicating Non-ST- and ST-Elevation Myocardial Infarction (2013) (1)
Characteristics of patients with stage D heart failure: Initial report from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE®-LM) (2005) (1)
DIURETIC DOSE AND OUTCOMES AMONG HOSPITALIZED HEART FAILURE PATIENTS: INSIGHTS FROM THE EVEREST TRIAL (2013) (1)
Future of Quality and Outcomes Research in Stroke. (2015) (1)
Abstract 19403: Gender and Socioeconomic Disparities With Health Status in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry (2017) (1)
Beneficial effects of weight loss associated with a high protein diet on cardiovascular risk profile, functional status and quality of life in obese heart failure patients: A feasibility study (2007) (1)
Prioritizing prevention of de novo and worsening chronic heart failure (2022) (1)
Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial. (2019) (1)
Abstract 248: IMPLEMENT-HF: An Initiative To Improve Guideline Adherence Across The Continuum (2022) (1)
Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry (2014) (1)
Abstract 17467: Percutaneous Coronary Intervention Among Patients With non-ST-segment Elevation Myocardial Infarction and Unstable Angina: Findings From the Improving Care for Cardiovascular Disease in China Project (2016) (1)
Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 score (2020) (1)
GW29-e1001 The use of P2Y12 inhibitors in ACS patients with culprit lesion of left main disease in China: findings from the CCC-ACS Project (2018) (1)
067 - Stroke and Myocardial Infarction Risk among Newly Diagnosed Heart Failure Patients with Reduced, Borderline, and Preserved Left Ventricle Ejection Fraction (2017) (1)
ANTI-HYPERGLYCEMIC MEDICATION USE AMONG MEDICARE BENEFICIARIES WITH HEART FAILURE, DIABETES, AND CHRONIC KIDNEY DISEASE (2015) (1)
Association Between Hospital Transcatheter Aortic Valve Replacement Volume and 30-Day Readmissions (2017) (1)
EFFICACY AND SAFETY OF PRETREATMENT AONG CONTEMPORARY ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY (2014) (1)
Abstract 168: The ADHERE Risk Model for In-hospital Worsening Heart Failure (2015) (1)
Response to letter regarding article, "Four-variable risk model in men and women with heart failure". (2014) (1)
Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice. (2003) (1)
TEN-YEAR MORTALITY OF ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED IN U.S. COMMUNITY PRACTICE (2017) (1)
Albuminuria and Heart Failure: JACC State-of-the-Art Review. (2023) (1)
PRIMARY PAYER STATUS AND OUTCOMES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2014) (1)
THE ASSOCIATION OF BETA-BLOCKER USE AND SELECTIVITY WITH OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM THE ORGANIZED PROGRAM TO INITIATE LIFE-SAVING TREATMENT IN HOSPITALIZED PATIENTS WITH HEART FAILURE (2012) (1)
1049-115 The value of B-type natriuretic peptide and cardiac troponin I as predictors of sudden death in patients with advanced heart failure (2004) (1)
ASSOCIATION OF ATRIAL FIBRILLATION AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF) (2019) (1)
Abstract 130: Clinically Important Difference in the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Score: Results from the ORBIT-AF Registry (2016) (1)
CARE AND OUTCOMES OF ASIAN ACUTE MYOCARDIAL INFARCTION PATIENTS: RESULTS FROM THE AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-CORONARY ARTERY DISEASE PROGRAM (2011) (1)
Patient Characteristics, Care Patterns, and Outcomes of Atrial Fibrillation Associated Hospitalizations in Patients with Chronic Kidney Disease and End-Stage Renal Disease. (2021) (1)
Abstract 17470: Quality of Care for Patients Hospitalized With Acute Coronary Syndrome in China: Findings From the Improving Care for Cardiovascular Disease in China (CCC) Project - Acute Coronary Syndrome Program (2016) (1)
National Trends in Heart Failure Hospitalization and Readmissions Associated With Policy Changes-Reply. (2021) (1)
Making heart failure count (2021) (1)
Sex-based differences in patients hospitalized with acute decompensated heart failure (2003) (1)
How Do Readmissions Impact Survival Among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS (2014) (1)
A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction (2022) (1)
Abstract 12886: In-hospital and Early Post-discharge Troponin Elevations Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial (2016) (1)
Abstract 16: Low Rates of Implantable Cardioverter-Defibrillator Use Among Medicare Patients with Low Ejection Fraction After Myocardial Infarction (2014) (1)
Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart Failure (2018) (1)
Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack. (2019) (1)
Abstract 15002: Hospital Strategies to Address Non-Adherence to Guideline-Recommended Dual Antiplatelet Therapy After Myocardial Infarction: Findings From the Affordability and Real-World Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS) (2016) (1)
GENDER AND RACIAL/ETHNIC DIFFERENCES IN SURVIVAL AFTER CARDIOPULMONARY RESUSCITATION FOR IN-HOSPITAL CARDIAC ARREST (2014) (1)
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation (2022) (1)
Remote Patient Management After Discharge of Hospitalized Heart Failure Patients: The Better Effectiveness After Transition - Heart Failure Study (2015) (1)
Lack of Association Between Spironolactone Use and 30-Day All-Cause Readmission In Hospitalized Medicare Beneficiaries With Systolic Heart Failure Eligible for Spironolactone Therapy (2014) (1)
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration. (2023) (1)
Abstract 9992: Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) (2015) (1)
Influence of Race on Improvements in Use of Guideline Recommended Heart Failure Therapies: Findings from IMPROVE HF (2010) (1)
Sex Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients with Pulmonary Embolism. (2022) (1)
Relationships between Weight, Adiposity, Functional Status, and Left Ventricle Characteristics in Overweight and Obese Patients with Heart Failure (2017) (1)
Higher not lower systolic blood pressure is independently associated with improved survival in heart failure (2004) (1)
Atrial fibrillation no longer increases mortality in advanced heart failure: A longitudinal study of 750 patients (1996) (1)
Levels in Patients With Coronary Artery Disease (2004) (1)
Role of Neurohormonal Antagonists in Management of Patients With Hypertension, Metabolic Syndrome, and Diabetes (2004) (1)
THIRTY-DAY READMISSION RATE AND COST AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES: A NATIONAL READMISSION DATABASE ANALYSIS (2017) (1)
Abstract P167: High vs. Standard Protein Diets in Obese Patients with Heart Failure: Effects on Chronic Disease Risks (2017) (1)
Tuesday, 28 August 2012 (2012) (1)
Gaps in the Heart Failure Guidelines. (2014) (1)
Chronic heart failure: applying new findings to optimize care and improve survival. Introduction. (2004) (1)
Exploring the Unmet Need in Acute Ischemic Stroke Patients Not Treated With Intravenous Alteplase: The Get With The Guidelines‐Stroke Registry (2021) (1)
REGIONAL DIFFERENCES IN CLINICAL PROFILE, QUALITY OF CARE AND OUTCOMES AMONG HISPANIC PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION IN THE GET WITH GUIDELINES-CORONARY ARTERY DISEASE REGISTRY (2011) (1)
The quality of care for patients hospitalized with ischemic verses nonischemic heart failure in the American Heart Association's Get With the Guidelines (GWTG-HF) Program (2007) (1)
Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure with Reduced Ejection Fraction: Beta-Blocker and outcomes in HFrEF by RVEF. (2021) (1)
Time to Revisit Using 10-Year Risk to Guide Statin Therapy. (2022) (1)
Reply (2020) (1)
Abstract 19900: Lack of Patient Understanding of Stroke Risk and Treatment Strategies in Those With Newly Diagnosed Atrial Fibrillation: A Concern and an Opportunity (2016) (1)
Strategies to reduce heart failure readmissions--reply. (2014) (1)
TCT-2 Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from the TRANSLATE-ACS Observational Study (2013) (1)
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice (2020) (1)
TCT-494 Safety and Effectiveness of Prasugrel vs. Clopidogrel in the Setting of Bivalirudin vs. Heparin Use: 30-day Results from TRANSLATE-ACS (2014) (1)
Implantable Cardioverter-Defibrillator Use AmongMedicare PatientsWith Low Ejection Fraction After AcuteMyocardial Infarction (2015) (1)
Importance of in-hospital initiation of evidence-based medical therapies for heart failure: taking advantage of the teachable moment. (2005) (1)
Abstract 141: Outcomes Associated with Temporarily Interrupting Anticoagulation in Outpatients with Atrial Fibrillation: Results from ORBIT-AF (2014) (1)
Impact of BMI on Heart Failure by Race/Ethnicity from Get With The Guidelines-Heart Failure Registry (2018) (1)
Abstract 18746: Variation in Intravenous Inotrope Use for Patients Hospitalized with Heart Failure: Data from Get withthe Guidelines (2012) (0)
Clinical Assessment Using Magnetic Resonance Imaging Detects Brain Injury to Regions that Control Memory and Executive Function in Heart Failure (2012) (0)
Abstract 17143: Shorter Length of Stay is Associated With Significantly Lower 30-day All-cause Readmission and 30-day All-cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure (2015) (0)
Use of Target Doses of Guideline Directed Medical Therapy in Heart Failure by Systolic Blood Pressure: Insights from the CHAMP-HF Registry (2018) (0)
EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE (2018) (0)
Abstract 18426: Impact of Body Mass Index on Heart Failure With Preserved or Reduced Ejection Fraction: Outcomes According to Race and Ethnicity From Get With The Guidelines-Heart Failure (GWTG-HF) Registry (2015) (0)
SMOKING STATUS AND SURVIVAL AFTER CARDIOPULMONARY RESUSCITATION FOR IN-HOSPITAL CARDIAC ARREST: ANALYSIS OF THE 2003-2011 NATIONWIDE INPATIENT SAMPLE DATABASES (2014) (0)
QUALITY OF CARE AND OUTCOMES AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CHRONIC RENAL INSUFFICIENCY: REPORT FROM THE GET WITH THE GUIDELINES PROGRAM (2011) (0)
HIGH AND LOW COST HOSPITAL STAYS FOR ACUTE HEART FAILURE IN THE US: FINDINGS FROM THE NATIONWIDE INPATIENT SAMPLE (NIS) 2011 (2014) (0)
Acute Heart Failure Syndromes: Current and Investigational Pharmacotherapeutic Options (2006) (0)
Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Insights From the Organized Program to Initiate Lifesaving Treatment in Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure: (2011) (0)
The reply. (2015) (0)
Abstract 233: Trends in Referral to Post-Acute Care Services after an Acute Stroke Hospitalization in the U.S.: Findings from the Get With The Guidelines-Stroke Program (2013) (0)
Abstract 18750: Systemic Lupus Erythematosus is Associated With Higher In-hospital Mortality Among Patients Hospitalized With Heart Failure: Findings From a United States National Study (2015) (0)
Modern Management of Chronic Heart Failure: From Stage a to Stage D and beyond (2006) (0)
981-52 Six-minute Walk Compared to Peak and Low-level Aerobic Capacity in 302 Patients with Heart Failure (1995) (0)
PRIOR HEART FAILURE (HF) HOSPITALIZATION AND 30-DAY AND 1-YEAR OUTCOMES IN PATIENTS WITH HF AND PRESERVED EJECTION FRACTION (HFPEF) (2018) (0)
Outcomes of Endovascular Therapy in Patients With Prestroke Mobility Impairment (2021) (0)
Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized with Heart Failure (2019) (0)
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease. (2023) (0)
OUTCOMES OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A UNITED STATES POPULATION-BASED STUDY (2015) (0)
Temporal Trends of Digoxin Use in Patients Hospitalized with Heart Failure: Analysis From the American Heart Association Get With The Guidelines - Heart Failure Registry (2015) (0)
Reply: The AVOID-HF Trial: Points to Consider. (2016) (0)
A Smoker's Paradox in Heart Transplant Recipients: Findings From the Nationwide Inpatient Sample 2003-2010 (2014) (0)
Trends in the Use of Guideline-based Therapies Among Dialysis Patients Hospitalized with Heart Failure: Findings from Get With The Guidelines-Heart Failure (2015) (0)
Interrupção da digoxina e desfechos em pacientes com insuficiência cardíaca com fração de ejeção reduzida (2019) (0)
Abstract 8: Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries (2013) (0)
Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guideline. (2003) (0)
Abstract 20782: Discharge Hospice Referral is Associated With Lower 30-Day All-Cause Readmission in Hospitalized Patients With Heart Failure: A Propensity-Matched Study of the Medicare-Linked OPTIMIZE-HF (2016) (0)
Abstract 26: Clinical models of 30-day outcomes among Medicare beneficiaries hospitalized with heart failure and preserved or reduced ejection fraction: derivation and validation of models from the Get With The Guidelines-Heart Failure Registry and Medicare Linked Database (2012) (0)
Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension. (2022) (0)
Abstract 25: Safety And Outcomes Of Endovascular Thrombectomy In Acute Ischemic Stroke Patients With Recent Use Of Non-vitamin K Antagonist Oral Anticoagulants (2023) (0)
Cardiac resynchronization therapy improves left ventricular volumes in patients with ejection fraction between 36 and 50% with left bundle branch block: MIRACLE EF study (2015) (0)
Abstract 10420: Utilization of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure: Has it Changed and is it Associated With Patient Outcomes? (2015) (0)
Abstract WMP85: Clinical Effectiveness of Direct Oral Anticoagulants (DOACs) vs. Warfarin in Older Ischemic Stroke Patients With Atrial Fibrillation: Findings From Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2019) (0)
Abstract 294: Changes in the U.S. Burden of Cardiovascular Mortality by Unique Weighting Methodologies (2019) (0)
Abstract 14117: Method of Assessing Medication Persistence and Clinical Outcomes: A Comparison of Patient Report and Pharmacy Fill Data From the ARTEMIS Trial (2018) (0)
Contractile Reserve and Echocardiographic Dyssynchrony Predict Early Response to Cardiac Resynchronization Therapy: Results of the Multicenter Benefit Trial (2012) (0)
Abstract 14895: Predictors of Six-Month Mortality for Older Medicare Beneficiaries Hospitalized for Heart Failure: Plans for the Development and Validation of University of Alabama at Birmingham Heart Failure Model to Optimize Discharge Hospice Referral (2014) (0)
Insulin-treated diabetes is associated with significant increase in mortality in patients with advanced heart failure (2003) (0)
Anti-inflammatory properties of HDL. (2004) (0)
Abstract TMP70: Assessment of Home Time Following Acute Ischemic Stroke in Medicare Beneficiaries (2016) (0)
Beneficial effects of weight loss with a high protein diet on body composition, functional status, lipid profiles, and quality of life in overweight and obese heart failure patients: a feasibility study (2008) (0)
Abstract 206: Impact of Inpatient Evaluation of Health Literacy on Outcomes in Post-MI Patients (2016) (0)
Abstract 11: Use of Novel Anticoagulants Among Atrial Fibrillation Patients Hospitalized with Ischemic Stroke or Transient Ischemic Attack: A Get With The Guidelines-Stroke Registry Analysis (2013) (0)
Journal Pre-proof Residual Stroke Risk Despite Oral Anticoagulation in Patients with Atrial Fibrillation (2022) (0)
Guideline-directed device therapies in heart failure: A clinical practice-based analysis using electronic health record data (2022) (0)
Abstract 12431: White Matter Brain Injury Increased in Heart Failure Subjects With Obstructive Sleep Apnea (2018) (0)
Abstract 3029: Improved Clinical Outcomes in Medicare Beneficiaries with Acute Ischemic Stroke During Initial Implementation of the Get With The Guidelines-Stroke (GWTG-S) Program 2003-2008 (2012) (0)
TRENDS IN INCIDENCE, EARLY INVASIVE STRATEGY AND OUTCOMES OF NON-ST ELEVATION MYOCARDIAL INFARCTION IN PATIENTS ≥75 YEARS OF AGE (2014) (0)
Abstract 149: Care for Heart Failure Patients at the End of Life: Hospital Readmission and Mortality Amongst Heart Failure Patients Discharged to Hospice (2018) (0)
REFERRAL TO HOSPICE AND PREDICTED MORTALITY RISK AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: FINDINGS FROM GWTG-HF (2011) (0)
Treatment Delay and Mortality across a Spectrum of Immunoreactive BNP Levels in Acute Decompensated Heart Failure: An ADHERE Analysis (2008) (0)
Abstract 20236: Effect of Carvedilol on Outcomes in Medicare Beneficiaries with Heart Failure: A Propensity-Matched Study (2010) (0)
Abstract 3173: Have Door-to-Balloon Times Improved After Initiation of the D2B Alliance? An Analysis of the Get-with-the-Guidelines Registry (2008) (0)
Abstract 17907: Is the Association of Left Ventricular Geometry with Cardiovascular Outcomes Independent of Left Ventricular Mass? (2010) (0)
110 SEX AND RACE BASED DIFFERENCES IN THE UTILIZATION OF LIPID LOWERING MEDICATIONS AFTER ACUTE MYOCARDIAL INFRACTION (2005) (0)
Program Patients Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in (2008) (0)
Abstract 11306: Heart Failure Associated with Neural Injury in a Critical Area for Planning (2010) (0)
BURDEN OF ARRHYTHMIAS IN PATIENTS WITH ALCOHOLIC CARDIOMYOPATHY: FINDINGS FROM THE NATIONWIDE INPATIENT SAMPLE 2003-2011 (2015) (0)
Regional Differences in Secondary Prevention Therapy-Geography Should Not Be Destiny. (2019) (0)
Abstract WP166: Longitudinal Outcomes of Medicare Beneficiaries With Transient Ischemic Attack: a GWTG-Stroke Study (2018) (0)
Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States (2022) (0)
Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India (2022) (0)
Abstract 19094: Use of ACE Inhibitors or Angiotensin Receptor Blockers is Associated With a Significantly Lower Risk of 30-day All-cause and Heart Failure Readmissions and All-cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure Developing Acute Kidney Injury (2015) (0)
Abstract 14555: Heart Failure is Accompanied by Loss of Brain Axons Between Short-Term Memory Areas (2011) (0)
Association Between Early Oral β-Blocker Therapy and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction With Mild-Moderate Heart Failure: Findings From the CCC-ACS Project (2022) (0)
SEX DIFFERENCES IN REVASCULARIZATION AND IN-HOSPITAL OUTCOMES OF NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN THE UNITED STATES (2017) (0)
Abstract 240: Regional Variation in 30-Day Ischemic Stroke Mortality and Readmissions in Get With the Guidelines-Stroke Hospitals (2016) (0)
Secondary Preventive Medication Persistence and Adherence One-Year After StrokeStroke (copy of NEUROLOGY/2011/379727, keeping 5 of 15 authors): One Year Medication Persistence Following Stroke (2012) (0)
Abstract 16058: Comparing Symptoms and Quality of Life in Women and Men with Atrial Fibrillation: Results from the Orbit-AF Registry (2012) (0)
Prevalence and Clinical Characteristics of Patients Reporting Illicit Drug Use in the Acute Decompensated Heart Failure Population: An Acute Decompensated Heart Failure Registry-Emergency Module [ADHERE-EM] Report (2007) (0)
Abstract 17512: Differences in Hospital Risk-standardized Mortality Rates for Percutaneous Coronary Intervention by Patient Age Group: Implications for Hospital Outcome Profiling (2016) (0)
ASSOCIATION OF ACADEMIC YEAR-END CHANGEOVER WITH SURVIVAL RATES AFTER IN-HOSPITAL CARDIAC ARREST: AN EXAMINATION OF THE “JULY EFFECT” (2017) (0)
Abstract 17901: A Comparison of Temporal Trends in In-hospital Adherence to Secondary Prevention Measures Among Patients Undergoing Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention or No Intervention: Insights From the GWTG-CAD (2012) (0)
OUTCOMES IN PATIENTS WITH A FAMILY HISTORY OF ATRIAL FIBRILLATION: FINDINGS FROM THE OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT OF ATRIAL FIBRILLATION (2015) (0)
Abstract 13793: National Survey of Care Processes to Reduce Readmission in Patients Hospitalized for Heart Failure: Factors Associated with Lower Readmission Rates (2011) (0)
Abstract 17121: Initiation of Anti-Hypertensive Therapy and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and a History of Hypertension (HTN) (2020) (0)
INTERNATIONAL VARIATION IN CARE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE: AN ANALYSIS OF THE ACUTE DECOMPENSATED HEART FAILURE NATIONAL REGISTRY UNITED STATES AND ACUTE DECOMPENSATED HEART FAILURE REGISTRY INTERNATIONAL (2011) (0)
Abstract 234: Prevalence and Prognosis of Hyperkalemia in Dialysis and Non-Dialysis Patients with Acute Myocardial Infarction (2014) (0)
EZETIMIBE USE AS AN ADJUNCT TO STATIN THERAPY AFTER MYOCARDIAL INFARCTION: INSIGHTS FROM ACTION REGISTRY-GET WITH THE GUIDELINES AND MEDICARE LINKED DATABASE (2016) (0)
Abstract 257: Discharge Heart Rate and Beta-blocker Dose in Patients Hospitalized with Acute Heart Failure (2015) (0)
Abstract 67: Endovascular Thrombectomy In Patients With Acute Ischemic Stroke And Recent Use Of Oral Vitamin K-Antagonists: The Get With The Guidelines-Stroke Program (2023) (0)
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project. (2022) (0)
Abstract 77: Balancing Risks and Benefits of Anticoagulation Therapy in Atrial Fibrillation in Community Practice: Results from the ORBIT-AF Registry (2012) (0)
PRE-IMPLANT COAGULOPATHY AND IN-HOSPITAL MORTALITY AMONG ADVANCED HEART FAILURE PATIENTS RECEIVING LEFT VENTRICULAR ASSIST DEVICE: A UNITED STATES NATIONAL STUDY (2016) (0)
Abstract 20721: Death Despite Enalapril Therapy vs. Survival Despite Placebo in the Studies of Left Ventricular Dysfunction (SOLVD) Trial: Insights into the Role of Traditional Risk Factors for Mortality in Heart Failure and Reduced Ejection Fraction (HFrEF) (2016) (0)
Get With The Guidelines-coronary artery disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarction (2010) (0)
Abstract 807: Incremental Value of Clinical Data Beyond Claims to Predict 30-Day Outcomes Following Heart Failure Admission: Results From the AHA's Get With the Guidelines-Heart Failure Registry (2009) (0)
Comment on "the relationship between the C-statistic of a risk-adjustment model and the accuracy of hospital report cards: a Monte Carlo study". (2013) (0)
Advances in the management of heart failure (2022) (0)
The role of statins in heart failure. Preface. (2008) (0)
Heart failure with preserved ejection fraction: disturbing trends. (2006) (0)
Improvements in Health Status Associated with Medication Adjustments in Outpatients with HFrEF: Insights from the CHAMP-HF Registry (2018) (0)
Abstract 10738: Comparative Outcomes of Sacubitril/Valsartan Use Among Medicare Beneficiaries NaïVe to Renin-angiotensin System Inhibitors and Hospitalized with Heart Failure (2021) (0)
SELF-REPORTED LOWER EXTREMITY EDEMA IN THE ABSENCE OF HEART FAILURE IS AN INDEPENDENT RISK FACTOR FOR INCIDENT HEART FAILURE AMONG COMMUNITY-DWELLING OLDER ADULTS (2015) (0)
THE IMPACT OF TEMPORARY INTERRUPTIONS OF WARFARIN ON DOWNSTREAM TIME IN THERAPEUTIC RANGE IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM ORBIT AF (2019) (0)
Enzymes and Proteins that are Associated with High Density Lipoprotein and their Role in the Anti-Inflammatory Capacity of HDL (1996) (0)
Abstract 21: Patient and Hospital Characteristics Associated with Assessment for Rehabilitation During Hospitalization for Acute Ischemic Stroke (2012) (0)
TEMPORAL TRENDS IN EARLY FOLLOW-UP AFTER HOSPITALIZATION FOR HEART FAILURE: DATA FROM GET WITH THE GUIDELINES-HEART FAILURE (2014) (0)
Abstract 18094: Multimorbidity and 30-Day All-Cause Readmission Among Hospitalized Medicare Beneficiaries With Heart Failure (2013) (0)
Abstract 15: The Design Of The Dashboard Activated Services And Telehealth For Heart Failure (DASH-HF) Study: A Pragmatic Quality Improvement Randomized Implementation Trial For Patients With Heart Failure With Reduced Ejection Fraction (2022) (0)
Abstract W P335: Variation and Trends in the Documentation of National Institutes of Health Stroke Scale (NIHSS) Among GWTG-Stroke Hospitals (2014) (0)
Abstract 103: Clinical Process and Outcome Improvements Based on Within Site Communication: Insights from the Patient Navigator Acute Myocardial Infarction and Heart Failure Program (2019) (0)
Abstract 9116: Overlap Between Cognitive Brain Damage and Reduced Cerebral Blood Flow in Heart Failure (2012) (0)
Pre-Implantation B-Type Natriuretic Peptide Is a Predictor of Positive Response to Cardiac Resynchronization Therapy (2006) (0)
No evidence of improved survival for women with advanced heart failure Analysis of a cohort of 1,366 patients (1999) (0)
A gender and racial gap in internal cardioverter defibrillator use among hospitalized heart failure patients: Data from the American Heart Association's Get With the Guidelines Heart Failure (GWTG-HF) Program (2007) (0)
TCT-323 Length of Stay Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Association With 30-Day Readmissions and Implications for Healthcare Costs (2017) (0)
Abstract 19999: A Drop in Admission Serum Creatinine is Prognostically Similar to a Rise in Admission Serum Creatinine in Hospitalized Medicare Beneficiaries with Heart Failure: Impact on 30-Day All-Cause Readmission (2014) (0)
Insuficiência cardíaca com fração de ejeção preservada e diabetes Revisão do Estado da Arte do JACC (2019) (0)
Get with the guidelines is associated with improved adherence to evidence based guidelines (2008) (0)
Heart Failure Hospitalization (HFH) Despite Digoxin Therapy Versus No HFH Despite Placebo in the Digitalis Investigation Group (DIG) Trial: Insights Into Risk Factors for HFH in hf and Reduced Ejection Fraction (HFrEF) (2017) (0)
Abstract 9: Clinical Effectiveness of Statin Therapy after Ischemic Stroke: Primary Results from the PROSPER Study (2015) (0)
CHARACTERIZING THE DIGITAL DIVIDE & ACCESS TO MOBILE HEALTH INTERVENTIONS IN HEART FAILURE: INSIGHTS FROM THE CONNECT-HF MHEALTH SUBSTUDY (2023) (0)
Abstract WMP32: Variation in the Rates of Acute Ischemic Stroke Transfers Between Hospitals in the United States (2016) (0)
Does Hospital Length of Stay for Heart Failure Influence Compliance with Performance Measures? (2007) (0)
Discharge Prescription of Angiotensin II Receptor Blockers and All-Cause Mortality in Hospitalized Medicare Beneficiaries with Heart Failure and Preserved Ejection Fraction: A Propensity-Matched Study of the OPTIMIZE-HF (2011) (0)
Abstract 213: The Smoking Paradox in Acute Ischemic Stroke: Findings from Get With The Guidelines - Stroke (2013) (0)
Abstract 5623: Early Antithrombotic Therapy Performance Measure in Ischemic Stroke and Clinical Outcomes (2009) (0)
Abstract 15991: Assessing Longitudinal Medication Use in Pragmatic Clinical Trials: Insights From the ARTEMIS Trial (2017) (0)
Abstract 18831: Temporal Trends in Incidence, Utilization of Pacemaker, and Outcomes of Complete Heart Block in ST-Elevation Myocardial Infarction (2014) (0)
Abstract 15862: Epidemiology and Outcomes of Resistant Hypertension in 5788 Community-Dwelling Older Adults (2011) (0)
Abstract 214: Improvement Among All Hospital Types and Reduced Hospital Level Variation in Use of Intravenous tPA for Acute Ischemic Stroke 2003-2011: Findings from Get With The Guideline-Stroke (2013) (0)
Abstract 18845: Visual Assessment of the Insular Cortices Using Routine Brain Magnetic Resonance Images in Heart Failure (2013) (0)
ELECTRONIC HEALTH RECORD CLINICAL DECISION SUPPORT TOOL IMPROVES STATIN PRESCRIPTION RATES FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (2021) (0)
Abstract 17473: Differences in Hospital Risk-standardized Mortality Rates for Acute Myocardial Infarction by Patient Age Group: Implications for Hospital Outcome Profiling (2016) (0)
ACC/AHA/AACVPR/AAFP/ANA Performance Measures (2014) (0)
PATTERNS OF ANGINA AND ANTIANGINAL MEDICATION USE AMONG PATIENTS FOLLOWING MI TREATED WITH PCI: INSIGHTS FROM TRANSLATE-ACS (2017) (0)
Abstract 1287: The Impact of Different Ranking Methods for Hospital's Heart Failure Quality of Care: Results From the AHA' s Get With the Guidelines-Heart Failure Registry (2009) (0)
Abstract 11909: Changes in Brain Caudate Nuclei Functional Connectivity in Heart Failure (2014) (0)
USE OF BETA-BLOCKERS AND REDUCTION IN ALL-CAUSE MORTALITY IN HOSPITALIZED MEDICARE BENEFICIARIES WITH ACUTE DIASTOLIC HEART FAILURE: A PROPENSITY-MATCHED STUDY OF THE OPTIMIZE-HF (2011) (0)
Abstract 15096: The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the Action Registry-GWTG (2017) (0)
Statin Therapy in Non-Ischemic Heart Failure: Potential Mechanisms of Benefit (2006) (0)
Abstract TMP39: Patterns of Discharge Antidepressant Therapy Use After Acute Ischemic Stroke: Insights From the Prosper Study (2018) (0)
EXAMINATION OF HS-CRP ELEVATION IN PATIENTS WITH HISTORY OF MYOCARDIAL INFARCTION IN THE U.S. (2017) (0)
TCT-382 Temporal Trends in Incidence and Outcomes of Acute Kidney Injury Complicating Peripheral Vascular Interventions in the United States. (2016) (0)
Abstract 17981: Regional Differences in Outcomes After Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest in the United States (2014) (0)
Abstract 12615: Angina Frequency and Unplanned Readmissions after Multivessel vs. Culprit Vessel Only Percutaneous Coronary Intervention Strategy Among Patients Presenting With Acute Myocardial Infarction- 6 Week Outcomes From the TRANSLATE-ACS Observational Study (2014) (0)
HIGH VERSUS STANDARD PROTEIN DIETS IN OBESE PATIENTS WITH HEART FAILURE: EFFECTS ON CHRONIC DISEASE RISKS (2017) (0)
Abstract 186: Improving Identification and Assessment of Readmission Risk for Acute Myocardial Infarction and Heart Failure Patients Following Implementation of a National Quality Improvement Program (2018) (0)
ARRHYTHMIAS AND ASSOCIATED OUTCOMES IN ADULTS WITH CONGENITAL HEART DISEASE IN THE UNITED STATES (2015) (0)
POST-DISCHARGE MORTALITY AND READMISSION IN HEART FAILURE PATIENTS WITH PRESERVED, BORDERLINE, AND REDUCED LEFT VENTRICULAR EJECTION FRACTION (2014) (0)
Abstract P337: Prediction of In-Hospital Major Bleeding Among Patients With Acute Myocardial Infarction: Results From 90,273 Patients in the Acute Coronary Treatment Intervention Outcomes Network Registry®- Get With the Guidelines™ (AR-G) (2011) (0)
Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial. (2023) (0)
Heart failure: Heart failure clinical trials: how do we define success? (2013) (0)
Abstract 269: Association of Atrial and Ventricular Arrhythmias with In-hospital Outcomes in Peripartum Cardiomyopathy (2015) (0)
INVASIVE MANAGEMENT STRATEGIES AND ANTI-THROMBOTIC TREATMENTS IN PATIENTS WITH NSTE-ACS IN CHINA (2017) (0)
Multi-level implementation strategies to improve uptake of evidence-based therapies in heart failure. (2023) (0)
Abstract 4: Variation and Temporal Trends in the Characteristics of US Hospitals Treating Acute Ischemic Stroke Patients with IV-tPA: Findings from GWTG-Stroke (2013) (0)
Abstract 16697: Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From the American Heart Association’s Get With the Guidelines-Heart Failure Registry (2016) (0)
PROLONGED CARDIOVASCULAR RISK AFTER ≥15 YEARS SMOKING CESSATION IN OLDER FORMER SMOKERS (2022) (0)
With great power comes great… reliability (2020) (0)
Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS Study (2011) (0)
Cost-effectiveness of evolocumab in patients with familial hypercholesterolemia in Belgium (2020) (0)
Reply: The Urgent Need for More Cardiac Rehabilitation in the Aim to "Preserve" Patients With Heart Failure. (2021) (0)
Patient and Practice Characteristics Associated with Sacubitril/Valsartan Use in the United States (2018) (0)
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. (2022) (0)
APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY (2023) (0)
Abstract 1338: Brain MRI Neural Responses to Hand-Grip in Heart Failure (2009) (0)
Health related quality of life of elderly patients with end-stage heart failure (2003) (0)
Heart failure in African Americans: Earlier onset, different etiologies, and poorer prognosis (2008) (0)
CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF HOSPITALIZED HEART FAILURE PATIENTS STRATIFIED BY ETIOLOGIES OF NON-ISCHEMIC CARDIOMYOPATHY (2014) (0)
Time to Quadruple Guideline-Directed Medical Therapy as a Key Performance Measure for Heart Failure. (2023) (0)
Door-to-Needle Time and Long-term Outcomes in Patients With Stroke-Reply. (2020) (0)
Abstract 183: Use, Safety and Outcomes with Thrombolysis in Ischemic Stroke among Pregnant and Non-Pregnant Women (2015) (0)
REGIONAL VARIATIONS IN IN-HOSPITAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE UNITED STATES (2017) (0)
Abstract 12817: Comparison of New York Heart Association Classification and Patient-reported Outcomes Among Heart Failure Patients in U.S. Clinical Practice: CHAMP-HF (2020) (0)
Are Patient Age and Gender Associated with Delivery of Recommended HF Therapies (2007) (0)
Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure (2022) (0)
Abstract 3149: Greater Fluid Retention is Associated with Increased Cardiovascular Death Risk in 34,003 CKD Patients on Hemodialysis (2007) (0)
P3797Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea (2019) (0)
MORTALITY IN HEART FAILURE WITH INDETERMINATE KIDNEY DISEASE (2023) (0)
Abstract WMP86: Reasons for Slower Door-to-Needle Times and Their Impact on Timing of Treatment and Outcomes: Findings From Get With The Guidelines-Stroke (2017) (0)
Abstract 13730: Brain Callosal Fiber Injury is Localized in Patients with Heart Failure (2010) (0)
Abstract 13037: Self-Care Questionnaire Detects More Brain Injury in Comparison to Cognitive Screener in Heart Failure (2016) (0)
TEMPORAL TRENDS IN SEVERITY IN CLINICAL RISK PROFILES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE (2020) (0)
ORTHOPNEA OR PAROXYSMAL NOCTURNAL DYSPNEA IN OLDER ADULTS WITHOUT PREVALENT HEART FAILURE IS A PREDICTOR, BUT NOT AN INDEPENDENT RISK FACTOR FOR INCIDENT HEART FAILURE: INSIGHTS FROM THE CARDIOVASCULAR HEALTH STUDY (2017) (0)
Pulse pressure predicts prognosis in heart failure independent of invasive hemomdynamic parameters (2004) (0)
Abstract 21227: Plasma Renin Activity, Response to Aliskiren, and Clinical Outcomes in Patients Hospitalized for Heart Failure: The ASTRONAUT Trial (2017) (0)
Clinical Investigations Comparison of Direct Body Composition Assessment Methods in Patients With Chronic Heart Failure (2010) (0)
PCV38 The IMPACT on Clinical an Economic VALUE of Patient Prioritization According to Risk: Evolocumab in Patients with Myocardial Infarction in Sweden (2020) (0)
Abstract 300: Race/Ethnicity Is Not Associated with Longer Door to Balloon Time or Increased Mortality in Patients Undergoing Primary PCI for STEMI: Findings from AHA-GWTG (2012) (0)
High Sensitivity Troponin I in Acute Decompensated Heart Failure (2011) (0)
Abstract 17341: A 19-Year-Old Female with Recurrent Chylopericardium (2014) (0)
USE OF DRUGS WITH BLOOD PRESSURE (BP) LOWERING PROPERTIES AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) AND LOW SYSTOLIC BP (SBP) (2018) (0)
Aldosterone Antagonists in Patients With Heart Failure. Authors' reply (2010) (0)
Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply. (2017) (0)
Abstract 109: In-Hospital Worsening Heart Failure is Associated With Poor Patient Outcomes and Increased Health Care Utilization (2014) (0)
Potential Mortality ReductionWith Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure (2016) (0)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (0)
Micronutrient Deficiencies (2010) (0)
Abstract 1531: Altered Brain Fiber Tracts in Heart Failure (2007) (0)
Contents (2020) (0)
Treating to low-density lipoprotein goal: a tool for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis or similar risk. (2005) (0)
Abstract 116: Unmet Need In Acute Ischemic Stroke Patients Not Treated With Alteplase (2022) (0)
Preventing heart failure hospital readmissions: Challenges and opportunities (2017) (0)
Is There a Role for Renal Denervation in the Treatment of Hypertension? (2023) (0)
Abstract 15861: Natural History of Atrial Fibrillation, HF With Preserved and Reduced Ejection Fraction in Community Dwelling Older Adults (2014) (0)
EARLY PHYSICIAN FOLLOW-UP AND 30-DAY READMISSION AMONG MEDICARE BENEFICIARIES HOSPITALIZED WITH HEART FAILURE: DATA FROM OPTIMIZE-HF AND GWTG-HF (2010) (0)
THE DYEVERT CONTRAST REDUCTION SYSTEM AND CONTRAST INDUCED NEPHROPATHY: IS IT ANY BETTER? (2022) (0)
In reply [7] (2007) (0)
UTILIZATION, CHARACTERISTICS, AND IN-HOSPITAL OUTCOMES FOR PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING IN-HOSPITAL CORONARY ARTERY BYPASS GRAFTING (CABG) (2016) (0)
GW29-e1055 Clinical Characteristics and Statin Prescription of Acute Coronary Syndrome Patients with Low-Density Lipoprotein Cholesterol Less than 55 mg/dL: Findings from CCC-ACS Project (2018) (0)
ASSOCIATION OF ARRHYTHMIAS WITH OUTCOMES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: AN ANALYSIS OF THE NATIONWIDE INPATIENT SAMPLE 2003-2011 (2015) (0)
Moderated ePoster Session 2 (2014) (0)
Abstract 295: Potential Effectiveness for Anticoagulation Among Elderly Heart Failure Patients without Atrial Fibrillation? An Analysis of the ADHERE Registry Linked to Medicare Claims (2012) (0)
CHARACTERISTICS OF AF PATIENTS WITH LARGE IMPROVEMENT IN SYMPTOMS AT ONE YEAR: SUPER-RESPONSE IN THE ORBIT-AF REGISTRY (2019) (0)
Quality of life in female heart transplant candidates and recipients (2002) (0)
Abstract P269: Linkage of Patients in a National Heart Failure Clinical Registry to Medicare Claims Data: An Analysis of Generalizability and Longitudinal Outcomes from ADHERE (2011) (0)
Abstract 10632: Variation in the Association Between Beta Blocker and/or Rasi Use After Discharge and Outcomes in Hfref by Age (2021) (0)
Abstract 10413: Clinical Outcomes with Metformin and Sulfonylurea Initiation Among Patients with Heart Failure and Diabetes: From Get with the Guidelines-Heart Failure (2021) (0)
A Comparison of COVID-19 and Influenza-Associated Myocarditis: A Nationwide Study in the United States (2023) (0)
Comment on “The Relationship Between the C-statistic of a Risk-adjustment (2013) (0)
Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF (2022) (0)
Abstract 20207: Effect of Metabolic Syndrome on Incident Peripheral Arterial Disease is Independent of Insulin Resistance: Insights from a Prospective Population Study (2010) (0)
Reply: Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure Patients. (2021) (0)
Abstract 3023: The Association of Insurance Status, Quality of Care, and In-Hospital Outcomes among Patients Hospitalized with Intracerebral Hemorrhage: Findings from GWTG-Stroke (2012) (0)
SINGLE INSTITUTION OUTCOME ANALYSIS OF 344 CONSECUTIVE PATIENTS RECEIVING DONOR HEARTS PRESERVED USING UNIVERSITY OF WISCONSIN SOLUTION.: Abstract# 621 (2000) (0)
S0618 Comparative Efficacy of Pharmacological Interventions in Preventing Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device: A Systematic Review and Network Meta-Analysis (2020) (0)
Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry (2022) (0)
PERMANENT PACEMAKER USE AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (2014) (0)
QUALITY OF CARE AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE IN RURAL VERSUS URBAN HOSPITALS: INSIGHTS FROM THE GWTG-HF REGISTRY (2023) (0)
Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF (2022) (0)
J-SHAPED RELATIONSHIP BETWEEN RESTING HEART RATE AND MORTALITY IN PATIENTS WITH PERMANENT AF: RESULTS FROM THE OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT OF ATRIAL FIBRILLATION (ORBIT-AF) (2015) (0)
Does the Effect of Beta-Blockers on Outcomes in Patients with Advanced Chronic Systolic Heart Failure Vary by Baseline Systolic Blood Pressure? Insights from the BEST Trial (2010) (0)
COST-EFFECTIVENESS OF MEDICAL THERAPY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (2023) (0)
RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AND ADVANCED KIDNEY DISEASE (2022) (0)
Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction. (2022) (0)
The relationship between body mass index and in-hospital outcomes in patients hospitalized with coronary artery disease: Analysis of 128, 108 hospitalizations in Get With the Guidelines (2005) (0)
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review. (2022) (0)
ARTHRITIS AND LOWER CARDIOVASCULAR MORTALITY IN OLDER ADULTS: FINDINGS FROM A POPULATION BASED STUDY (2014) (0)
Outcomes, Health Policy and Managed Care Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure (2009) (0)
Abstract 13542: Five-Year Outcomes in Patients Hospitalized With Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction in the Medicare Population (2017) (0)
HYPERKALEMIA AFTER HOSPITALIZATION FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: FINDINGS FROM THE ASTRONAUT TRIAL (2018) (0)
Annals for Hospitalists Inpatient Notes - Clinical Pearls-Stopping, Starting, and Optimizing Guideline-Directed Medical Therapy in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. (2022) (0)
Abstract 17419: Sex and Race Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults (2015) (0)
Abstract 17004: Cardiogenic Shock Complicating Non-ST-Elevation Myocardial Infarction: Temporal Trends in the United States, 2003-2011 (2014) (0)
Psychological well-being of caregivers influences the quality of life of advanced heart failure patients (2001) (0)
Abstract 12797: Temporal Changes in Mortality Risk Post-Discharge After Hospitalization for Heart Failure (2014) (0)
Abstract 35: Unmet Need In Acute Ischemic Stroke Patients Arriving After 4.5 Hours (2022) (0)
Significant Gaps in Adherence to Guideline Recommended Adjunctive Heart Failure Therapies among Outpatient Cardiology Practices: Findings from IMPROVE HF (2008) (0)
Abstract 12: National Surveillance of Stroke Quality of Care and Outcomes Using Post-stratification Survey Weights on the Get With the Guidelines-stroke Patient Registry (2020) (0)
HEART FAILURE WITH REDUCED EJECTION FRACTION CARE PATTERNS IN THE OUTPATIENT PRACTICE SETTING: INITIAL FINDINGS FROM CHAMP-HF (2017) (0)
Aldosterone Antagonists in Patients With Heart Failure—Reply (2010) (0)
Abstract 20456: Renin-Angiotensin System Inhibition and Reduction in All-Cause Mortality in Medicare Beneficiaries Hospitalized with Acute Diastolic Heart Failure: A Propensity-Matched Study of the OPTIMIZE-HF Registry (2010) (0)
Abstract 20774: Discharge Heart Rate and Outcomes in Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge Heart Failure (2016) (0)
MINI-FOCUS ISSUE: LEFT VENTRICULAR EJECTION FRACTION: HFmrEF and HFpEF (0)
Abstract 368: Association of Atrial Fibrillation with In-hospital Outcomes in ST-Elevation Myocardial Infarction - A Propensity Matched Study (2015) (0)
Quality of Care and Outcomes for Patients With Stroke in the United States Admitted During the International Stroke Conference (2018) (0)
Abstract 17202: Comparative Performance of the R2Chads2, Chads2, and Cha2Ds2-vasc Scores in Atrial Fibrillation (2015) (0)
Risks and Benefits AssociatedWith Prestroke Antiplatelet Therapy Among PatientsWith Acute Ischemic Stroke TreatedWith Intravenous Tissue Plasminogen Activator (2016) (0)
Abstract 122: Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Adults With Diabetes Mellitus: Insights From the Get With the Guidelines - Heart Failure Registry (2018) (0)
A Comparison of COVID-19 and Influenza in Heart Transplant Recipients: A Nationwide Study in the United States (2023) (0)
Abstract 18879: Low Income is Associated With Higher Risk of Cardiovascular Events and Mortality in Community Dwelling, Medicare Eligible, College Educated Older Adults With Background Professional Occupation (2013) (0)
Influence of Atrial Fibrillation on the Use of CRT and ICD Therapy in Heart Failure: Findings from IMPROVE HF (2009) (0)
Process Improvement in Heart Failure. (2020) (0)
infarction clinical care transforming contemporary acute myocardial GWTG : − The NCDR ACTION Registry (0)
TEMPORAL TRENDS IN UTILIZATION OF FRACTIONAL FLOW RESERVE FOR PATIENTS WITH STABLE CORONARY ARTERY DISEASE IN THE UNITED STATES (2016) (0)
Abstract 8493: Lack of Association between Discharge Prescription of Aldosterone Antagonists and Outcomes in Medicare Beneficiaries with Heart Failure and Preserved Ejection Fraction: A Propensity-Matched Study of the OPTIMIZE-HF (2011) (0)
Reply: To PMID 24846806. (2015) (0)
Abstract 2237: Brain White Matter Regulating Autonomic and Cognitive Functions is Damaged in Heart Failure (2007) (0)
In response to Nagarajan's letter to the editor “Improvement in ejection fraction—but do not forget the basics, the medications” (2012) (0)
Abstract 18263: Incident Heart Failure and All-Cause Mortality in Older Current Smokers and Former Smokers with 15 or More Years of Abstinence: Findings From a Prospective Population Study (2011) (0)
Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials (2022) (0)
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). (2020) (0)
144-LB: Medicaid Expansion and Utilization of Antihyperglycemic Therapies (2020) (0)
Rapidly Improving Health-Related Social Needs Assessment Through A National Collaborative (2023) (0)
Does the Day of the Week Heart Failure Patients Are Admitted Influence Length of Stay or Mortality Risk? Findings from OPTIMIZE-HF (2007) (0)
Very Elevated High-Density Lipoprotein Cholesterol and Mortality-The Good Gone Bad? (2022) (0)
RELATIONSHIP BETWEEN CARDIOLOGY PRACTICE TEACHING STATUS AND IMPROVEMENT IN THE USE OF EVIDENCE-BASED THERAPY FOR HEART FAILURE: FINDINGS FROM IMPROVE HF (2010) (0)
Abstract 1890: Sleep-Disordered Breathing Related to Gray Matter Loss in Heart Failure (2006) (0)
Abstract WP380: Hospital-Level Variability in Diagnostic Testing and Ischemic Stroke Subtype Documentation (2019) (0)
Abstract 12017: New-Onset Diabetes After Heart Transplantation is associated With Worse Long-term Survival: A Propensity Matched Analysis of a National Registry. (2016) (0)
Get with The Guidelines and Guideline Directed Medical Therapy: Why it Matters (2022) (0)
Hospital at Home as a Novel Care Strategy for Worsening Heart Failure. (2023) (0)
BNP-guided heart failure therapy in older patients. (2009) (0)
Abstract 13160: Persistence of Secondary Prevention Medications after Acute Myocardial Infarction: Insights from the TRANSLATE-ACS Study (2012) (0)
INVESTIGATION OF THE RELATIONSHIP BETWEEN HBA1C LEVEL AND OUTCOMES IN HEART FAILURE PATIENTS WITH AND WITHOUT DIABETES MELLITUS (2011) (0)
Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure in Sinus Rhythm and Atrial Fibrillation (2012) (0)
Abstract 325: Paradoxical Relationship Between Bleeding Risk, Stroke Risk, and Time in Therapeutic Range for Atrial Fibrillation Patients on Warfarin: Data from ORBIT-AF (2014) (0)
Abstract 17098: Smoking is an Independent Modifiable Risk Factor for Incident Heart Failure in Community-Dwelling Older Adults: Findings from a Prospective Population Study (2010) (0)
Contemporary Trends and Comparison of Racial Differences in Hospitalizations of Adults With Congenital Heart Disease. (2022) (0)
Title Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure Permalink (2017) (0)
ASSOCIATION BETWEEN ASSIGNMENT TO AN ACCOUNTABLE CARE ORGANIZATION AND QUALITY OF CARE AND OUTCOMES AMONG MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2019) (0)
An anti‐inflammatory peptide combination reduces oxidative effect of plasma from cardiomyopathy patients (2010) (0)
Abstract 3610: Troponin and BNP: Heart Failure's Deadly Duo (2006) (0)
DIGOXIN INITIATION IS NOT ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: INSIGHTS FROM THE MEDICARE-LINKED OPTIMIZE-HF REGISTRY (2020) (0)
414 Clinical differences between high and low mortality risk stratified patients hospitalized with acutely decompensated heart failure: adhere® Registry Data (2004) (0)
Abstract 18743: Digoxin and Hospital Readmission in Older Patients With Heart Failure and Reduced Ejection Fraction Receiving Beta Blockers: A Propensity Matched Study of Medicare Linked OPTIMIZE HF (2017) (0)
Abstract TMP89: Prior Antithrombotic Use is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke: Evidence From Get With the Guidelines-stroke (2016) (0)
Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS (2022) (0)
Corrigendum to `Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States☆' [The American Journal of Cardiology 123/7 (2019) 1187-1189]. (2019) (0)
TRENDS IN OUT-OF-POCKET COST FOR PATIENTS WITH CARDIOVASCULAR DISEASE: THE MEDICAL EXPENDITURE PANEL SURVEY 2009-2018 (2022) (0)
ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL (2023) (0)
P1225Cost-effectiveness of evolocumab in patients with high atherosclerotic cardiovascular risk in Sweden (2019) (0)
Abstract 112: Use of Evidence-Based Therapies in the Treatment of Cardiovascular Comorbidities and Risk Factors in Patients with Atrial Fibrillation: Findings From the ORBIT-AF Registry (2012) (0)
Abstract TMP14: Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Myocardial Infarction (2019) (0)
Is the American Heart Association's Get With the Guidelines (GWTG) program associated with improvements in the quality of care in hospitalized patients undergoing revascularization? (2005) (0)
Abstract 10: Contraindications to Oral Anticoagulation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) (2013) (0)
Iconographies supplémentaires de l'article : Relation of Smoking Status to Outcomes After Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest (2014) (0)
Abstract TMP83: Association Between Hospital Procedural Volumes and Clinical Outcomes For Patients With Non-Traumatic Subarachnoid Hemorrhage (2020) (0)
Increased Global and Regional Brain Mean Diffusivity in Patients with Heart Failure (2012) (0)
Abstract 114: Equitable Improvements in Sex and Race/Ethnic Specific Door-to-Needle Times in Acute Ischemic Stroke: Findings From Target: Stroke Phase I (2016) (0)
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure (2021) (0)
Abstract 17148: Association of Atrial Fibrillation With Short-Term Outcomes in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (2018) (0)
SELECTION OF PRASUGREL VERSUS CLOPIDOGREL AMONG MYOCARDIAL INFARCTION PATIENTS WITH HIGH VERSUS LOW PREDICTED MORTALITY AND BLEEDING RISKS: INSIGHTS FROM TRANSLATE-ACS (2015) (0)
Abstract 809: Greater Fluid Retention is Associated with Increased Cardiovascular Mortality in Different Groups of CKD Patients on Hemodialysis (2008) (0)
Abstract P165: Is Knowledge Given, Knowledge Gained? American Heart Association Heart Failure Protocols and Educational Content within the Intel® Health Guide System (2011) (0)
Adherence to best practices: How do patient race and gender affect physician performance? (2007) (0)
Abstract W P57: Thrombolytic Therapy in Patients With Mild Stroke: An Observational Study (2014) (0)
Abstract 13211: Prognostic Significance of Physical Trigger Type in Takotsubo Cardiomyopathy (2019) (0)
Sodium–glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation (2022) (0)
MEDICATION DOSING ADHERENCE IN OUTPATIENTS WITH HEART FAILURE FOLLOWING IMPLEMENTATION OF A PRACTICE-BASED PERFORMANCE IMPROVEMENT INTERVENTION: RESULTS FROM IMPROVE HF (2010) (0)
Hydroxychloroquine and Risk of Long QT Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study with 19-Year Follow-up. (2022) (0)
OUTCOME DIFFERENCES BETWEEN PREVALENT USERS VS. NEW USERS OF THE SAME DRUG: WHEN DRUG EFFECT OR SELECTION BIAS CANNOT EXPLAIN POOR OUTCOMES AMONG PREVALENT USERS (2022) (0)
Utilization of Implantable Cardioverter Defibrillators Among Patients with a Left Ventricular Assist Device: Insights From a National Database. (2022) (0)
Abstract T P319: Patient Characteristics and Outcomes in Pregnancy-Related Intracerebral Hemorrhage (2015) (0)
ASSOCIATION OF NEW ONSET ATRIAL FIBRILLATION WITH ALL-CAUSE MORTALITY IN COVID 19 PATIENTS. (2022) (0)
Heart Failure is Associated With Worse Quality of Life and Survival But Similar Stroke Risk in Atrial Fibrillation (2015) (0)
PROFILE OF PATIENTS DISCHARGED AGAINST MEDICAL ADVICE: IS THERE A COST? (2020) (0)
TCT-838 The Changing Landscape of Aortic Valve Replacement in the United States: Insights from a National Database (2018) (0)
Effect of aMultifaceted Quality Improvement Intervention on Hospital Personnel Adherence to PerformanceMeasures in PatientsWith Acute Ischemic Stroke in China A Randomized Clinical Trial (2018) (0)
Abstract WMP19: Are “Drip and Ship” Patients Different than Other rt-PA Treated Patients? Clinical Characteristics and Patient Outcomes. (2013) (0)
Abstract 18913: Regional Variation in Heart Transplant Outcomes in the United States: Trends Over Time (2013) (0)
Abstract 17027: Generalizability of the US FDA Label for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in the GWTG-HF Registry (2020) (0)
Abstract 15007: Association Of Dual Eligibility For Medicare And Medicaid With Heart Failure Quality And Outcomes Among Gwtg-hf Hospitals (2020) (0)
Clinical Investigations Trends in Heart Failure Clinical Trials From 2001e2012 (2016) (0)
ASSOCIATION OF OBESITY WITH SURVIVAL AFTER CARDIOPULMONARY RESUSCITATION FOR IN-HOSPITAL CARDIAC ARREST: ANALYSIS OF THE 2003-2011 NATIONAL INPATIENT SAMPLE DATABASES (2016) (0)
Abstract TP314: Current Use of Strategies to Improve Door-to-Needle Times With Tissue Plasminogen Activator in Acute Ischemic Stroke: Findings From the Target: Stroke Phase II Survey (2016) (0)
AHA Scientific Statement (2008) (0)
ADMISSION-TO-DISCHARGE WEIGHT CHANGE AND 30-DAY POST-DISCHARGE OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF) (2019) (0)
Correlates of fatigue in advanced heart failure patients (2006) (0)
Abstract 13909: Temporal Association Between Breast Cancer and Heart Failure in Postmenopausal Women (2019) (0)
Permanent pacemaker utilization in older patients with syncope and carotid sinus syndrome. (2014) (0)
THE IMPACT OF THE CURRENT VERSUS PRIOR CARDIAC RESYNCHRONIZATION GUIDELINES ON THE PROPORTION OF HOSPITALIZED HEART FAILURE PATIENTS ELIGIBLE FOR THERAPY (2017) (0)
CULPRIT ONLY VERSUS MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A META-ANALYSIS OF OBSERVATIONAL STUDIES (2016) (0)
GW29-e1000 Reperfusion therapy and antithrombotic treatments in patients 75 years and older with ST-segment elevation myocardial infarction in China: findings from the CCC-ACS Project (2018) (0)
Abstract 20566: Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes among Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge SBP (2016) (0)
Abstract TMP54: Seasonal Patterns of Ischemic Stroke in the United States (2017) (0)
Abstract 377: Characteristics, Care, and Outcomes of Asian American Heart Failure Patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program (2014) (0)
PRE-PANDEMIC PREVALENCE AND CONTROL RATES OF HYPERTENSION IN THE USA: NHANES 2017-2020 (2022) (0)
Temporal trends and rural–urban disparities in cerebrovascular risk factors, in-hospital management and outcomes in ischaemic strokes in China from 2005 to 2015: a nationwide serial cross-sectional survey (2022) (0)
COST-EFFECTIVENESS OF SGLT2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (2023) (0)
The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction. (2022) (0)
DONOR-RECIPIENT RACE MISMATCH INCREASES GRAFT FAILURE AND MORTALITY AFTER ADULT HEART TRANSPLANTATION: A PROPENSITY-MATCHED STUDY OF THE UNITED NETWORK FOR ORGAN SHARING DATABASE (2015) (0)
Abstract 63: The Smoking Paradox in Patients Hospitalized with Coronary Artery Disease: Findings from Get With The Guidelines - CAD (2013) (0)
Abstract 17846: Weighing The Evidence: Geographic Variation And The Obesity Paradox In Patients With Acute Decompensated Heart Failure In The Ascend-hf Trial (2013) (0)
ARE THERE DIFFERENCES IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COUNSELING RATES AMONG ELIGIBLE PATIENTS HOSPITALIZED FOR HEART FAILURE? NATIONAL RESULTS FROM THE AMERICAN HEART ASSOCIATION’S GET WITH THE GUIDELINES- HEART FAILURE PROGRAM (2015) (0)
LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILURE (2020) (0)
Works Title Global and regional brain mean diffusivity changes in patients with heart failure (2015) (0)
Heart Failure Data Challenge: Democratizing Data, Modernizing Methods, and Interpreting Inequity. (2022) (0)
Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure (2023) (0)
The American Journal of Cardiolofy: Introduction (2004) (0)
Abstract 12097: Resting Supine Heart Rate and Risk of Incident Heart Failure and All-Cause Mortality in 5475 Community-Dwelling Older Adults During 13 Years of Follow-Up (2011) (0)
Abstract TP116: Procoagulant Reversal Of Warfarin After Intracranial Hemorrhage Is Not Associated With Improved Functional Outcome When Coagulation Is Abnormal Without Full Anticoagulation (2023) (0)
Abstract 13608: Center Variation in Home Time Following Acute Ischemic Stroke (2015) (0)
Reply: To PMID 25465933. (2015) (0)
HIGHER BODY MASS INDEX IN EARLY ADULTHOOD AND SUBSEQUENT RISK OF HEART FAILURE (2022) (0)
Abstract 14223: Atrial Fibrillation, Clinical Outcomes, and Post-discharge Natriuretic Peptide Trajectory Among Patients Hospitalized for Heart Failure: Findings From the ASTRONAUT Trial (2015) (0)
Congestive Heart Failure Relationships between emerging measures of heart failure processes of care and clinical outcomes (2010) (0)
Abstract 19151: Clinical Predictors of Response to Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction due to Non-Ischemic Cardiomyopathy (2014) (0)
MANAGEMENT OF PATIENTS WITH NON-ST SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION IN THE UNITED KINGDOM, SWEDEN AND THE UNITED STATES: A COMPARISON OF MINAP/NICOR, SWEDEHEART/RIKS-HIA AND ACTION REGISTRY-GWTG (2013) (0)
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. (2023) (0)
Fatigue and Depression in Relation to Systolic Heart Failure Patient's Adjustment to Family Roles (2006) (0)
In-hospital initiation of beta-blocker therapy for heart failure (2002) (0)
Abstract 266: No Impact of Electronic Health Records on Quality of Care and Outcomes for Ischemic Stroke (2014) (0)
Abstract 18927: Systolic Blood Pressure (SBP) <130 mmHg and Outcomes in Patients With Heart Failure and Preserved Ejection (HFpEF) and Hypertension (HTN) (2017) (0)
CARE AND OUTCOMES OF HISPANICS ADMITTED WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION: FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE (2011) (0)
HEALTH-ECONOMIC BENEFITS OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING IN HIGH RISK PATIENTS: A DISCRETE-EVENT SIMULATION MODEL (2012) (0)
Early ACEI/ARB use and in-hospital outcomes of acute myocardial infarction patients with systolic blood pressure <100 mmHg and undergoing percutaneous coronary intervention: Findings from the CCC-ACS project (2022) (0)
TREATMENT AND STROKE RISK IN LOW RISK CHA2DS2VASC ATRIAL FIBRILLATION PATIENTS: FINDINGS FROM THE ORBIT-AF REGISTRY (2016) (0)
Abstract WP372: International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke (2019) (0)
Reply (2021) (0)
Abstract 19573: Factors Associated With Improvement in Ejection Fraction in Heart Failure Patients Following Implementation of a Practice-Based Performance Intervention: Findings From IMPROVE HF (2010) (0)
STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With Care. (2023) (0)
Considering dose in pharmacological therapies for heart failure – Authors' reply (2021) (0)
Omitted Conflict of Interest Disclosures. (2019) (0)
EARLY (1-10 DAYS) READMISSION IS ASSOCIATED WITH A SIGNIFICANTLY LOWER 2-12 MONTHS POST-DISCHARGE ALL-CAUSE MORTALITY AMONG OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE WITH 30-DAY ALL-CAUSE READMISSIONS (2016) (0)
SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE (2020) (0)
Authors' Reply (2014) (0)
Evaluation of CAD risk factor modification following coronary artery calcium screening: An early outcomes study (1999) (0)
Is History of Depression a Predictor of In-Hospital Treatment and Early Post-Discharge Outcomes in Patients with Heart Failure? A Report from OPTIMIZE-HF (2007) (0)
Title Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome (2014) (0)
Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. (2023) (0)
Abstract P423: Longitudinal Participation in the American Heart Association’s Workplace Health Achievement Index is Associated With Improvements in Workplace Culture of Health (2019) (0)
Abstract 10919: Prevalence, Awareness, Treatment, and Control of Hypertension in Hospitalized Patients with Atrial Fibrillation in China: Findings from the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation Project (2021) (0)
Clinical profile of the acute heart failure patient (2005) (0)
Abstract 335: Association of Amyloidosis With In-hospital & 30-day Outcomes Among Patients Hospitalized With Heart Failure (2020) (0)
948-46 Preserved Cardiac Baroreflex Control of Renal Cortical Blood Flow in Advanced Heart Failure Patients: A Positron Emission Tomography Study (1995) (0)
Abstract 3003: Greater Improvement in Heart Failure Care Quality With a Performance Improvement Initiative is Largely Independent of Patient and Practice Characteristics (2009) (0)
STALLED NATIONAL PROGRESS IN HEART FAILURE HOSPITALIZATIONS AMONG PATIENTS WITH DIABETES MELLITUS (2020) (0)
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials. (2023) (0)
Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure (2022) (0)
PREDICTORS OF 6-MONTH HEART FAILURE READMISSION AND DEATH IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED VERSUS REDUCED EJECTION FRACTION (2018) (0)
Abstract 18829: Cardiac Resynchronization Therapy Among Patients With Heart Failure With Reduced Ejection Fraction and Right Bundle Branch Block: A United States Population Based Study (2013) (0)
Achievement and Quality Measure Attainment in Patients Hospitalized with Atrial Fibrillation: Results from the Get With The Guidelines® – Atrial Fibrillation (GWTG-AFIB) Registry (2021) (0)
Smoking cessation in heart failure: easier said than done: reply (2009) (0)
IMPACT OF HEART FAILURE HOSPITALIZATION ON GUIDELINE-DIRECTED MEDICAL THERAPY PRESCRIBING PATTERNS AMONG PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: AN ANALYSIS FROM CHAMP-HF (2020) (0)
Abstract WP344: Lower Hemoglobin A1c is Associated With Higher In-Hospital Mortality in Intracerebral Hemorrhage (2017) (0)
Percutaneous Coronary Intervention Treatments, Trends, and Outcomes of Acute Myocardial Infarction and (2011) (0)
Poor Medication Adherence Is Associated With Worse Health Status In Heart Failure With Reduced Ejection Fraction (2022) (0)
ASSESSMENT OF STROKE RISK IN ATRIAL FIBRILLATION: PHYSICIAN ESTIMATE VERSUS CHADS2 RISK SCORE: RESULTS FROM ORBIT-AF (2014) (0)
Two-year follow-up of psychological state in patients referred for heart transplant (2004) (0)
Reply: To PMID 23219302. (2013) (0)
Correction (2011) (0)
Venous Thromboembolism Prophylaxis among Elderly Heart Failure Patients and 60-Day Outcomes: An Analysis from ADHERE Linked to Medicare Claims (2010) (0)
Abstract 16571: The Potential Impact of Expanding Cardiac Rehabilitation Coverage in Heart Failure: Insights From Get With the Guidelines Heart Failure (2015) (0)
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry. (2023) (0)
THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMS (2019) (0)
RISK FACTORS AND PREVALENCE TRENDS FOR APPARENT TREATMENT-RESISTANT HYPERTENSION; A POPULATION BASED STUDY IN USA FROM 2004-2018 (2023) (0)
Abstract 18743: Lack of Evidence of Higher 30-day All-cause Readmission Among Older African American (vs. White) Medicare Beneficiaries Hospitalized for Heart Failure (2015) (0)
Abstract 3798: Impact of Worsening Renal Function During Hospitalization for Heart Failure on 30 Day Outcomes Among Medicare Beneficiaries in OPTIMIZE-HF (2009) (0)
Reply (2019) (0)
TCT-672 Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States (2018) (0)
Association of Readmission Penalty Amount with Subsequent 30-Day Risk Standardized Readmission and Mortality Rates Among Patients Hospitalized with Heart Failure: An Analysis of Get With The Guidelines - Heart Failure Participating Centers. (2021) (0)
HEART TRANSPLANT RECIPIENTS WITH PRE-TRANSPLANT COAGULOPATHY HAVE AN INCREASED INDEPENDENT RISK OF IN-HOSPITAL MORTALITY: A PROPENSITY-MATCHED NATIONWIDE INPATIENT SAMPLE STUDY (2014) (0)
Abstract 19925: Isolated Diastolic Hypotension is a Risk Factor for Incident Heart Failure in Community-Dwelling Older Adults with Wide Pulse Pressure (2010) (0)
TRENDS IN UTILIZATION OF SURROGATE ENDPOINTS IN CONTEMPORARY CARDIOVASCULAR CLINICAL TRIALS: A SYSTEMATIC REVIEW (2016) (0)
Systolic blood pressure and outcomes in patients hospitalized with acute heart failure. Authors' reply (2007) (0)
Abstract 15734: Intersection of Atrial Fibrillation and Heart Failure With Mildly Reduced and Preserved Ejection Fraction in >400,000 Participants in the Get With the Guidelines® Heart Failure Registry (2022) (0)
THE ASSOCIATION BETWEEN ANTICOAGULATION AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: FINDINGS FROM THE ADHERE REGISTRY (2012) (0)
INITIATION OF ANTI-HYPERTENSIVE DRUGS AND OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) (2020) (0)
Acute Giant-Cell Myocarditis (2003) (0)
HEALTHCARE UTILIZATION FOR US VETERANS WITH HEART FAILURE DURING THE COVID19 PANDEMIC (2023) (0)
National Trends In The Utilization Of Short-term Mechanical Circulatory Support Devices During Ventricular Tachycardia Ablation Related Hospitalizations (2022) (0)
CHARACTERIZING THE WAITLISTED, RECIPIENT AND DECEASED DONOR POPULATIONS IN CARDIAC TRANSPLANTATION, 1987-2016 (2020) (0)
Abstract 1: The Impact of State Medicaid Expansions on Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure (2018) (0)
Measuring CME Outcomes: Assessment of an HFSA Annual Meeting Symposium (2012) (0)
Abstract 18519: Increased Mean Diffusivity (Brain Injury) Values in Insular, Hippocampal, Frontal, and Cerebellar Sites in Heart Failure (2013) (0)
The Authors' reply (2011) (0)
OUTCOMES IN HOSPITALIZED OLDER AFRICAN AMERICAN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) (2019) (0)
Abstract 82: Patient and Hospital Characteristics of Pregnancy-Related Stroke from the Get With The Guidelines Stroke Registry (2015) (0)
Abstract 21045: A Prospective Population Study of the Rate and Risk of Hospitalization among Medicare-Eligible Community-Dwelling Older Adults with Incident Heart Failure (2010) (0)
Post-Operative Acute Renal Failure Adversely Impacts Long-Term Survival After Successful Heart Transplant: Analysis of a National Database (2017) (0)
Abstract 2940: Higher Systolic Blood Pressure is Associated with Improved Survival in Both Ischemic and Non-Ischemic Systolic Heart Failure Independent of Invasive Hemodynamics and Medical Therapy (2008) (0)
Abstract TMP75: Clinical Care and Outcomes of Asian Acute Ischemic Stroke Patients (2018) (0)
Abstract 14583: Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-day Readmission (2020) (0)
Discharge Hospice Referral Is Associated with Lower 30-Day All-Cause Hospital Readmission in Medicare Beneficiaries with Heart Failure (2013) (0)
May 3 , 2016 improvements in population health through strengthened surveillance of CVD and stroke (2016) (0)
INITIATION OF LOOP DIURETICS HAS NO ASSOCIATION WITH 30-DAY ALL-CAUSE OR HEART FAILURE READMISSIONS OR ALL-CAUSE MORTALITY IN OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2016) (0)
Abstract 23237: Improvement in Quality of Care for Atrial Fibrillation in Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) (2016) (0)
The Association between Beta-Blocker and Renin Angiotensin System Inhibitor Use After HFrEF Hospitalization and Outcomes in Older Patients. (2022) (0)
Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction (2022) (0)
30-DAY REHOSPITALIZATION FOR NEW ONSET HEART FAILURE AFTER AN INITIAL NON-CARDIOVASCULAR HOSPITALIZATION (2020) (0)
Abstract 3189: The Relationship Between Body Mass Index and Cardiopulmonary Exercise Testing in Chronic Systolic Heart Failure (2009) (0)
ASSOCIATION BETWEEN GUIDELINE-DIRECTED MEDICAL THERAPIES FOR COMORBID CONDITIONS AND CLINICAL OUTCOMES AMONG INDIVIDUALS WITH ATRIAL FIBRILLATION (2019) (0)
Stroke Rapid-Treatment Readiness Tool (2015) (0)
SEASONAL, REGIONAL, AND CIRCADIAN VARIATIONS OF ACUTE MYOCARDIAL INFARCTION: FINDINGS FROM THE GET WITH THE GUIDELINES- CORONARY ARTERY DISEASE (GWTG-CAD) PROGRAM (2015) (0)
Hypertension 102: Treating the Insulin Resistant Heart (2007) (0)
Abstract 19349: Blood Pressure Control in Community Dwelling Patients with Atrial Fibrillation: Results from the ORBIT-AF Registry (2014) (0)
Abstract 12105: Non-Heart Failure Admitting Diagnosis and Outcomes in Older Patients With Heart Failure With Preserved and Reduced Ejection Fraction (HFpEF and HFrEF) (2019) (0)
Impaired Cerebellar and Limbic Responses to the Valsalva Maneuver in Heart Failure (2012) (0)
Abstract 303: Adoption of the Novel Oral Anticoagulant Dabigatran in Patients with Atrial Fibrillation Receiving Warfarin in Community Practice: Findings from ORBIT AF (2013) (0)
Abstract 14128: Abnormalities in Sarcoplasmic Reticulum Ca2+ -Sequestering Proteins in Skeletal Muscle in Humans With Advanced Heart Failure (2011) (0)
The reply. (2015) (0)
Composite measure performance in Get With the Guidelines: CAD, stroke, heart failure (2007) (0)
Reply: Graphing Ratio Measures on Forest Plot. (2018) (0)
P-Type Natriuretic Peptide Levels n Obese Patients With Advanced Heart Failure (2016) (0)
Abstract 68: Risk Score for Intracranial Hemorrhage in Patients with Acute Ischemic Stroke Treated With Intravenous t-PA. (2012) (0)
Editorial Expression of Concern: Water and sodium in heart failure: a spotlight on congestion (2021) (0)
Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure. (2023) (0)
Non-Invasive Bioelectrical Impedance for Predicting Clinical Outcomes in Outpatients with Heart Failure (2015) (0)
OCTOGENARIAN PATIENTS WITH HEART FAILURE AND EJECTION FRACTION <45%, PRE-DISCHARGE PRESCRIPTIONS FOR ANGIOTENSIN CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS AND LOWER 30-DAY ALL-CAUSE HOSPITAL READMISSION (2014) (0)
Abstract 15971: Quality of Care for Patients With Non-ST-Segment Elevation Acute Coronary Syndrome in China: Findings From Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project (2018) (0)
Abstracts of the 33rd Annual Meeting & Scientific Sessions of the North American Society for Cardiac Imaging (2005) (0)
Abstract 10198: Association Between Admission Low-Density Lipoprotein Cholesterol and In-Hospital Mortality Among Inpatients with Acute Myocardial Infarction in China: Findings from CCC-ACS Project (2021) (0)
Healthcare Providers, and Health Policy Makers Community Level, 2013 Update : A Scientific Statement for Public Health Practitioners, American Heart Association Guide for Improving Cardiovascular Health at the (2013) (0)
Association Between 2010 Medicare Reform and Inpatient Rehabilitation Access in People With Intracerebral Hemorrhage (2021) (0)
Abstract WMP8: Use, Characteristics, and Outcomes of Endovascular Thrombectomy in Acute Ischemic Stroke Patients Beyond 6 Hours of Stroke Onset in US Clinical Practice (2020) (0)
421-P: Documentation of Heart Failure in Outpatients with Type 2 Diabetes and Evidence of Volume Overload: A Report from the Diabetes Collaborative Registry (DCR) (2019) (0)
Abstract WP13: Time to Treatment With Endovascular Reperfusion Therapy and Outcome From Acute Ischemic Stroke in the National US GWTG-Stroke Population (2019) (0)
Abstract 4735: Is Improved Adherence to Guideline Based Care Among Patients Hospitalized With Acute Myocardial Infarction Restricted to Lower Risk? (2009) (0)
Abstract 15501: Successes and Ongoing Opportunities in National Efforts to Improve STEMI Care: Mission: Lifeline Update 2010-2018 (2019) (0)
An updated cost-effectiveness analysis of evolocumab therapy for reducing cardiovascular events in very high-risk patients with atherosclerotic cardiovascular disease according to the 2018 ACC/AHA guideline (2019) (0)
Potential Global Impact of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure. (2023) (0)
Abstract 13799: Comparing Incidence of Stroke and Non-CNS Embolism in Patients With Symptomatic and Asymptomatic Atrial Fibrillation: Insights From the ORBIT AF Registry (2017) (0)
GPIIB/IIIA INHIBITORS USE IMPROVES OUTCOMES AFTER ASPIRATION THROMBECTOMY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION: A METAREGRESSION ANALYSIS (2015) (0)
Abstract 2946: Does Aspirin Use Adversely Influence Intermediate Term Outcomes for Hospitalized Heart Failure Patients Who Are Treated with Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers? Findings from Optimize-HF (2008) (0)
Abstract 16941: Machine Learning Enhanced Predictions of Hospital Readmission or Death in Heart Failure (2017) (0)
Abstract 18919: Race/Ethnic Differences in Mortality Among Patients Hospitalized with Intracerebral Hemorrhage (2012) (0)
BNP as Treatment Marker (2019) (0)
Adoption of Sacubitril/Valsartan Among Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The Get With the Guidelines - Heart Failure Registry. (2022) (0)
Error in Figure. (2019) (0)
CARDIOVERSIONS AND ATRIAL FIBRILLATION: PATIENT OUTCOMES IN THE UNITED STATES: DATA FROM ORBIT-AF (2014) (0)
Aging: The Age, Gene/Environment Susceptibility (AGES) Cardiac Hemodynamics are Linked With Structural and Functional Features of Brain (2015) (0)
Abstract 17788: Heavy Smoking in the Past Is a Risk Factor for Incident Heart Failure in Older Adults Despite >=15 Years of Abstinence: Findings from a Prospective Population Study (2010) (0)
Is aggressive or moderate lipid lowering more effective in slowing vascular calcification in postmenopausal women? (2006) (0)
Influence of Advance Practice Nurse and Dedicated Heart Failure Clinics on Delivery of Recommended Therapies in Outpatient Cardiology Practices: IMPROVE HF Findings (2008) (0)
Abstract T MP43: Patient Characteristics and Outcomes in Pregnancy-Related Ischemic Stroke (2015) (0)
Predictors of Length of Stay in Patients Hospitalized with Heart Failure: A Report from OPTIMIZE-HF (2007) (0)
Body Mass Index Adversely Affects Survival in Left Ventricular Assist Device Bridged Patients Undergoing Heart Transplantation (2016) (0)
Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes Among Hospitalized Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) and Stable Admission-to Discharge SBP (2017) (0)
Abstract MP28: Heart Rate At Hospital Discharge Is Associated With Adverse Long Term Outcomes In Patients With Heart Failure (2014) (0)
Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA (2020) (0)
Abstract 17333: Can Pre-Admission Medication Adherence Predict Post-Discharge P2Y12 Inhibitor Adherence Among Patients With Myocardial Infarction? (2017) (0)
TEMPORAL TRENDS IN INCIDENCE OF VENTRICULAR ARRHYTHMIAS AND ASSOCIATION OF VENTRICULAR ARRHYTHMIAS WITH OUTCOMES IN ST-ELEVATION MYOCARDIAL INFARCTION (2015) (0)
Left ventricular functional impairment in chronic heart failure patients is independent of extent of perfusion defects and viable myocardium (2002) (0)
TRENDS IN MEDICATION USE AND COST AMONG US ADULTS WITH HEART FAILURE: INSIGHTS FROM THE 2009-2018 MEDICAL EXPENDITURE PANEL SURVEY (2022) (0)
ASSOCIATION OF HOSPITAL TEACHING STATUS WITH IN-HOSPITAL MORTALITY OF ST-ELEVATION MYOCARDIAL INFARCTION (2016) (0)
Translating evidence into practice: use of statins in real-world patients with heart failure. (2008) (0)
Do BNP Levels and Prognostic Value Vary by Race/Ethnicity in Patients Hospitalized With Heart Failure? (2012) (0)
Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials: Inconsistent Outcome Reporting in HF RCTs. (2022) (0)
Abstract 10950: Real-World Practice of Reperfusion and Revascularization in Patients with St-Segment Elevation Myocardial Infarction in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project (2021) (0)
E-055 Patient characteristics, quality and outcomes after endovascular therapy for in-hospital ischemic stroke (2020) (0)
Abstract 17495: Achievement of Secondary Prevention Performance Measures in Patients with Coronary Artery Disease in Teaching and Non-Teaching Hospitals: Results from the Get With The Guidelines CAD Program (2010) (0)
AMONG OLDER HEART FAILURE (HF) PATIENTS WITH IN-HOSPITAL ACUTE KIDNEY INJURY (AKI), AN IMPROVEMENT IN KIDNEY FUNCTION IS ASSOCIATED WITH A HIGHER RISK OF POST-DISCHARGE MORTALITY BUT NOT READMISSION (2017) (0)
Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors among Medicare Beneficiaries Hospitalized for Heart Failure. (2021) (0)
Abstract TP306: Characteristics and Outcomes Among Patients Transferred to Regional Stroke Centers Across the United States for Specialized Stroke Care (2016) (0)
Abstract 16707: High versus Low-to-Moderate Intensity Statin Treatment and One-Year Clinical Outcomes Among Older Patients With Coronary Artery Disease (2014) (0)
Vasopeptidase inhibition in patients with heart failure. (2001) (0)
BURDEN OF 30-DAY READMISSIONS IN ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE IN THE UNITED STATES: A NATIONAL PERSPECTIVE (2017) (0)
Abstract 13006: High Use of Concomitant Antiplatelet Therapy with Oral Anticoagulation in Patients with Atrial Fibrillation: Results from the ORBIT-AF Registry (2012) (0)
Association between Sacubitril/Valsartan Initiation and Health Status Outcomes inHeart Failure with Reduced Ejection Fraction:Findings from the CHAMP-HF Registry (2018) (0)
Abstract 5: Differences in Stroke Care Among Patients in the REGARDS Study by Admission to a Hospital Participating versus Not Participating in GWTG-Stroke (2018) (0)
pooled individuals from 3 longstanding US cohorts — the REGARDS study ( Reasons for Geographic and Racial Differences in Stroke ) the MESA ( Multi-Ethnic Study of Atherosclerosis (2017) (0)
Elevated troponin I in heart failure: a marker for poor prognosis (2003) (0)
SMOKING AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) (2018) (0)
GENDER DIFFERENCES IN BASELINE CHARACTERISTICS, QUALITY OF CARE MEASURES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE DECOMPENSATED HEART FAILURE IN ASIA-PACIFIC AND LATIN AMERICA REGIONS: ANALYSIS OF THE ACUTE DECOMPENSATED HEART FAILURE INTERNATIONAL REGISTRY (ADHERE-INTERNATIONAL) (2012) (0)
BNP Levels in Outpatients with Heart Failure: Frequency of Assessment, Relationship to Symptoms, Disease Severity, and HF Quality of Care Measures (2009) (0)
Accepted Manuscript Characterization of Cardiac Injury During Acute Heart Failure and a Possible Target for Therapy (2014) (0)
Abstract 3595: Comparative Predictors of Mortality and Urgent Transplantation in Patients With Advanced Heart Failure (2009) (0)
Clinical significance of treatment of left ventricular dysfunction (2006) (0)
Abstract WMP2: Outcomes of Endovascular Therapy Following Interhospital Transfer (2018) (0)
Abstract 9: Post-Discharge Use of Statin and Lipid Testing After Myocardial Infarction (2016) (0)
Abstract 131: Impact of Concomitant Use of Antiplatelet and Anticoagulation Therapies on Outcomes in Patients With Intracerebral Hemorrhage (2018) (0)
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in Vha Heart Failure Patients by Ethnicity (2016) (0)
Abstract 17576: Readmission for Stroke and Quality of Care Among Patients Hospitalized With Transient Ischemic Attack (TIA): Findings From Get With the Guidelines (GWTG)-Stroke (2013) (0)
817-6 Delineation of the pericardiophrenic vein for optimal left ventricular lead placement (2004) (0)
Abstract 17009: Clinical Characteristics and In-hospital Outcomes of Cardiac Transplant Recipients With Allograft Vasculopathy Undergoing Percutaneous Coronary Intervention: Insights from the National Cardiovascular Data Registry (2014) (0)
Axial and Radial Diffusivity Measures Detect Brain Tissue Injury in Heart Failure Patients (2009) (0)
Use and Predictors of Heart Failure Disease Management Referral in Patients Hospitalized With Heart Failure: Insights from the American Heart Association – Get with the Guidelines Program (2010) (0)
tatin Therapy Is Associated With Improved urvival in Ischemic and Non-Ischemic Heart Failure (2016) (0)
Abstract 057: Understanding of Treatment Strategies Among Patients Newly Diagnosed With Atrial Fibrillation: Findings From SATELITTE (2017) (0)
Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction. (2021) (0)
Imaging Modality for Left Ventricular Ejection Fraction Estimation and Effect of Implantable Cardioverter Defibrillator on Mortality in Patients with Heart Failure. (2023) (0)
idlion of Improvement ' . ; rral for Heart Tra splantati (2016) (0)
Abstract 85: The Important Role of Drip and Ship Administration in Expanded Use of Thrombolytic Therapy in the United States (2015) (0)
Introduction to ACCORD-PMI: the Advisory Council on Care Optimization to Reduce Death Post-MI. (2008) (0)
CRT-800.17 National Estimate of 30-Day Readmission Rate and Associated Cost: A Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in the United States (2017) (0)
Abstract P34: Hospital Level Variation in Clinical Outcomes for Medicare Beneficiaries Hospitalized With Ischemic Stroke (2011) (0)
NON-INFERIORITY DESIGNS OVER THE LAST DECADE OF CONTEMPORARY CARDIOVASCULAR CLINICAL TRIALS (2016) (0)
Abstract 12291: Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Gastrointestinal Malignancy or Recent Bleeding (2018) (0)
BLOOD PRESSURE AND RISK FOR STROKE OR BLEEDING EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ORBIT AF STUDY (2015) (0)
SEX-RELATED VARIATIONS IN IN-HOSPITAL OUTCOMES IN PATIENTS WITH HEART FAILURE RECEIVING LEFT VENTRICULAR ASSIST DEVICES: FINDINGS FROM NATIONWIDE INPATIENT SAMPLE STUDY 2002-2012 (2016) (0)
IMPROVING HEART FAILURE CARE:Strategies for Increasing Utilization of Beta-Blockade. In-Hospital Initiation of Beta-Blocker Therapy for Heart Failure (2002) (0)
INITIATION OF LOOP DIURETIC THERAPY IS ASSOCIATED WITH A LOWER RISK OF 30-DAY ALL-CAUSE READMISSION IN PATIENTS WITH HEART FAILURE NOT RECEIVING DIURETICS PRIOR TO HOSPITALIZATION (2018) (0)
Abstract 8398: Trends in Clinical and Demographic Features of Patients with Acute Myocardial Infarction in the First Decade of the 21st Century. A Report from the American Heart Association Get-With-The-Guidelines Coronary Artery Disease Program (2011) (0)
Early Assessment and Treatment Acute Heart Failure Syndromes in Patients With Coronary Artery Disease (2009) (0)
SGLT-2-Inhibitors in Heart Failure (2020) (0)
Abstract 4206: Invasive Treatments for Obese Patients with CAD: An Explanation for the "Obesity Paradox"? Analysis of 130,139 Hospitalizations in Get With The Guidelines (2006) (0)
Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS (2012) (0)
Abstract 15556: Treatment Strategies and Outcomes in Patients With Chronic Hepatitis C Presenting With Acute Myocardial Infarction (2013) (0)
Medicare Hospital Outcome Measures and Unrelated Socioeconomic and Clinical Factors (2015) (0)
Abstract 20091: Instrumental Activities of Daily Living Impairment is an Independent Predictor of Incident Heart Failure, Acute Myocardial Infarction and All-Cause Mortality in Community-Dwelling Older Adults (2010) (0)
Abstract 14332: Factors Associated With Quality of Life in Atrial Fibrillation: Results From the ORBIT-AF Registry (2015) (0)
Cardiopulmonary bypass and thyroid hormone metabolism. Discussion (1993) (0)
Abstract W MP113: Type and Timing of Venous Thromboembolism Prophylaxis after Intracerebral Hemorrhage (2015) (0)
Abstract 15347: Symptom Status and Treatment Strategy in Contemporary Management of Atrial Fibrillation: Findings From the ORBIT-AF Registry (2011) (0)
Fifth Pivotal Research in Cardiology in the Elderly (PRICE-V) Symposium Preventive Cardiology in the Elderly (2011) (0)
Abstract P188: Quality of Care and Outcomes in Women Hospitalized for Heart Failure (2011) (0)
Abstract 17212: 30-day All-cause Readmission is Associated With a Significantly Higher Subsequent All-cause Mortality and Costly Readmissions Among Older Medicare Beneficiaries Hospitalized for Heart Failure (2015) (0)
Abstract 12458: Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease (2016) (0)
Abstract WP292: Changing Landscape of Stroke Systems of Care: Increase in Inter Hospital Transfer in the United States (2018) (0)
In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome Project. (2022) (0)
Abstract WMP92: Quality of Care and Outcomes for Acute Ischemic Stroke Patients Admitted During the International Stroke Conference (2017) (0)
Clinical and Research Considerations for Patients with Hypertensive Acute Heart Failure (2016) (0)
Abstract P384: Outcomes of Endovascular Therapy in Patients With Pre-Stroke Mobility Impairment (2021) (0)
Abstract 255: The Development of an Observational Registry of Treatment Patterns in US Heart Failure Patients with Reduced Ejection Fraction (HFrEF) (2016) (0)
Effect of Left Ventricular Diastolic Dysfunction on Incident Heart Failure and Mortality is Independent of Left Ventricular Geometry, Mass and Systolic Function (2010) (0)
Abstract 17: Racial and Ethnic Differences in Outcomes in Older Patients with Acute Ischemic Stroke (2013) (0)
Abstract 17325: Association of Risk Adjusted 30 Day Heart Failure Readmission Rates Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes: Findings From the American Heart Association Get With the Guidelines-Heart Failure Program (2016) (0)
Abstract 18345: Coronary Artery Disease With Acute Myocardial Infarction, but Not Without, is an Independent Risk Factors for Incident Heart Failure Among Community-Dwelling Older Adults (2013) (0)
Anemia, Kidney Disease, and Inpatient Outcomes for Heart Failure in California – 2000-2006 (2009) (0)
Abstract 10: Intracranial Hemorrhage Risks among Warfarin Treated Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy (2012) (0)
Predicting Heart Transplant Outcomes: Do We Have a Reliable Instrument to Assess Psychosocial Risk? (2014) (0)
Abstract TP305: International Comparison of Patient Characteristics and Performance Measures in Acute Ischemic Stroke: Analysis of the American Heart Association Get With the Guidelines-Stroke Registry and China National Stroke Registry (2016) (0)
Features and Hospital Outcomes for Nonadherent Patients with Heart Failure: Findings from GWTG-HF (2008) (0)
CHANGES IN HOSPITAL PERFORMANCE AND TRANSITION-CARE MEASURES 1-YEAR AFTER INITIATION OF THE PATIENT NAVIGATOR PROGRAM (2018) (0)
Admission Electrocardiogram Diagnosed Atrial Fibrillation is Independently Associated with 30-Day All-Cause Readmission in Older Medicare Beneficiaries Hospitalized for Heart Failure (2016) (0)
385 USE OF LIPID LOWERING THERAPY IS ASSOCIATED WITH IMPROVED HDL FUNCTION IN METABOLIC SYNDROME AND CORONARY HEART DISEASE PATIENTS, EVEN WITH COMPARABLE LDL, HDL, AND TRIGLYCERIDE LEVELS (2005) (0)
The Association of Metabolic Syndrome and Insulin Resistance with Incident Heart Failure is Independent of Each Other and Other Risk Factors including C-Reactive Protein (2010) (0)
Abstract 9193: Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From ASCEND-HF (2012) (0)
Arrhythmias in Hospitalized Heart Transplanted Patients: A United States National Study (2017) (0)
Abstract 207: Hospital Case Volume is Associated With Mortality in Patients Hospitalized With Subarachnoid Hemorrhage (2014) (0)
Abstract 18350: Impact of Amount vs Duration of Smoking on Incident Heart Failure and Mortality Among Community-dwelling Older Adults: Need to Reassess the Role of Pack-years as a Tool to Estimate Smoking (2015) (0)
Abstract T P399: Patient Characteristics and Outcomes in Pregnancy-Related Subarachnoid Hemorrhage (2015) (0)
Abstract 103: Intravenous Thrombolysis for In-Hospital Ischemic Stroke in the Endovascular Era: Findings From the National Get With the Guidelines-Stroke Registry (2020) (0)
Abstract P301: Are Variations in Delivery of Guideline Recommended Therapies by Cardiology Practices Reduced After Implementation of a Performance Improvement Initiative? Findings From IMPROVE HF (2011) (0)
Abstract 15590: Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Oral Anticoagulants (2017) (0)
Is the Association of Left Ventricular Geometry with Cardiovascular Outcomes Independent of Left Ventricular Mass (2010) (0)
Abstract 2288: Brain White Matter Abnormalities in Heart Failure (2006) (0)
Abstract 127: Differences in Care Patterns, Health Status, and Outcomes of Atrial Fibrillation in Patients With and Without Diabetes: Findings From the ORBIT-AF Registry (2017) (0)
ASSOCIATION BETWEEN ELEVATED B-TYPE NATRIURETIC PEPTIDE, DISEASE PROGRESSION, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ATRIAL FIBRILLATION (2018) (0)
CHARACTERISTICS OF HIGH-PERFORMING HOSPITALS FOR CARDIOGENIC SHOCK FOLLOWING ACUTE MYOCARDIAL INFARCTION (2022) (0)
What is the best measure for rewarding quality of care: Defect-free vs. composite scoring? An analysis from the American Heart Association's Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) Program (2007) (0)
Angiotensin receptor antagonist therapy fails to reduce heart failure mortality. (2002) (0)
DIFFERENCES IN MANAGEMENT AND OUTCOMES OF ST-ELEVATION MYOCARDIAL INFARCTION IN NURSING HOME VERSUS COMMUNITY-DWELLING OLDER PATIENTS: A PROPENSITY MATCHED STUDY (2014) (0)
PREDICTORS OF DEFECT-FREE COMPLIANCE WITH PROCESS MEASURES IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM GET WITH THE GUIDELINES CAD (2011) (0)
Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry. (2013) (0)
WEEKEND VERSUS WEEKDAY PRESENTATION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: FINDINGS FROM A UNITED STATES NATIONWIDE ANALYSIS (2017) (0)
Early International Normalized Ratio (INR) Monitoring and Long-Term Clinical Outcomes in Warfarin Users with Heart Failure: Findings from ADHERE Linked with Medicare Claims (2012) (0)
Abstract 228: National Prevalence of Substance Use Disorders Among Hospitalized Heart Failure Patients (2018) (0)
Abstract 20596: A Prospective Examination of the Obesity Paradox in Heart Failure: Insights from a Population Study (2010) (0)
Assessment and treatment of acute heart failure—Case study: Dry and warm profile (2004) (0)
650 Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From ASCEND-HF (2012) (0)
Title Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure Permalink (2006) (0)
Abstract 12637: Regional Differences in Management and Outcomes of Unstable Angina/Non-ST-Elevation Myocardial Infarction in the United States (2013) (0)
Retraction (2011) (0)
Evidence-Based Policy Making: Assessment of the American Heart Association’s Strategic Policy Portfolio A Policy Statement From the American Heart (2016) (0)
Reply: effect of ivabradine on early readmissions after hospitalization for worsening heart failure. (2015) (0)
Abstract 17301: Sleep Apnea is a Predictor of Incident Heart Failure in Community-Dwelling Older Adults: Findings from a Prospective Population Study (2010) (0)
Update on pharmacological advances. (2004) (0)
Abstract 21161: Use of an Open Access Multi-Sponsor Data Sharing Platform in Cardiology (2017) (0)
Results of the RISK Trial: Renal Function and Female Gender Are Strongly Associated with Early Response to Cardiac Resynchronization Therapy (2012) (0)
The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failure. (2013) (0)
SECONDHAND SMOKE IS LINKED TO HIGHER RISK OF NON-CARDIOVASCULAR MORTALITY BUT NOT OF CARDIOVASCULAR MORTALITY IN COMMUNITY-DWELLING OLDER ADULTS: FINDINGS FROM CARDIOVASCULAR HEALTH STUDY (CHS) (2018) (0)
Current Smoking and a “Non-Paradoxical” Association with Mortality among Community-Dwelling Older Heart Failure Patients: Findings From the Cardiovascular Health Study (2016) (0)
HIGH-DOSE BETA-BLOCKERS (BB) AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) AND HEART RATE ≥70 BEATS PER MINUTE (BPM) (2018) (0)
Acute coronary events as a trigger of sudden death in heart failure. (2001) (0)
ADHERENCE TO GUIDELINE RECOMMENDATIONS IN ATRIAL FIBRILLATION: FINDINGS FROM ORBIT-AF (2016) (0)
Abstract 1554: Is Exercise Adherence Associated With Clinical Outcomes in Patients With Advanced Heart Failure? (2009) (0)
Variation in HF Quality of Care among US Outpatient Practices: Analysis of 131 Cardiology Practices in IMPROVE HF (2007) (0)
Abstract 21189: High Diastolic Blood Pressure (DBP) and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Hypertension (HTN): Findings From Medicare-Linked OPTIMIZE-HF Registry (2017) (0)
DOES THE SMOKER'S PARADOX EXIST IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION? (2016) (0)
Clinical Characteristics and Outcomes for Hospitalized Heart Failure (HF) Patients with Chronic Obstructive Pulmonary Disease (COPD): Findings from OPTIMIZE-HF (2011) (0)
OUTCOMES OF CARDIAC CATH/PCI IN PATIENTS WITH AF: INSIGHTS FROM THE ORBIT II REGISTRY (2018) (0)
Abstract 9232: Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure (2012) (0)
Abstract 20752: Clinical Effectiveness of Digoxin in Hospitalized Older Patients With Heart Failure and Preserved Ejection Fraction: A Propensity-Matched Study of Medicare-Linked OPTIMIZE-HF (2016) (0)
Adverse Outcomes With Use of Hydralazine and Nitrate Combination Therapy in Hospitalized Older Non-black Patients With Heart Failure and Reduced Ejection Fraction (HFREF) (2017) (0)
Abstract WMP90: Comparison of Acute Ischemic Stroke Care Between Comprehensive Stroke Centers and Primary Stroke Centers Participating in Get With the Guidelines-Stroke (2018) (0)
Abstract 102: The Association of Patient Navigator Program Features and Hospital Strategies with Processes and Outcome Metrics in Acute Myocardial Infarction and Heart Failure (2019) (0)
Opportunities for Improving Global Cardiovascular Quality of Care and Outcomes (2014) (0)
257 HIGH TEMPORAL RESOLUTION BREATH-HOLD CINE MAGNETIC RESONANCE IMAGING CORRELATES WITH TISSUE DOPPLER IMAGING IN REVEALING VENTRICULAR DSSYNCHRONY IN HEART FAILURE. (2006) (0)
Abstract 10131: Baseline Characteristics, Quality of Care, and Short-Term outcomes of Young Patients Presenting with ST-Segment Elevation Myocardial Infarction: Insight from the Get With the Guidelines CAD Registry (2010) (0)
The Effect of Obesity on Sympathetic Activation in Heart Failure (2008) (0)
Abstract TMP19: Intravenous Recombinant Tissue-type Plasminogen Activator Use in Young Adults With Acute Ischemic Stroke (2017) (0)
Abstract 19100: Medication Initiation Burden Required to Comply with Hospital Quality Measures for Heart Failure (2014) (0)
Disease-Based Registries in Improving Quality and Outcomes Synthesizing Lessons Learned From Get With The Guidelines: The Value of (2013) (0)
ANTIPLATELET THERAPY PRESCRIPTION PATTERNS AND ASSOCIATIONS WITH CLINICAL OUTCOMES IN MEDICARE BENEFICIARIES WITH ATRIAL FIBRILLATION PRESCRIBED NO ORAL ANTICOAGULATION AFTER ACUTE ISCHEMIC STROKE (2019) (0)
Abstract 18703: Impact of the 2014 Atrial Fibrillation Guideline on the Proportion of Patients Recommended for Oral Anticoagulation (2014) (0)
Patient Characteristics That Predict Failure to Achieve Target Beta Blocker Dosing in Heart Failure with Reduced Ejection Fraction Patients (2016) (0)
Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials (2018) (0)
CLINICAL EFFECTIVENESS OF SPIRONOLACTONE IN HOSPITALIZED OLDER ELIGIBLE (EF LESS THAN OR EQUAL TO 35% AND EGFR GREATER THAN OR EQUAL TO 30 ML/MIN/1.73 M2) PATIENTS WITH HEART FAILURE (2017) (0)
Abstract 15447: Trends in Use of Pulmonary Artery Catheterization in Heart Failure in the United States, 2006 - 2012 (2015) (0)
Abstract 227: Prescribing Warfarin at Discharge for Heart Failure Patients without Atrial Fibrillation Findings from the Get With The Guidelines-Heart Failure Registry (2013) (0)
Abstract 30: Door-to-puncture and First Pass Times for Endovascular Thrombectomy: Predictors and Changes Over Time in GWTG-stroke (2017) (0)
Transient and Persistent Worsening Renal Function during Acute Heart Failure Hospitalization: Insights from the ADHERE Registry Linked to Medicare Claims (2014) (0)
Abstract 16757: Early Ambulation Among Hospitalized Heart Failure Patients is Associated With Decreased Length of Stay and Higher Rates of Discharge to Home (2016) (0)
Abstract 15673: 30-Day Outcomes Associated With Atrial Fibrillation in Patients With Heart Failure and Reduced and Preserved Ejection Fraction (2013) (0)
Statins Do Not Significantly Affect Muscle Sympathetic Nerve Activity in Humans with Non-Ischemic Heart Failure (2009) (0)
Top Ten Things To Know Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke (2012) (0)
Rapid Reperfusion Therapy in Acute Ischemic Stroke Reduces Complications and Improves Outcomes (2014) (0)
251 Coronary angiography, subsequent use of medical therapy/revascularization, and survival in acute heart failure: a report from OPTIMIZE‐HF (2008) (0)
Abstract 15680: Sinus Node Dysfunction in Associated With Higher Symptom Burden and Increased Risk of Progression to Permanent Atrial Fibrillation: Results From ORBIT-AF Registry (2014) (0)
Abstract 14951: Use of Aldosterone Antagonists at Discharge after Myocardial Infarction: Results from the NCDR (2012) (0)
PRE-HEART-TRANSPLANT DEPRESSION IS ASSOCIATED WITH LOWER RISK OF IN-HOSPITAL MORTALITY: A PARADOX, CONFOUNDING, OR UNDERDIAGNOSIS PHENOMENA? FINDINGS FROM A US NATIONAL STUDY (2014) (0)
NUISANCE BLEEDING IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT OF ATRIAL FIBRILLATION (ORBIT-AF) (2017) (0)
Abstract 165: Age Related Variations in Improvement in Door-to-Needle Times in Acute Ischemic Stroke: Findings From Target: Stroke Phase I (2016) (0)
Abstract 21191: Low Diastolic Blood Pressure (DBP) and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Hypertension (HTN): Findings From Medicare-Linked OPTIMIZE-HF Registry (2017) (0)
SERUM MAGNESIUM LEVELS AND POSTDISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR HEART FAILURE: INSIGHTS FROM THE EVEREST TRIAL (2013) (0)
COMPARISON OF HOSPITAL PERFORMANCE OF ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE QUALITY MEASURES: FINDINGS FROM THE GET WITH THE GUIDELINES REGISTRY (2010) (0)
Impact of health insurance status on outcome in patients with advanced heart failure referred for heart transplantation (1998) (0)
Abstract 18707: Do Patients with Heart Failure and Atrial Fibrillation Adhere to Warfarin After Hospital Discharge? Findings from the Get With The Guidelines-Heart Failure Registry and Medicare Linked Database (2012) (0)
Heart, Lung, and Blood Institute Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and (2006) (0)
Abstract 6239: The Impact of Hospital Primary Angioplasty Volume in ST-Elevation Myocardial Infarction on Quality and Outcomes: Insights from Get With The Guidelines (2008) (0)
Abstract 17432: Association of Hospital Excess Readmission Ratio With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the NCDR ACTION Registry-GWTG (2016) (0)
Abstract 214: Strict versus Lenient versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure: Findings From the Get With the Guidelines - Heart Failure Program (2018) (0)
ASSOCIATION OF PRE-EXISTING MEDICAL COMORBIDITY WITH SHORT-TERM MORTALITY IN TAKOTSUBO CARDIOMYOPATHY (2019) (0)
Abstract 15946: Heart Failure With Preserved Ejection Fraction (HFpEF) and Atrial Fibrillation (AF) is Prognostically Equivalent to HF With Reduced Ejection Fraction (HFrEF) With or Without AF Among Community-Dwelling Older Adults (2014) (0)
Process Measures, Outcome Measures, and Heart Failure—Reply (2010) (0)
NON VITAMIN K ORAL ANTICOAGULANTS ARE NOT ASSOCIATED WITH INCREASED RISK OF PERIOPERATIVE BLEEDING IN PATIENTS UNDERGOING CARDIAC SURGERY (2019) (0)
Depressed Regional Circumferential Strain Is Associated with Increased BNP in Heart Failure (2006) (0)
Abstract 22: Affordable Care Act Medicaid Expansion Then and Now: Racial/Ethnic Differences in Receipt of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations (2020) (0)
TCT-432 Association of Primary Insurance Status with Use of Revascularization and In-hospital Outcomes in Patients with Non-ST-segment Elevation Myocardial Infarction in the United States (2017) (0)
Differential Association of Insulin Resistance and Metabolic Syndrome With Acute Myocardial Infarction and All-Cause Mortality in Older Adults (2010) (0)
Characteristics Associated With Facebook Use and Interest in Digital Disease Support Among Older Adults With Atrial Fibrillation: Cross-Sectional Analysis of Baseline Data From the Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF) Cohort (e15320) (2020) (0)
Abstract WP46: Patient Characteristics, Quality and Outcomes After Endovascular Therapy for In-Hospital Ischemic Stroke (2020) (0)
Abstract W MP106: Clinical Effectiveness of Anticoagulation with Warfarin among Ischemic Stroke Patients with Atrial Fibrillation: Findings from the Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2015) (0)
Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia Heart Failure (2008) (0)
Abstract 17152: Frequency and Management of Major Bleeding in Atrial Fibrillation Patients Treated With Warfarin and Non-vitamin K Oral Anticoagulants in Community Practice: Results From the ORBIT-AF II Registry (2015) (0)
Abstract 22: Association of Hospital Race and Payer Mix With Inpatient Mortality Among Patients Admitted for Acute Coronary Syndrome, Heart Failure and Arrhythmia (2018) (0)
Abstract TP351: Early Comfort Care Measures in Acute Stroke Patients: Analysis From the Get With the Guidelines Stroke Registry (2016) (0)
5 6 Developed in Collaboration With the American Academy of Family Physicians, American College 7 of Chest Physicians, Heart Rhythm Society and International Society for Heart and Lung (2013) (0)
TRENDS IN INCIDENCE AND OUTCOMES OF POSTINFARCTION INTRACARDIAC MURAL THROMBUS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: FINDINGS FROM THE NATIONWIDE INPATIENT SAMPLE 2003-2011 (2015) (0)
Abstract 174: Comparison of Performance Measures and 30-Day Patient Outcomes among Hospitals that Do and Do not Participate in ACTION Registry- Get With The Guidelines (2013) (0)
Abstract 10: Pre-stroke Antithrombotic Therapy and Stroke Severity in Acute Ischemic Stroke Patients with Atrial Fibrillation (2016) (0)
Abstract 11525: Physical Activity and Incident Heart Failure in Community Dwelling Older Adults with and without Metabolic Syndrome (2011) (0)
Abstract 1293: Antithrombotic Therapy at Hospital Discharge Performance Measure in Ischemic Stroke and Clinical Outcomes (2009) (0)
Abstract 283: Association of Body Mass Index with Outcomes in Patients with Atrial Fibrillation: Results From the ORBIT-AF Registry (2015) (0)
Abstract P246: Hospital Acquired Pneumonia and Dysphagia Screening in Patients With Acute Ischemic Stroke: Findings From Get With the Guidelines-Stroke (2011) (0)
Reliability of Heart Failure Patient Care: Initial Results from the American Heart Association's Get With The Guidelines (GWTG) Heart Failure Program (2006) (0)
CHRONIC ALPHA BLOCKER USE AND OUTCOMES IN OLDER MALE MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2017) (0)
Abstract TMP36: Disability, Quality of Life and Institutionalization After Inpatient Rehabilitation and Skilled Nursing Facility Care for Ischemic Stroke Patients (2016) (0)
Novel Plasma Biomarker Candidates in Patients With Congestive Heart Failture (2010) (0)
IMPACT OF SEVERE DYSPNEA ON OUTCOMES AND HEALTH CARE COSTS IN PATIENTS HOSPITALIZED WITH HEART FAILURE (2014) (0)
Abstract W P272: Healthcare Resource Availability, Acute Ischemic Stroke Outcomes and Quality of Care (2015) (0)
Abstract W P269: High vs. Moderate-intensity Statin Therapy After Ischemic Stroke: Findings from PROSPER (2015) (0)
Abstract 17428: Discharge Prescriptions for Spironolactone and 30-day All-cause Readmission in Hospitalized Medicare Beneficiaries With Heart Failure, LVEF Less Than 45% and eGFR Less Than 45 (2013) (0)
DISCHARGE HOME HEALTH REFERRAL IS ASSOCIATED WITH HIGHER POST-DISCHARGE 30-DAY ALL-CAUSE READMISSION AND ALL-CAUSE MORTALITY AMONG OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2016) (0)
Abstract 17834: Incident Cardioversion is Associated with Reduced Mortality among Older Adults with Atrial Fibrillation: Insights from the AFFIRM Trial (2010) (0)
Neurohumoral Modulators in Heart Failure (2005) (0)
Abstract 17225: Therapeutic Strategies Following Major Bleeding in Atrial Fibrillation: Findings From ORBIT-AF (2015) (0)
Abstract TMP9: Hospitals' Performance on Timely Reperfusion in Stroke and Myocardial Infarction is not Correlated (2016) (0)
Outpatient Documentation of NYHA Functional Class and/or Activity Level in HF Patients: A Report from IMPROVE HF (2007) (0)
Comparison of Medical Treatment in Outpatients Receiving Device Therapy for Systolic Dysfunction: A Report from IMPROVE HF (2008) (0)
Abstract 15956: Triple Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and History of Coronary Artery Disease: Insights From the ORBIT-AF Registry (2013) (0)
Abstract 18273: Frailty and Mortality in Older Patients With Acute Myocardial Infarction: Observations From the NCDR ACTION Registry-GWTG (2017) (0)
Abstract 173: Patterns and Predictors of Emergency Medical Services Pre-Notification of Potential Stroke Cases in the United States: Findings from GWTG-Stroke (2012) (0)
Abstract 130: Deep Vein Thrombosis/Pulmonary Embolization in the Get With The Guidelines-Stroke Acute Ischemic Stroke Population: Incidence and Patterns of Prophylaxis (2012) (0)
Abstract 272: Association of Renal Insufficiency With Outcomes of Percutaneous Coronary Intervention (2015) (0)
Abstract 16863: Racial Differences in Atrial Fibrillation Prevalence and Anticoagulation Use (2012) (0)
Abstract 17293: Outcomes and Temporal Trends of Percutaneous Coronary Intervention at Centers With and without On-site Cardiac Surgery in the United States (2016) (0)
Abstract 12: Heart Failure Medications Prescribed at Discharge for Patients With Left Ventricular Assist Devices (2016) (0)
ASSOCIATIONS OF SYSTOLIC BLOOD PRESSURE (SBP) <120 (VERSUS 120-139) MMHG WITH OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) WITHOUT HYPERTENSION (HTN) (2018) (0)
The University of California at Los Angeles experience in heart transplantation. (1995) (0)
Journal Pre-proof Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations in COVID-19 Pandemic, 2020 (2022) (0)
Abstract 200: Is Risk-standardized In-hospital Stroke Mortality an Adequate Proxy for Risk-standardized 30-day Stroke Mortality Data? Findings From the GWTG-Stroke Program (2017) (0)
Abstract 7: Risk of Intracranial Hemorrhage Among Acute Ischemic Stroke Patients Receiving Prior Antiplatelet Therapy and Treated with Intravenous Tissue Plasminogen Activator (2014) (0)
USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF (2019) (0)
pidemiology of Dialysis atients and Heart Failure Patients (2006) (0)
Diabetes is Associated with Worse In-Hospital and 30-Day Post-Discharge Morbidity in Patients with Heart Failure with Preserved Ejection Fraction: Findings from the Get With The Guidelines Heart Failure Registry (2018) (0)
Influence on the American Heart Association's Get With the Guidelines (GWTG) heart failure program on the quality of care for patients hospitalized with heart failure (2006) (0)
Comparison of Survival between Pediatric and Adult Patients after Biventricular Assist Device Implantation: Analysis of the UNOS Database (2014) (0)
QUALITY OF CARE AND OUTCOMES IN 5,339 PATIENTS AGED 80 OR ABOVE PRESENTING WITH ST-ELEVATION MYOCARDIAL INFARCTION: ANALYSIS FROM AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES: CORONARY ARTERY DISEASE (2011) (0)
Abstract 18059: Clinical Profile and Prognostic Significance of Post-Discharge Hemodilution Among Patients Hospitalized for Heart Failure: Insights From the EVEREST Trial (2017) (0)
Response to Letter Regarding Article, "Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure. (2016) (0)
Testing a Dietary Intervention Called parts per thousand Pro-Heartt" to Reduce Adiposity and Enhance Cardiac Structure, Functional Status, Lipid Profiles, Glycemic Control, and Quality Of Life in Obese, Diabetic Patients with Advanced Heart Failure (2012) (0)
Non-ST-Segment Elevation Acute Coronary Syndrome Mortality: An Analysis of B-Type Natriuretic Peptide and Cardiac Troponin (2005) (0)
Abstract 203: Use of Endovascular Therapy and Trends in Clinical Outcomes within the Nationwide Get With The Guidelines-Stroke Registry (2015) (0)
Abstract P133: Geospatial Mapping of Prehospital Delay in Acute Ischemic Stroke and Association With Social Vulnerability (2021) (0)
Abstract P83: Predictors of Length of Stay for HF Patients: Results from Get With the Guidelines (2011) (0)
Abstract 5595: Secondary Prevention Performance Measures in Acute Coronary Syndrome Patients with Prior Monovascular or Polyvascular Atherosclerosis in the Get with the Guidelines Database (2008) (0)
TCT-440 Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Prior Coronary Artery Bypass Grafting: Trends in Utilization and a Propensity-Score Matched Analysis of In-hospital Outcomes (2017) (0)
CHAGAS HEART DISEASE: A UNITED STATES NATIONAL STUDY (2017) (0)
Abstract P252: Discharge Antithrombotic Therapy for Ischemic Stroke Patients With Prior Aspirin Failure (2021) (0)
Abstract 11785: National Hospitalizations for Supraventricular Tachycardia in the United States, 2010 Through 2017 (2021) (0)
Abstract 18258: Mild Aortic Regurgitation and Increased Risk of Incident Heart Failure among Community-Dwelling Older Adults: Findings from a Prospective Population Study (2010) (0)
Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women". (2016) (0)
Abstract 278: Trends in Prescribing Patterns for Patients Hospitalized With Heart Failure With Preserved Ejection Fraction Before and After Clinical Trial Presentation (2018) (0)
Abstract 152: Persistence of Warfarin versus Dabigatran Therapy in Patients with Atrial Fibrillation: Results from the ORBIT AF Registry (2015) (0)
Abstract 17: Association Between Pre-stroke Depression and Patient Reported Outcomes After Acute Ischemic Stroke (2018) (0)
FACTORS ASSOCIATED WITH IMPROVEMENT IN GUIDELINE-BASED USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ELIGIBLE HEART FAILURE PATIENTS BY IMPLEMENTING A PRACTICE-BASED PERFORMANCE IMPROVEMENT INTERVENTION: RESULTS FROM IMPROVE HF (2011) (0)
Abstract 10215: Predictors of Cause-Specific Hospitalization in US Outpatients With Atrial Fibrillation: Results From the ORBIT-AF Study (2013) (0)
Abstract 18877: The Scope of Sacubitril/Valsartan Eligibility Post-Heart Failure Hospitalization: Findings From the Get With the Guidelines-Heart Failure Registry (2016) (0)
Towards Health Equity, presented by HRS RACIAL AND ETHNIC INEQUITIES IN ORAL ANTICOAGULATION AND ASSOCIATED OUTCOMES FOR PATIENTS WITH ATRIAL FIBRILLATION - THE GET WITH THE GUIDELINES ATRIAL FIBRILLATION REGISTRY (2022) (0)
Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States (2022) (0)
Abstract 15192: Implementation of the Hospital Readmissions Reduction Program, Readmissions, and Mortality in Heart Failure (2017) (0)
Improved Clinical Outcomes in Medicare Beneficiaries with Acute Ischemic Stroke during Initial Implementation of the Get with the Guidelines-Stroke Program 2003-2008 (IN2-2.002) (2012) (0)
The reply. (2014) (0)
Abstract T P313: Sex-age Interactions and Differences in Outcomes After Intracerebral Hemorrhage (2015) (0)
Error in Conflicts of Interest Disclosures. (2017) (0)
Abstract 206: Pre-notification by Emergency Medical Services is Associated with More Timely Evaluation and Treatment of Acute Ischemic Stroke (2012) (0)
CQ & CORE 心不全心不全患者では太っているほうが予後良好なのか? (2013) (0)
Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction. (2022) (0)
Patients With Biventricular Mechanical Support Can Be Safely Discharged to Home To Await Heart Transplant (2012) (0)
Prevalence and Characteristics of Prolonged QRS Duration in Outpatients with Left Ventricular Systolic Dysfunction: An IMPROVE HF Analysis (2009) (0)
285 Contemporary Use of Renin-Angiotensin System Blockers in Acute Coronary Syndromes: Findings From Get With The Guidelines-Coronary Artery Disease Program (2012) (0)
Abstract WP381: Cryptogenic Stroke: Contemporary Characteristics, Treatments, and Outcomes in the United States (2019) (0)
Heart Failure/Transplantation Cost-Effectiveness of Screening With B-Type Natriuretic Peptide to Identify Patients With Reduced Left Ventricular Ejection Fraction (2004) (0)
Abstract 197: Root Cause Analysis of 30-day Heart Failure Readmission Elucidates Acute Kidney Injury as a Common Offender (2017) (0)
Renin-Angiotensin system antagonists and mortality in patients with heart failure. (2013) (0)
Abstract 12927: Concurrent Pneumonia has no Association With 30-Day All-Cause or Heart Failure Readmissions but is Associated With Higher 30-Day Pneumonia Readmission and MayBe Associated With Higher 30-Day All-Cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure (2015) (0)
Abstract 15883: Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized With Heart Failure (2017) (0)
Abstract WP375: Quality of Care and In-Hospital Outcomes by Race and Ethnicity among Patients Hospitalized with Intracerebral Hemorrhage: Findings from 123,623 Patients in the Get With The Guidelines-Stroke Program (2013) (0)
ASSOCIATION OF CHRONIC KIDNEY DISEASE WITH USE OF REVASCULARIZATION AND IN-HOSPITAL MORTALITY IN PATIENTS WITH CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION (2018) (0)
Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein ≥190 mg/dL (2017) (0)
Association of Chronic Renal Insufficiency With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement (2017) (0)
Holding the Readmission Gates: Incentivizing Quality and Cost-Effective Care for Heart Failure. (2017) (0)
Effect ofMedication Copayment Vouchers on P 2 Y 12 Inhibitor Use andMajor Adverse Cardiovascular Events Among Patients WithMyocardial Infarction The ARTEMIS Randomized Clinical Trial (2018) (0)
GW29-e1086 Prescription of dabigatran and rivaroxaban at discharge for atrial fibrillation patients with different classes of renal function: Findings from the CCC- atrial fibrillation project (2018) (0)
Abstract 35: Safety and Outcomes of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Stroke: Findings From Get With the Guidelines-Stroke (2019) (0)
Abstract 12095: Altered Brain Functional Connectivity During Valsalva Maneuver in Heart Failure (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gregg C. Fonarow?

Gregg C. Fonarow is affiliated with the following schools:

Gregg C. Fonarow's Academic­Influence.com Rankings

Why Is Gregg C. Fonarow Influential?

Gregg C. Fonarow's Published Works

Published Works

What Schools Are Affiliated With Gregg C. Fonarow?

Gregg C. Fonarow's AcademicInfluence.com Rankings